data_1ckw_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1ckw _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.441 ' O ' ' CG2' ' A' ' 4' ' ' THR . 11.6 t . . . . . 0 N--CA 1.49 1.551 0 CA-C-O 121.379 0.609 . . . . 0.0 109.359 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.448 ' O ' HG12 ' A' ' 9' ' ' ILE . 70.9 mt -93.76 -39.2 10.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.33 -0.856 . . . . 0.0 109.61 -179.858 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.54 -41.89 12.43 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.253 -0.905 . . . . 0.0 109.272 179.912 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.459 ' HA ' HD13 ' A' ' 10' ' ' ILE . 16.6 tp10 -59.41 -15.44 16.96 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.311 -0.868 . . . . 0.0 109.382 179.881 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -87.84 -42.62 12.42 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.25 -0.906 . . . . 0.0 109.388 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.448 HG12 ' O ' ' A' ' 5' ' ' ILE . 23.9 mm -61.64 -40.62 87.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.225 -0.922 . . . . 0.0 109.191 179.827 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.459 HD13 ' HA ' ' A' ' 7' ' ' GLU . 15.2 mt -48.89 -30.95 3.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.235 -0.916 . . . . 0.0 108.882 179.593 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -86.51 -33.78 13.01 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.531 -1.427 . . . . 0.0 109.531 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 44.1 t -70.25 -37.64 71.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.225 -1.162 . . . . 0.0 109.415 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -76.49 -42.8 42.21 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.223 -0.923 . . . . 0.0 109.431 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.403 ' HB2' ' O ' ' A' ' 10' ' ' ILE . 0.2 OUTLIER -49.03 -22.33 0.87 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.304 -0.873 . . . . 0.0 109.397 179.837 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.481 ' O ' ' HB2' ' A' ' 19' ' ' TYR . 1.7 t70 -94.67 -56.89 2.63 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.211 -0.93 . . . . 0.0 109.686 -179.906 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.494 ' O ' ' N ' ' A' ' 20' ' ' ARG . 0.9 OUTLIER -46.12 -39.9 10.19 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.275 -0.89 . . . . 0.0 109.046 -179.943 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.605 ' CG ' ' N ' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -65.82 -56.38 12.2 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 108.674 -0.861 . . . . 0.0 108.674 179.536 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.605 ' N ' ' CG ' ' A' ' 17' ' ' TYR . 2.3 ttt-85 -67.49 -1.55 5.1 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.656 -0.652 . . . . 0.0 109.467 179.66 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . 0.593 ' HA ' ' CG1' ' A' ' 22' ' ' VAL . 6.1 m-85 -119.63 -8.6 9.93 Favored 'General case' 0 C--N 1.308 -1.221 0 CA-C-O 121.616 0.722 . . . . 0.0 109.066 -179.725 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.494 ' N ' ' O ' ' A' ' 16' ' ' GLU . 6.8 ttt-85 -64.34 -45.39 88.05 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.562 -0.712 . . . . 0.0 111.648 -178.19 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 3.5 t -127.85 48.8 2.21 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.697 -1.252 . . . . 0.0 110.609 -178.234 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.593 ' CG1' ' HA ' ' A' ' 19' ' ' TYR . 0.6 OUTLIER -138.06 -37.42 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.759 0 O-C-N 121.433 -0.792 . . . . 0.0 109.921 -179.29 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.53 ' CD1' ' O ' ' A' ' 19' ' ' TYR . 5.1 mt . . . . . 0 N--CA 1.489 1.517 0 O-C-N 121.134 -0.979 . . . . 0.0 109.598 -179.383 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 13.3 t . . . . . 0 N--CA 1.491 1.623 0 CA-C-O 121.18 0.514 . . . . 0.0 109.745 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 20.8 mm -65.25 -16.44 20.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.195 -0.94 . . . . 0.0 109.663 -179.803 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -128.42 -28.11 2.58 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.133 -0.98 . . . . 0.0 109.945 -179.738 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -82.62 -29.06 30.37 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.127 -0.983 . . . . 0.0 109.767 -179.805 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 4.3 t-20 -67.39 -49.1 65.32 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.107 -0.996 . . . . 0.0 109.238 179.776 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.44 HG21 HD11 ' A' ' 9' ' ' ILE . 47.5 mm -57.53 -37.88 60.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.305 -0.872 . . . . 0.0 109.348 179.909 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.417 ' O ' ' N ' ' A' ' 14' ' ' TYR . 56.7 mt -53.5 -44.77 57.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.201 -0.937 . . . . 0.0 108.75 179.662 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.459 ' O ' ' HB2' ' A' ' 15' ' ' ASP . . . -69.32 -13.41 67.58 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 108.943 -1.663 . . . . 0.0 108.943 179.426 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 55.1 t -98.32 -12.38 8.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.406 -1.056 . . . . 0.0 109.169 179.675 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.432 ' O ' ' HB3' ' A' ' 17' ' ' TYR . 23.2 p -120.64 -34.48 3.58 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.272 -0.892 . . . . 0.0 109.505 -179.823 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.417 ' N ' ' O ' ' A' ' 10' ' ' ILE . 1.8 t80 -77.26 -42.78 35.77 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.201 -0.937 . . . . 0.0 109.33 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.459 ' HB2' ' O ' ' A' ' 11' ' ' GLY . 3.1 m-20 -62.13 -54.35 42.49 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.218 -0.926 . . . . 0.0 109.103 179.83 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.45 ' O ' ' N ' ' A' ' 20' ' ' ARG . 1.6 tt0 -54.92 -43.86 73.7 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.204 -0.935 . . . . 0.0 108.891 179.58 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.526 ' CG ' ' N ' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -61.03 -58.31 8.96 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 179.159 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.526 ' N ' ' CG ' ' A' ' 17' ' ' TYR . 5.3 ttm180 -58.78 -14.92 10.03 Favored 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 108.898 -0.779 . . . . 0.0 108.898 179.455 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . 0.53 ' HA ' ' CG1' ' A' ' 22' ' ' VAL . 3.1 m-85 -97.42 -27.63 14.37 Favored 'General case' 0 C--N 1.307 -1.252 0 O-C-N 121.462 -0.774 . . . . 0.0 109.709 -179.629 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.45 ' N ' ' O ' ' A' ' 16' ' ' GLU . 0.0 OUTLIER -65.96 -10.56 40.39 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.184 -0.948 . . . . 0.0 109.999 -179.353 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 5.5 t -111.16 14.91 21.77 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.032 -1.043 . . . . 0.0 109.436 179.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.53 ' CG1' ' HA ' ' A' ' 19' ' ' TYR . 0.1 OUTLIER -146.75 -39.94 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.594 0 O-C-N 121.549 -0.72 . . . . 0.0 109.447 -178.299 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 5.4 mm . . . . . 0 N--CA 1.488 1.439 0 O-C-N 121.203 -0.935 . . . . 0.0 109.494 -179.677 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 4.2 t . . . . . 0 N--CA 1.493 1.675 0 N-CA-C 109.26 -0.645 . . . . 0.0 109.26 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.417 HG21 ' O ' ' A' ' 5' ' ' ILE . 52.4 mt -75.06 -16.97 16.1 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.474 0 O-C-N 121.444 -0.785 . . . . 0.0 109.419 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 9.3 pttt -107.02 -30.5 8.78 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.265 -0.897 . . . . 0.0 109.468 179.828 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -62.23 -22.29 65.84 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.19 -0.944 . . . . 0.0 109.195 179.831 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 12.3 t-20 -80.73 -52.25 7.74 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.265 -0.897 . . . . 0.0 109.297 179.864 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.505 ' O ' ' N ' ' A' ' 12' ' ' VAL . 41.2 mm -63.14 -45.93 97.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.307 -0.871 . . . . 0.0 109.481 179.927 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 48.0 mt -47.8 -29.17 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.138 -0.976 . . . . 0.0 109.074 179.883 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -81.63 -23.88 57.23 Favored Glycine 0 N--CA 1.489 2.172 0 N-CA-C 109.157 -1.577 . . . . 0.0 109.157 179.583 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.505 ' N ' ' O ' ' A' ' 9' ' ' ILE . 75.6 t -65.02 -33.85 66.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.45 -1.029 . . . . 0.0 109.335 179.721 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -75.1 -30.76 60.98 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.227 -0.92 . . . . 0.0 109.329 179.77 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -56.76 -45.72 81.86 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.292 -0.88 . . . . 0.0 109.389 179.846 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.564 ' HB3' ' CE2' ' A' ' 19' ' ' TYR . 67.9 m-20 -55.91 -45.65 78.61 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.271 -0.893 . . . . 0.0 109.211 179.809 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -51.16 -42.5 60.84 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.338 -0.851 . . . . 0.0 108.768 179.507 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.533 ' CD1' ' C ' ' A' ' 17' ' ' TYR . 0.0 OUTLIER -64.66 -62.32 1.65 Allowed 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 179.261 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.523 ' N ' ' CG ' ' A' ' 17' ' ' TYR . 0.0 OUTLIER -54.42 -20.08 6.8 Favored 'General case' 0 C--N 1.303 -1.413 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 179.321 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . 0.564 ' CE2' ' HB3' ' A' ' 15' ' ' ASP . 4.6 m-30 -88.25 -22.32 24.01 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 179.631 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.463 ' O ' ' HG3' ' A' ' 20' ' ' ARG . 24.3 tpp180 -67.18 -18.45 65.27 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.335 -0.853 . . . . 0.0 110.107 -179.439 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 4.1 t -105.8 16.51 25.13 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.993 -1.067 . . . . 0.0 109.832 -179.734 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.511 ' CG1' ' O ' ' A' ' 18' ' ' ARG . 0.1 OUTLIER -149.58 -44.83 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.298 -1.639 0 O-C-N 121.333 -0.854 . . . . 0.0 109.837 -178.461 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.469 HG13 ' HB3' ' A' ' 19' ' ' TYR . 11.5 mm . . . . . 0 N--CA 1.487 1.41 0 O-C-N 121.083 -1.011 . . . . 0.0 109.96 -179.431 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 4.1 t . . . . . 0 N--CA 1.491 1.61 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.487 ' N ' HD12 ' A' ' 5' ' ' ILE . 3.3 mm -84.49 -12.08 11.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.32 -0.863 . . . . 0.0 109.547 -179.82 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -113.94 -22.09 10.28 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.27 -0.894 . . . . 0.0 109.436 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 4.9 tm-20 -86.42 -11.77 50.98 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.29 -0.881 . . . . 0.0 109.578 -179.745 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 18.0 t-20 -95.92 -49.18 5.41 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.245 -0.909 . . . . 0.0 109.355 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 49.1 mm -62.13 -34.96 66.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.284 -0.885 . . . . 0.0 109.541 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.409 ' O ' ' HB2' ' A' ' 14' ' ' TYR . 10.4 tt -49.41 -35.1 8.44 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 O-C-N 121.234 -0.916 . . . . 0.0 109.15 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.493 ' O ' ' N ' ' A' ' 15' ' ' ASP . . . -76.21 -39.92 30.5 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 109.059 -1.616 . . . . 0.0 109.059 179.666 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.464 ' O ' ' HB2' ' A' ' 16' ' ' GLU . 55.2 t -54.22 -32.7 23.94 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.319 -1.106 . . . . 0.0 109.066 179.581 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -96.08 -5.47 40.82 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.365 -0.835 . . . . 0.0 109.204 179.762 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.434 ' O ' ' CD2' ' A' ' 17' ' ' TYR . 1.8 m-85 -111.35 -56.32 2.39 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.22 -0.925 . . . . 0.0 109.382 179.917 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.493 ' N ' ' O ' ' A' ' 11' ' ' GLY . 14.3 t70 -58.4 -46.16 86.95 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.054 -1.029 . . . . 0.0 109.176 179.832 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.464 ' HB2' ' O ' ' A' ' 12' ' ' VAL . 1.9 tp10 -56.83 -48.43 78.04 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.268 -0.895 . . . . 0.0 109.221 179.774 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.62 ' CG ' ' N ' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -55.54 -55.8 27.75 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 179.404 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.62 ' N ' ' CG ' ' A' ' 17' ' ' TYR . 0.0 OUTLIER -58.93 -15.08 11.13 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 108.963 -0.755 . . . . 0.0 108.963 179.59 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . 0.575 ' HA ' ' CG1' ' A' ' 22' ' ' VAL . 3.1 m-85 -102.83 -16.2 16.0 Favored 'General case' 0 C--N 1.305 -1.336 0 O-C-N 121.614 -0.679 . . . . 0.0 110.383 -178.918 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.437 ' N ' ' O ' ' A' ' 16' ' ' GLU . 0.0 OUTLIER -70.68 -21.1 62.62 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.172 -0.955 . . . . 0.0 110.998 -178.657 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 4.9 t -122.51 41.88 3.31 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.705 -1.247 . . . . 0.0 110.23 -179.112 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.575 ' CG1' ' HA ' ' A' ' 19' ' ' TYR . 0.3 OUTLIER -155.35 -37.34 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 O-C-N 121.155 -0.966 . . . . 0.0 110.195 -178.531 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.406 HD13 HG22 ' A' ' 23' ' ' ILE . 12.3 mm . . . . . 0 N--CA 1.489 1.486 0 O-C-N 121.061 -1.025 . . . . 0.0 109.72 -179.239 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 11.1 t . . . . . 0 N--CA 1.491 1.585 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 24.4 mm -81.93 -30.96 10.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.34 -0.85 . . . . 0.0 109.627 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 19.5 ttpt -87.56 -29.89 20.94 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.205 -0.934 . . . . 0.0 109.621 -179.863 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.474 ' O ' HG21 ' A' ' 10' ' ' ILE . 0.8 OUTLIER -74.79 -47.29 31.59 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.226 -0.921 . . . . 0.0 109.495 -179.916 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 33.1 t-20 -48.82 -35.08 13.68 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.24 -0.913 . . . . 0.0 109.208 179.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 31.9 mm -69.29 -33.42 57.78 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.189 -0.945 . . . . 0.0 109.085 179.694 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.474 HG21 ' O ' ' A' ' 7' ' ' GLU . 2.4 tt -60.28 -40.4 83.68 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.242 -0.911 . . . . 0.0 108.709 179.595 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.44 ' N ' HG21 ' A' ' 10' ' ' ILE . . . -62.96 -20.91 62.95 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 108.586 -1.805 . . . . 0.0 108.586 179.319 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.46 ' O ' HG11 ' A' ' 12' ' ' VAL . 49.6 t -88.66 -29.68 5.32 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.425 0 O-C-N 121.621 -0.929 . . . . 0.0 109.069 179.635 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 38.0 t -95.17 -0.63 53.09 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.294 -0.879 . . . . 0.0 109.453 179.827 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.448 ' HB2' ' O ' ' A' ' 10' ' ' ILE . 0.9 OUTLIER -99.26 -16.8 18.38 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.163 -0.961 . . . . 0.0 109.49 179.946 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 29.8 t0 -95.42 -54.82 3.25 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.23 -0.919 . . . . 0.0 109.415 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -52.18 -41.46 62.65 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.167 -0.958 . . . . 0.0 109.012 179.705 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.603 ' CG ' ' N ' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -59.14 -55.7 31.62 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 179.366 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.603 ' N ' ' CG ' ' A' ' 17' ' ' TYR . 9.3 ttm180 -66.96 -6.04 15.18 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 179.652 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . 0.52 ' CD2' HD11 ' A' ' 23' ' ' ILE . 2.4 m-85 -107.59 -16.58 14.32 Favored 'General case' 0 C--N 1.305 -1.336 0 O-C-N 121.341 -0.85 . . . . 0.0 109.873 -179.265 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 1.9 mmt180 -74.78 -21.66 59.2 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.259 -0.9 . . . . 0.0 110.234 -179.323 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 8.5 t -107.71 24.63 12.62 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.036 -1.04 . . . . 0.0 109.997 -179.577 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.528 ' CG1' ' O ' ' A' ' 18' ' ' ARG . 0.1 OUTLIER -146.77 -49.46 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.547 0 O-C-N 121.333 -0.854 . . . . 0.0 109.631 -178.82 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.52 HD11 ' CD2' ' A' ' 19' ' ' TYR . 2.5 mp . . . . . 0 N--CA 1.489 1.503 0 O-C-N 120.977 -1.077 . . . . 0.0 109.409 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.417 HG21 ' N ' ' A' ' 5' ' ' ILE . 7.3 t . . . . . 0 N--CA 1.49 1.538 0 CA-C-O 121.328 0.585 . . . . 0.0 109.546 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.417 ' N ' HG21 ' A' ' 4' ' ' THR . 2.5 mp -62.8 -21.87 28.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.171 -0.956 . . . . 0.0 109.464 -179.943 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 19.9 mmtt -102.96 -41.08 6.24 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.322 -0.861 . . . . 0.0 109.339 179.858 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -67.62 -12.24 59.98 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.241 -0.912 . . . . 0.0 109.459 179.89 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 30.3 t-20 -87.67 -50.53 6.43 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.275 -0.89 . . . . 0.0 109.244 179.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.421 HD11 HG22 ' A' ' 9' ' ' ILE . 24.7 mm -70.69 -18.72 21.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.277 -0.889 . . . . 0.0 109.21 179.765 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.438 ' O ' ' N ' ' A' ' 14' ' ' TYR . 1.9 mm -66.64 -57.3 10.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.312 -0.867 . . . . 0.0 109.058 179.786 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -55.54 -20.45 23.84 Favored Glycine 0 N--CA 1.488 2.146 0 N-CA-C 109.065 -1.614 . . . . 0.0 109.065 179.658 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.456 ' O ' HG11 ' A' ' 12' ' ' VAL . 69.0 t -86.76 -21.64 7.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.303 -1.116 . . . . 0.0 109.484 179.788 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.1 p -116.27 2.14 13.21 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.21 -0.931 . . . . 0.0 109.642 -179.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.438 ' N ' ' O ' ' A' ' 10' ' ' ILE . 0.3 OUTLIER -125.16 -35.36 2.64 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.215 -0.928 . . . . 0.0 109.663 -179.935 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.409 ' O ' ' HB2' ' A' ' 19' ' ' TYR . 1.0 OUTLIER -76.35 -38.97 55.1 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.123 -0.986 . . . . 0.0 109.408 -179.983 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -58.18 -43.46 87.5 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.294 -0.879 . . . . 0.0 109.464 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.632 ' CG ' ' N ' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -62.91 -59.68 4.51 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 179.488 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.632 ' N ' ' CG ' ' A' ' 17' ' ' TYR . 4.8 ttm180 -53.92 -20.48 6.13 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 179.302 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . 0.477 ' HA ' HG11 ' A' ' 22' ' ' VAL . 3.1 m-30 -92.39 -12.46 32.21 Favored 'General case' 0 C--N 1.305 -1.354 0 O-C-N 121.624 -0.673 . . . . 0.0 109.567 -179.725 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.28 -35.13 63.74 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.322 -0.861 . . . . 0.0 110.069 -179.442 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 48.3 t -90.41 21.35 3.93 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.142 -0.974 . . . . 0.0 109.882 -179.621 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.535 ' CG1' ' O ' ' A' ' 18' ' ' ARG . 0.2 OUTLIER -150.09 -43.07 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.556 0 O-C-N 121.371 -0.831 . . . . 0.0 109.541 -178.777 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 3.8 mm . . . . . 0 N--CA 1.489 1.491 0 O-C-N 121.172 -0.955 . . . . 0.0 109.597 -179.669 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.422 ' O ' ' HB2' ' A' ' 8' ' ' ASN . 15.1 t . . . . . 0 N--CA 1.49 1.57 0 CA-C-O 121.172 0.51 . . . . 0.0 109.729 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 2.5 mp -51.87 -21.38 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.233 -0.917 . . . . 0.0 109.477 -179.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 18.4 ttpt -93.4 -60.1 1.86 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.189 -0.944 . . . . 0.0 109.602 -179.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 7.3 tt0 -58.87 -24.86 62.74 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.237 -0.915 . . . . 0.0 109.753 -179.755 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . 0.422 ' HB2' ' O ' ' A' ' 4' ' ' THR . 6.0 t-20 -61.98 -45.76 92.25 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.092 -1.005 . . . . 0.0 109.555 -179.909 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.461 ' O ' ' N ' ' A' ' 12' ' ' VAL . 19.6 mm -69.52 -49.0 63.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.298 -0.876 . . . . 0.0 109.527 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.476 HG23 HD11 ' A' ' 10' ' ' ILE . 64.1 mt -46.5 -27.56 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.201 -0.937 . . . . 0.0 109.166 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -86.93 -26.88 30.36 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.329 -1.509 . . . . 0.0 109.329 179.809 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.461 ' N ' ' O ' ' A' ' 9' ' ' ILE . 76.5 t -60.03 -47.06 93.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.332 -1.099 . . . . 0.0 109.311 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 7.6 t -77.19 -16.66 59.0 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.263 -0.898 . . . . 0.0 109.283 179.708 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -86.15 -23.77 26.45 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.345 -0.847 . . . . 0.0 109.324 179.805 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.449 ' O ' ' C ' ' A' ' 16' ' ' GLU . 27.7 m-20 -76.44 -55.77 5.23 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.355 -0.841 . . . . 0.0 109.555 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.449 ' C ' ' O ' ' A' ' 15' ' ' ASP . 0.3 OUTLIER -43.77 -32.63 1.08 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.127 -0.983 . . . . 0.0 108.838 179.72 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -65.94 -48.79 70.2 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 108.385 -0.968 . . . . 0.0 108.385 179.116 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.543 ' O ' ' CG1' ' A' ' 22' ' ' VAL . 21.7 ttt180 -73.27 4.11 4.97 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.476 -0.765 . . . . 0.0 109.062 179.199 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 8.3 m-85 -119.78 -4.73 10.19 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.419 -0.8 . . . . 0.0 109.038 -179.297 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 1.7 tpt180 -95.52 -68.14 0.82 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.516 -0.74 . . . . 0.0 111.372 -178.296 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 18.3 t -85.25 20.36 1.99 Allowed 'General case' 0 N--CA 1.496 1.845 0 O-C-N 120.964 -1.085 . . . . 0.0 110.697 -178.406 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.543 ' CG1' ' O ' ' A' ' 18' ' ' ARG . 0.2 OUTLIER -134.04 -63.43 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.783 0 O-C-N 121.347 -0.846 . . . . 0.0 109.032 -179.183 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.406 HD13 HG23 ' A' ' 22' ' ' VAL . 3.3 mt . . . . . 0 N--CA 1.489 1.492 0 O-C-N 121.238 -0.913 . . . . 0.0 109.288 179.782 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.457 ' O ' ' HB2' ' A' ' 8' ' ' ASN . 15.0 t . . . . . 0 N--CA 1.49 1.562 0 N-CA-C 109.592 -0.521 . . . . 0.0 109.592 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 23.0 mm -74.88 -28.88 21.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.318 -0.864 . . . . 0.0 109.25 179.792 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 7.6 mtpt -106.21 -37.06 6.69 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.475 -0.766 . . . . 0.0 109.274 179.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.14 -15.91 62.92 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.313 -0.867 . . . . 0.0 108.992 179.775 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . 0.457 ' HB2' ' O ' ' A' ' 4' ' ' THR . 48.3 t-20 -78.76 -54.71 5.8 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.421 -0.8 . . . . 0.0 109.354 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.489 HD11 HG22 ' A' ' 9' ' ' ILE . 46.8 mm -67.99 -30.64 48.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.205 -0.934 . . . . 0.0 109.276 179.83 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 3.3 mm -50.91 -36.36 15.4 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 O-C-N 121.279 -0.888 . . . . 0.0 109.208 179.755 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -89.99 -32.47 9.84 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 179.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.457 ' HB ' ' HA ' ' A' ' 9' ' ' ILE . 47.4 t -70.48 -37.92 71.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.22 -1.165 . . . . 0.0 109.318 179.942 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -71.38 -13.31 61.81 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.3 -0.875 . . . . 0.0 109.468 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.464 ' O ' ' HB3' ' A' ' 17' ' ' TYR . 2.3 m-85 -77.96 -49.63 13.73 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.206 -0.934 . . . . 0.0 109.406 179.862 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.454 ' OD1' ' CE1' ' A' ' 19' ' ' TYR . 6.3 t0 -56.56 -46.07 80.92 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.182 -0.949 . . . . 0.0 109.1 179.799 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.402 ' C ' ' O ' ' A' ' 15' ' ' ASP . 0.6 OUTLIER -46.73 -39.26 11.28 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 108.204 -1.035 . . . . 0.0 108.204 179.401 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.464 ' HB3' ' O ' ' A' ' 14' ' ' TYR . 0.2 OUTLIER -64.1 -61.54 2.19 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 107.668 -1.234 . . . . 0.0 107.668 178.781 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.553 ' O ' ' CG1' ' A' ' 22' ' ' VAL . 4.0 ttt85 -52.37 -22.36 4.54 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 178.805 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . 0.514 ' HA ' HG11 ' A' ' 22' ' ' VAL . 7.8 m-30 -91.79 -8.94 45.28 Favored 'General case' 0 C--N 1.305 -1.347 0 CA-C-O 121.346 0.593 . . . . 0.0 109.747 -179.637 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.44 ' O ' ' HG2' ' A' ' 20' ' ' ARG . 0.4 OUTLIER -75.14 -28.02 60.0 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.287 -0.883 . . . . 0.0 110.299 -179.121 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 7.4 t -105.48 28.4 7.44 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.981 -1.074 . . . . 0.0 110.047 -179.487 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.553 ' CG1' ' O ' ' A' ' 18' ' ' ARG . 0.2 OUTLIER -155.02 -41.12 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.56 0 O-C-N 121.316 -0.865 . . . . 0.0 109.356 -178.833 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.464 ' CD1' ' CG ' ' A' ' 19' ' ' TYR . 4.6 mt . . . . . 0 N--CA 1.491 1.591 0 O-C-N 121.259 -0.901 . . . . 0.0 109.13 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 12.8 t . . . . . 0 N--CA 1.489 1.492 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.464 ' O ' HG12 ' A' ' 9' ' ' ILE . 21.5 mm -76.83 -43.1 33.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.375 -0.828 . . . . 0.0 109.746 -179.784 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.483 ' O ' HG13 ' A' ' 10' ' ' ILE . 0.2 OUTLIER -102.07 -15.16 16.83 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.217 -0.927 . . . . 0.0 109.746 -179.592 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 7.1 mt-10 -70.79 -29.5 65.72 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 120.96 -1.088 . . . . 0.0 109.572 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 41.3 t-20 -94.45 -37.83 11.23 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.162 -0.961 . . . . 0.0 109.701 -179.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.464 HG12 ' O ' ' A' ' 5' ' ' ILE . 18.7 mm -65.53 -41.9 91.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.172 -0.955 . . . . 0.0 109.487 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.483 HG13 ' O ' ' A' ' 6' ' ' LYS . 19.3 mt -49.64 -42.07 17.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.173 -0.954 . . . . 0.0 108.636 179.693 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -68.62 -32.07 74.26 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 108.662 -1.775 . . . . 0.0 108.662 179.14 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 68.3 t -73.1 -33.18 41.63 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 O-C-N 121.437 -1.037 . . . . 0.0 108.89 179.395 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.583 ' O ' ' CD2' ' A' ' 17' ' ' TYR . 0.4 OUTLIER -91.04 17.55 7.86 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.439 -0.788 . . . . 0.0 109.187 179.744 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -118.96 -25.18 6.32 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.385 -0.822 . . . . 0.0 109.301 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.506 ' O ' ' HB2' ' A' ' 19' ' ' TYR . 0.1 OUTLIER -94.58 -50.48 5.17 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.291 -0.88 . . . . 0.0 109.425 179.951 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.402 ' C ' ' HB2' ' A' ' 19' ' ' TYR . 1.2 tt0 -51.57 -33.46 32.63 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.403 -0.81 . . . . 0.0 109.665 179.917 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.627 ' CD1' ' N ' ' A' ' 17' ' ' TYR . 3.8 m-30 -82.11 -59.8 2.44 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.293 -0.879 . . . . 0.0 109.042 -179.872 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.516 ' O ' HG11 ' A' ' 22' ' ' VAL . 1.0 OUTLIER -49.97 -24.51 2.62 Favored 'General case' 0 C--N 1.306 -1.302 0 N-CA-C 106.48 -1.674 . . . . 0.0 106.48 177.555 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . 0.612 ' HA ' ' CG1' ' A' ' 22' ' ' VAL . 0.1 OUTLIER -60.55 -35.71 76.7 Favored 'General case' 0 N--CA 1.484 1.245 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 178.502 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.448 ' N ' ' O ' ' A' ' 17' ' ' TYR . 30.8 mtp180 -68.56 -27.66 66.27 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.277 -0.89 . . . . 0.0 109.462 -179.696 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 5.7 t -92.13 29.37 1.65 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.283 -0.886 . . . . 0.0 109.336 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.612 ' CG1' ' HA ' ' A' ' 19' ' ' TYR . 0.3 OUTLIER -150.34 -40.61 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.298 -1.644 0 O-C-N 121.609 -0.682 . . . . 0.0 109.229 -178.492 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.592 HD13 ' CD1' ' A' ' 19' ' ' TYR . 2.7 mt . . . . . 0 N--CA 1.491 1.595 0 O-C-N 121.072 -1.018 . . . . 0.0 108.86 179.492 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.1 t . . . . . 0 N--CA 1.491 1.585 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.417 ' O ' HG12 ' A' ' 9' ' ' ILE . 7.1 mt -70.44 -35.15 60.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.174 -0.954 . . . . 0.0 109.275 179.897 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.47 -27.08 58.71 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.299 -0.875 . . . . 0.0 109.435 179.794 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -65.9 -25.14 67.03 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.269 -0.894 . . . . 0.0 109.382 179.889 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 9.3 t-20 -84.21 -48.65 9.57 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.361 -0.837 . . . . 0.0 109.255 179.768 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.417 HG12 ' O ' ' A' ' 5' ' ' ILE . 37.5 mm -50.03 -38.37 14.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.307 -0.871 . . . . 0.0 108.917 179.719 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 21.7 mt -50.9 -40.81 20.87 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 179.562 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -68.79 -35.72 80.6 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 108.875 -1.69 . . . . 0.0 108.875 179.45 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 71.8 t -74.37 -9.96 13.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.345 -1.091 . . . . 0.0 109.225 179.592 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -103.17 -47.31 4.37 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.451 -0.78 . . . . 0.0 109.578 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -54.61 -41.33 69.85 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.184 -0.947 . . . . 0.0 109.652 -179.817 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 2.2 t0 -68.9 -47.51 65.63 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.228 -0.92 . . . . 0.0 109.116 179.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.448 ' O ' ' HB2' ' A' ' 19' ' ' TYR . 0.2 OUTLIER -47.53 -31.91 4.8 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.268 -0.895 . . . . 0.0 108.828 179.611 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.575 ' CG ' ' N ' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -71.99 -65.84 0.72 Allowed 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 179.425 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.575 ' N ' ' CG ' ' A' ' 17' ' ' TYR . 5.0 ttp180 -47.04 -26.02 0.95 Allowed 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 179.215 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . 0.631 ' CG ' ' CD1' ' A' ' 23' ' ' ILE . 1.6 m-85 -66.5 -48.81 68.61 Favored 'General case' 0 C--N 1.302 -1.462 0 CA-C-O 121.242 0.544 . . . . 0.0 109.733 179.713 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -53.87 -18.94 3.79 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.323 -0.861 . . . . 0.0 109.665 -179.741 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 2.4 t -89.14 -19.5 25.43 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.23 -0.919 . . . . 0.0 110.569 -179.42 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.456 ' CG1' ' O ' ' A' ' 18' ' ' ARG . 0.3 OUTLIER -123.13 -8.4 7.95 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.689 0 O-C-N 121.168 -0.958 . . . . 0.0 110.364 -178.133 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.631 ' CD1' ' CG ' ' A' ' 19' ' ' TYR . 2.5 mp . . . . . 0 N--CA 1.492 1.649 0 O-C-N 120.923 -1.111 . . . . 0.0 109.923 -179.8 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 10.7 t . . . . . 0 N--CA 1.49 1.542 0 CA-C-O 121.276 0.56 . . . . 0.0 109.498 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.446 ' O ' HG12 ' A' ' 9' ' ' ILE . 12.0 mt -82.6 -29.22 8.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.169 -0.957 . . . . 0.0 109.368 -179.961 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.473 ' HB3' ' CD1' ' A' ' 10' ' ' ILE . 4.8 mttm -83.3 -45.01 14.29 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.243 -0.91 . . . . 0.0 109.421 179.941 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -51.8 -20.56 2.25 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.27 -0.894 . . . . 0.0 109.556 179.886 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 10.8 t-20 -87.41 -42.75 12.6 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.195 -0.941 . . . . 0.0 109.462 -179.86 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.446 HG12 ' O ' ' A' ' 5' ' ' ILE . 17.6 mm -78.12 -38.72 24.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.248 -0.907 . . . . 0.0 109.555 -179.923 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.473 ' CD1' ' HB3' ' A' ' 6' ' ' LYS . 1.1 mp -54.15 -42.2 54.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.107 -0.996 . . . . 0.0 109.001 179.946 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.412 ' HA2' ' HB2' ' A' ' 14' ' ' TYR . . . -59.01 -36.28 87.63 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.296 -1.522 . . . . 0.0 109.296 179.828 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.431 ' HB ' ' O ' ' A' ' 9' ' ' ILE . 24.8 t -58.52 -42.41 84.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.282 -1.128 . . . . 0.0 109.419 179.969 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 8.5 t -85.03 -19.32 32.15 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.168 -0.957 . . . . 0.0 109.521 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.412 ' HB2' ' HA2' ' A' ' 11' ' ' GLY . 1.5 m-85 -78.0 -21.74 50.39 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.268 -0.895 . . . . 0.0 109.362 179.917 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.407 ' O ' ' HB2' ' A' ' 19' ' ' TYR . 76.0 m-20 -74.09 -55.8 5.68 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.312 -0.867 . . . . 0.0 109.428 179.917 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.468 ' OE1' ' HA ' ' A' ' 16' ' ' GLU . 0.9 OUTLIER -50.72 -41.27 56.09 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.265 -0.897 . . . . 0.0 109.11 179.949 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.629 ' CG ' ' N ' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -67.11 -62.18 1.56 Allowed 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 179.465 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.629 ' N ' ' CG ' ' A' ' 17' ' ' TYR . 0.3 OUTLIER -51.3 -22.52 2.86 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 179.223 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . 0.499 ' HA ' ' CD1' ' A' ' 23' ' ' ILE . 3.3 m-85 -85.26 -27.48 25.99 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.762 -0.587 . . . . 0.0 109.77 -179.86 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.29 4.95 13.62 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.251 -0.906 . . . . 0.0 109.634 -179.795 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 4.2 t -111.13 -29.99 7.65 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.137 -0.977 . . . . 0.0 110.68 -179.517 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.474 HG12 ' O ' ' A' ' 18' ' ' ARG . 2.0 m -111.83 -38.35 3.12 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.679 0 O-C-N 121.114 -0.991 . . . . 0.0 110.413 -177.81 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.499 ' CD1' ' HA ' ' A' ' 19' ' ' TYR . 3.0 mp . . . . . 0 N--CA 1.491 1.61 0 O-C-N 121.015 -1.053 . . . . 0.0 109.829 -179.478 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.428 ' OG1' ' HB2' ' A' ' 8' ' ' ASN . 3.3 t . . . . . 0 N--CA 1.492 1.671 0 CA-C-O 121.536 0.684 . . . . 0.0 109.295 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 2.5 mp -64.85 -16.67 20.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.581 -0.699 . . . . 0.0 109.802 -179.892 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 12.8 tttt -116.42 -30.43 5.89 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.111 -0.993 . . . . 0.0 109.666 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -78.76 -25.44 44.44 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.197 -0.939 . . . . 0.0 109.582 -179.915 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . 0.428 ' HB2' ' OG1' ' A' ' 4' ' ' THR . 0.4 OUTLIER -83.0 -26.62 31.08 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.238 -0.914 . . . . 0.0 109.478 -179.929 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.479 ' O ' ' N ' ' A' ' 12' ' ' VAL . 24.9 mm -86.01 -48.24 16.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.232 -0.918 . . . . 0.0 109.515 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.488 HD13 HG22 ' A' ' 10' ' ' ILE . 0.4 OUTLIER -48.02 -32.16 3.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.288 -0.883 . . . . 0.0 109.117 -179.851 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.451 ' O ' ' OD2' ' A' ' 15' ' ' ASP . . . -75.25 -27.31 64.17 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 108.964 -1.655 . . . . 0.0 108.964 179.547 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.479 ' N ' ' O ' ' A' ' 9' ' ' ILE . 45.9 t -55.54 -27.27 20.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.345 -1.091 . . . . 0.0 109.141 179.808 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -107.55 -4.47 18.33 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.303 -0.873 . . . . 0.0 109.498 179.906 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.432 ' HB2' ' HA2' ' A' ' 11' ' ' GLY . 0.3 OUTLIER -100.08 -21.28 15.65 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.189 -0.944 . . . . 0.0 109.658 -179.834 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.478 ' OD1' ' N ' ' A' ' 16' ' ' GLU . 2.3 p30 -95.32 -44.71 7.46 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.235 -0.916 . . . . 0.0 109.418 179.874 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.478 ' N ' ' OD1' ' A' ' 15' ' ' ASP . 0.1 OUTLIER -56.96 -45.46 82.85 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.173 -0.954 . . . . 0.0 109.103 179.805 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.661 ' CG ' ' N ' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -59.75 -56.77 17.72 Favored 'General case' 0 N--CA 1.487 1.378 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 179.234 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.661 ' N ' ' CG ' ' A' ' 17' ' ' TYR . 0.0 OUTLIER -53.43 -20.88 5.15 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 178.881 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . 0.529 ' HA ' ' CG1' ' A' ' 22' ' ' VAL . 2.5 m-30 -90.69 -12.91 35.32 Favored 'General case' 0 C--N 1.306 -1.323 0 CA-C-O 121.422 0.63 . . . . 0.0 109.386 179.768 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.431 ' N ' ' O ' ' A' ' 17' ' ' TYR . 0.9 OUTLIER -71.76 -31.72 66.94 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.374 -0.829 . . . . 0.0 110.371 -179.208 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 3.1 t -96.17 24.37 5.72 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.031 -1.043 . . . . 0.0 109.796 -179.567 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.529 ' CG1' ' HA ' ' A' ' 19' ' ' TYR . 0.2 OUTLIER -149.82 -40.4 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.299 -1.598 0 O-C-N 121.346 -0.846 . . . . 0.0 109.426 -178.889 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.505 ' CD1' ' CD2' ' A' ' 19' ' ' TYR . 7.7 mt . . . . . 0 N--CA 1.489 1.523 0 O-C-N 121.26 -0.9 . . . . 0.0 109.299 -179.886 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.9 t . . . . . 0 N--CA 1.491 1.587 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.487 HG23 HD11 ' A' ' 5' ' ' ILE . 33.8 mt -99.01 -19.2 5.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.273 -0.892 . . . . 0.0 109.307 179.889 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -102.02 18.71 20.02 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.321 -0.862 . . . . 0.0 109.56 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -136.9 -39.92 0.61 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.106 -0.996 . . . . 0.0 109.563 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 21.5 t-20 -94.52 -53.01 4.06 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.307 -0.87 . . . . 0.0 109.503 -179.863 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.457 HG12 ' HA ' ' A' ' 5' ' ' ILE . 34.8 mm -55.83 -20.86 9.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.245 -0.91 . . . . 0.0 109.329 179.983 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 23.9 mt -68.77 -43.55 82.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.309 -0.869 . . . . 0.0 109.198 179.809 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -65.65 -31.6 80.48 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.358 -1.497 . . . . 0.0 109.358 179.851 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 39.4 t -58.64 -29.02 38.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.262 -1.14 . . . . 0.0 109.448 179.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.577 ' O ' ' CZ ' ' A' ' 17' ' ' TYR . 22.6 m -86.2 -34.07 20.59 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.203 -0.936 . . . . 0.0 109.468 -179.996 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.584 ' HA ' ' CD2' ' A' ' 17' ' ' TYR . 0.3 OUTLIER -75.76 -27.3 58.0 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.256 -0.902 . . . . 0.0 109.434 -179.996 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.464 ' O ' ' CD1' ' A' ' 19' ' ' TYR . 0.7 OUTLIER -61.55 -45.04 95.83 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.287 -0.883 . . . . 0.0 109.31 179.902 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.403 ' O ' ' HB2' ' A' ' 19' ' ' TYR . 0.0 OUTLIER -60.29 -41.34 93.18 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.254 -0.904 . . . . 0.0 109.377 179.896 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.602 ' N ' ' CD1' ' A' ' 17' ' ' TYR . 1.2 m-30 -67.07 -42.15 85.18 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.273 -0.892 . . . . 0.0 108.943 179.978 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.529 ' O ' ' CG1' ' A' ' 22' ' ' VAL . 0.0 OUTLIER -80.58 7.64 9.59 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 108.62 -0.882 . . . . 0.0 108.62 178.725 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . 0.602 ' CG ' ' CD1' ' A' ' 23' ' ' ILE . 3.2 m-30 -103.34 -42.62 5.66 Favored 'General case' 0 C--N 1.309 -1.16 0 O-C-N 121.493 -0.754 . . . . 0.0 109.456 -179.577 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 29.1 mtp180 -56.45 -33.81 66.24 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.441 -0.787 . . . . 0.0 110.276 -179.255 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 23.3 t -84.16 12.38 6.59 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.111 -0.993 . . . . 0.0 110.277 -179.35 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.555 ' CG2' ' N ' ' A' ' 23' ' ' ILE . 0.1 OUTLIER -146.73 -78.55 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.299 -1.601 0 O-C-N 121.184 -0.947 . . . . 0.0 110.094 -178.718 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.602 ' CD1' ' CG ' ' A' ' 19' ' ' TYR . 1.7 mp . . . . . 0 N--CA 1.49 1.575 0 O-C-N 121.032 -1.043 . . . . 0.0 109.432 -179.62 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.443 ' SD ' HG12 ' A' ' 5' ' ' ILE . 0.1 OUTLIER . . . . . 0 N--CA 1.493 1.694 0 CA-C-O 120.775 0.322 . . . . 0.0 110.28 . . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -75.43 -1.2 11.02 Favored 'Trans proline' 0 C--N 1.305 -1.736 0 O-C-N 123.984 1.518 . . . . 0.0 110.569 -179.852 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -166.45 34.89 0.23 Allowed Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.651 -1.379 . . . . 0.0 109.651 -179.848 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.441 ' O ' ' CG2' ' A' ' 4' ' ' THR . 11.6 t -147.92 47.58 1.08 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.262 -1.14 . . . . 0.0 109.359 179.84 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.448 ' O ' HG12 ' A' ' 9' ' ' ILE . 70.9 mt -93.76 -39.2 10.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.33 -0.856 . . . . 0.0 109.61 -179.858 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.54 -41.89 12.43 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.253 -0.905 . . . . 0.0 109.272 179.912 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.459 ' HA ' HD13 ' A' ' 10' ' ' ILE . 16.6 tp10 -59.41 -15.44 16.96 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.311 -0.868 . . . . 0.0 109.382 179.881 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -87.84 -42.62 12.42 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.25 -0.906 . . . . 0.0 109.388 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.448 HG12 ' O ' ' A' ' 5' ' ' ILE . 23.9 mm -61.64 -40.62 87.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.225 -0.922 . . . . 0.0 109.191 179.827 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.459 HD13 ' HA ' ' A' ' 7' ' ' GLU . 15.2 mt -48.89 -30.95 3.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.235 -0.916 . . . . 0.0 108.882 179.593 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -86.51 -33.78 13.01 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.531 -1.427 . . . . 0.0 109.531 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 44.1 t -70.25 -37.64 71.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.225 -1.162 . . . . 0.0 109.415 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -76.49 -42.8 42.21 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.223 -0.923 . . . . 0.0 109.431 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.403 ' HB2' ' O ' ' A' ' 10' ' ' ILE . 0.2 OUTLIER -49.03 -22.33 0.87 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.304 -0.873 . . . . 0.0 109.397 179.837 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.481 ' O ' ' HB2' ' A' ' 19' ' ' TYR . 1.7 t70 -94.67 -56.89 2.63 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.211 -0.93 . . . . 0.0 109.686 -179.906 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.494 ' O ' ' N ' ' A' ' 20' ' ' ARG . 0.9 OUTLIER -46.12 -39.9 10.19 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.275 -0.89 . . . . 0.0 109.046 -179.943 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.605 ' CG ' ' N ' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -65.82 -56.38 12.2 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 108.674 -0.861 . . . . 0.0 108.674 179.536 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.605 ' N ' ' CG ' ' A' ' 17' ' ' TYR . 2.3 ttt-85 -67.49 -1.55 5.1 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.656 -0.652 . . . . 0.0 109.467 179.66 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . 0.593 ' HA ' ' CG1' ' A' ' 22' ' ' VAL . 6.1 m-85 -119.63 -8.6 9.93 Favored 'General case' 0 C--N 1.308 -1.221 0 CA-C-O 121.616 0.722 . . . . 0.0 109.066 -179.725 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.494 ' N ' ' O ' ' A' ' 16' ' ' GLU . 6.8 ttt-85 -64.34 -45.39 88.05 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.562 -0.712 . . . . 0.0 111.648 -178.19 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 3.5 t -127.85 48.8 2.21 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.697 -1.252 . . . . 0.0 110.609 -178.234 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.593 ' CG1' ' HA ' ' A' ' 19' ' ' TYR . 0.6 OUTLIER -138.06 -37.42 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.759 0 O-C-N 121.433 -0.792 . . . . 0.0 109.921 -179.29 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.53 ' CD1' ' O ' ' A' ' 19' ' ' TYR . 5.1 mt -60.02 -46.76 93.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.134 -0.979 . . . . 0.0 109.598 -179.383 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.438 ' O ' ' HG2' ' A' ' 24' ' ' LYS . 3.4 ttmm -52.8 91.87 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.24 -0.913 . . . . 0.0 109.342 179.805 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.482 ' N ' ' O ' ' A' ' 23' ' ' ILE . . . . . . . . 0 N--CA 1.49 1.535 0 CA-C-O 118.0 -1.0 . . . . 0.0 109.488 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.622 0 CA-C-O 120.798 0.333 . . . . 0.0 110.185 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -74.73 1.38 7.64 Favored 'Trans proline' 0 C--N 1.306 -1.673 0 O-C-N 124.058 1.557 . . . . 0.0 110.52 -179.874 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . 0.451 ' O ' ' HB2' ' A' ' 7' ' ' GLU . . . -83.71 -21.4 57.95 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 13.3 t -129.12 -31.7 2.09 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.342 -1.093 . . . . 0.0 109.745 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 20.8 mm -65.25 -16.44 20.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.195 -0.94 . . . . 0.0 109.663 -179.803 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -128.42 -28.11 2.58 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.133 -0.98 . . . . 0.0 109.945 -179.738 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.451 ' HB2' ' O ' ' A' ' 3' ' ' GLY . 0.0 OUTLIER -82.62 -29.06 30.37 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.127 -0.983 . . . . 0.0 109.767 -179.805 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 4.3 t-20 -67.39 -49.1 65.32 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.107 -0.996 . . . . 0.0 109.238 179.776 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.44 HG21 HD11 ' A' ' 9' ' ' ILE . 47.5 mm -57.53 -37.88 60.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.305 -0.872 . . . . 0.0 109.348 179.909 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.417 ' O ' ' N ' ' A' ' 14' ' ' TYR . 56.7 mt -53.5 -44.77 57.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.201 -0.937 . . . . 0.0 108.75 179.662 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.459 ' O ' ' HB2' ' A' ' 15' ' ' ASP . . . -69.32 -13.41 67.58 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 108.943 -1.663 . . . . 0.0 108.943 179.426 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 55.1 t -98.32 -12.38 8.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.406 -1.056 . . . . 0.0 109.169 179.675 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.432 ' O ' ' HB3' ' A' ' 17' ' ' TYR . 23.2 p -120.64 -34.48 3.58 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.272 -0.892 . . . . 0.0 109.505 -179.823 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.417 ' N ' ' O ' ' A' ' 10' ' ' ILE . 1.8 t80 -77.26 -42.78 35.77 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.201 -0.937 . . . . 0.0 109.33 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.459 ' HB2' ' O ' ' A' ' 11' ' ' GLY . 3.1 m-20 -62.13 -54.35 42.49 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.218 -0.926 . . . . 0.0 109.103 179.83 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.45 ' O ' ' N ' ' A' ' 20' ' ' ARG . 1.6 tt0 -54.92 -43.86 73.7 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.204 -0.935 . . . . 0.0 108.891 179.58 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.526 ' CG ' ' N ' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -61.03 -58.31 8.96 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 179.159 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.526 ' N ' ' CG ' ' A' ' 17' ' ' TYR . 5.3 ttm180 -58.78 -14.92 10.03 Favored 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 108.898 -0.779 . . . . 0.0 108.898 179.455 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . 0.53 ' HA ' ' CG1' ' A' ' 22' ' ' VAL . 3.1 m-85 -97.42 -27.63 14.37 Favored 'General case' 0 C--N 1.307 -1.252 0 O-C-N 121.462 -0.774 . . . . 0.0 109.709 -179.629 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.45 ' N ' ' O ' ' A' ' 16' ' ' GLU . 0.0 OUTLIER -65.96 -10.56 40.39 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.184 -0.948 . . . . 0.0 109.999 -179.353 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 5.5 t -111.16 14.91 21.77 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.032 -1.043 . . . . 0.0 109.436 179.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.53 ' CG1' ' HA ' ' A' ' 19' ' ' TYR . 0.1 OUTLIER -146.75 -39.94 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.594 0 O-C-N 121.549 -0.72 . . . . 0.0 109.447 -178.299 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 5.4 mm -86.35 -69.82 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 O-C-N 121.203 -0.935 . . . . 0.0 109.494 -179.677 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -69.39 -177.51 1.17 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.163 -0.961 . . . . 0.0 109.393 179.876 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.597 0 CA-C-O 117.98 -1.01 . . . . 0.0 109.481 -179.959 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.3 ttp . . . . . 0 N--CA 1.491 1.581 0 CA-C-O 120.817 0.342 . . . . 0.0 110.187 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -74.17 1.95 6.68 Favored 'Trans proline' 0 C--N 1.305 -1.713 0 O-C-N 124.079 1.568 . . . . 0.0 110.626 179.818 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . 0.536 ' O ' ' CG2' ' A' ' 4' ' ' THR . . . 135.87 -113.22 1.06 Allowed Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 179.905 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.536 ' CG2' ' O ' ' A' ' 3' ' ' GLY . 4.2 t 40.59 29.2 0.06 Allowed 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.617 -0.931 . . . . 0.0 109.26 -179.846 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.45 ' N ' ' O ' ' A' ' 3' ' ' GLY . 52.4 mt -75.06 -16.97 16.1 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.474 0 O-C-N 121.444 -0.785 . . . . 0.0 109.419 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 9.3 pttt -107.02 -30.5 8.78 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.265 -0.897 . . . . 0.0 109.468 179.828 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -62.23 -22.29 65.84 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.19 -0.944 . . . . 0.0 109.195 179.831 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 12.3 t-20 -80.73 -52.25 7.74 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.265 -0.897 . . . . 0.0 109.297 179.864 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.505 ' O ' ' N ' ' A' ' 12' ' ' VAL . 41.2 mm -63.14 -45.93 97.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.307 -0.871 . . . . 0.0 109.481 179.927 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 48.0 mt -47.8 -29.17 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.138 -0.976 . . . . 0.0 109.074 179.883 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -81.63 -23.88 57.23 Favored Glycine 0 N--CA 1.489 2.172 0 N-CA-C 109.157 -1.577 . . . . 0.0 109.157 179.583 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.505 ' N ' ' O ' ' A' ' 9' ' ' ILE . 75.6 t -65.02 -33.85 66.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.45 -1.029 . . . . 0.0 109.335 179.721 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -75.1 -30.76 60.98 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.227 -0.92 . . . . 0.0 109.329 179.77 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -56.76 -45.72 81.86 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.292 -0.88 . . . . 0.0 109.389 179.846 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.564 ' HB3' ' CE2' ' A' ' 19' ' ' TYR . 67.9 m-20 -55.91 -45.65 78.61 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.271 -0.893 . . . . 0.0 109.211 179.809 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -51.16 -42.5 60.84 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.338 -0.851 . . . . 0.0 108.768 179.507 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.533 ' CD1' ' C ' ' A' ' 17' ' ' TYR . 0.0 OUTLIER -64.66 -62.32 1.65 Allowed 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 179.261 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.523 ' N ' ' CG ' ' A' ' 17' ' ' TYR . 0.0 OUTLIER -54.42 -20.08 6.8 Favored 'General case' 0 C--N 1.303 -1.413 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 179.321 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . 0.564 ' CE2' ' HB3' ' A' ' 15' ' ' ASP . 4.6 m-30 -88.25 -22.32 24.01 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 179.631 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.463 ' O ' ' HG3' ' A' ' 20' ' ' ARG . 24.3 tpp180 -67.18 -18.45 65.27 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.335 -0.853 . . . . 0.0 110.107 -179.439 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 4.1 t -105.8 16.51 25.13 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.993 -1.067 . . . . 0.0 109.832 -179.734 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.511 ' CG1' ' O ' ' A' ' 18' ' ' ARG . 0.1 OUTLIER -149.58 -44.83 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.298 -1.639 0 O-C-N 121.333 -0.854 . . . . 0.0 109.837 -178.461 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.469 HG13 ' HB3' ' A' ' 19' ' ' TYR . 11.5 mm -79.46 -65.61 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.41 0 O-C-N 121.083 -1.011 . . . . 0.0 109.96 -179.431 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.427 ' HG2' ' O ' ' A' ' 24' ' ' LYS . 0.1 OUTLIER -79.92 -10.8 59.81 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.173 -0.954 . . . . 0.0 109.637 -179.951 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.423 ' HB1' ' O ' ' A' ' 20' ' ' ARG . . . . . . . . 0 N--CA 1.491 1.579 0 CA-C-O 117.977 -1.011 . . . . 0.0 109.555 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.478 ' N ' ' HD3' ' A' ' 2' ' ' PRO . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.752 0 N-CA-C 110.141 -0.318 . . . . 0.0 110.141 . . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . 0.478 ' HD3' ' N ' ' A' ' 1' ' ' MET . 50.3 Cg_endo -80.17 13.5 2.18 Favored 'Trans proline' 0 C--N 1.306 -1.681 0 O-C-N 124.086 1.572 . . . . 0.0 110.875 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -49.16 119.78 6.52 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.697 -1.361 . . . . 0.0 109.697 -179.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 4.1 t -111.9 36.86 3.14 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.283 -1.128 . . . . 0.0 109.378 179.735 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.487 ' N ' HD12 ' A' ' 5' ' ' ILE . 3.3 mm -84.49 -12.08 11.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.32 -0.863 . . . . 0.0 109.547 -179.82 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -113.94 -22.09 10.28 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.27 -0.894 . . . . 0.0 109.436 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 4.9 tm-20 -86.42 -11.77 50.98 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.29 -0.881 . . . . 0.0 109.578 -179.745 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 18.0 t-20 -95.92 -49.18 5.41 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.245 -0.909 . . . . 0.0 109.355 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 49.1 mm -62.13 -34.96 66.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.284 -0.885 . . . . 0.0 109.541 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.409 ' O ' ' HB2' ' A' ' 14' ' ' TYR . 10.4 tt -49.41 -35.1 8.44 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 O-C-N 121.234 -0.916 . . . . 0.0 109.15 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.493 ' O ' ' N ' ' A' ' 15' ' ' ASP . . . -76.21 -39.92 30.5 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 109.059 -1.616 . . . . 0.0 109.059 179.666 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.464 ' O ' ' HB2' ' A' ' 16' ' ' GLU . 55.2 t -54.22 -32.7 23.94 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.319 -1.106 . . . . 0.0 109.066 179.581 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -96.08 -5.47 40.82 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.365 -0.835 . . . . 0.0 109.204 179.762 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.434 ' O ' ' CD2' ' A' ' 17' ' ' TYR . 1.8 m-85 -111.35 -56.32 2.39 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.22 -0.925 . . . . 0.0 109.382 179.917 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.493 ' N ' ' O ' ' A' ' 11' ' ' GLY . 14.3 t70 -58.4 -46.16 86.95 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.054 -1.029 . . . . 0.0 109.176 179.832 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.464 ' HB2' ' O ' ' A' ' 12' ' ' VAL . 1.9 tp10 -56.83 -48.43 78.04 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.268 -0.895 . . . . 0.0 109.221 179.774 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.62 ' CG ' ' N ' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -55.54 -55.8 27.75 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 179.404 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.62 ' N ' ' CG ' ' A' ' 17' ' ' TYR . 0.0 OUTLIER -58.93 -15.08 11.13 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 108.963 -0.755 . . . . 0.0 108.963 179.59 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . 0.575 ' HA ' ' CG1' ' A' ' 22' ' ' VAL . 3.1 m-85 -102.83 -16.2 16.0 Favored 'General case' 0 C--N 1.305 -1.336 0 O-C-N 121.614 -0.679 . . . . 0.0 110.383 -178.918 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.437 ' N ' ' O ' ' A' ' 16' ' ' GLU . 0.0 OUTLIER -70.68 -21.1 62.62 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.172 -0.955 . . . . 0.0 110.998 -178.657 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 4.9 t -122.51 41.88 3.31 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.705 -1.247 . . . . 0.0 110.23 -179.112 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.575 ' CG1' ' HA ' ' A' ' 19' ' ' TYR . 0.3 OUTLIER -155.35 -37.34 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 O-C-N 121.155 -0.966 . . . . 0.0 110.195 -178.531 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.406 HD13 HG22 ' A' ' 23' ' ' ILE . 12.3 mm -71.31 -60.08 2.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.061 -1.025 . . . . 0.0 109.72 -179.239 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -177.64 -73.68 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.288 -0.883 . . . . 0.0 109.545 -179.936 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.548 0 CA-C-O 118.028 -0.987 . . . . 0.0 109.392 179.963 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.6 mtp . . . . . 0 N--CA 1.491 1.618 0 CA-C-O 120.719 0.295 . . . . 0.0 110.26 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -73.81 -0.78 9.88 Favored 'Trans proline' 0 C--N 1.305 -1.728 0 O-C-N 124.112 1.585 . . . . 0.0 110.485 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -102.0 -161.45 26.59 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 -179.854 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 11.1 t -124.92 35.13 4.84 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.255 -1.144 . . . . 0.0 109.47 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 24.4 mm -81.93 -30.96 10.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.34 -0.85 . . . . 0.0 109.627 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 19.5 ttpt -87.56 -29.89 20.94 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.205 -0.934 . . . . 0.0 109.621 -179.863 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.474 ' O ' HG21 ' A' ' 10' ' ' ILE . 0.8 OUTLIER -74.79 -47.29 31.59 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.226 -0.921 . . . . 0.0 109.495 -179.916 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 33.1 t-20 -48.82 -35.08 13.68 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.24 -0.913 . . . . 0.0 109.208 179.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 31.9 mm -69.29 -33.42 57.78 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.189 -0.945 . . . . 0.0 109.085 179.694 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.474 HG21 ' O ' ' A' ' 7' ' ' GLU . 2.4 tt -60.28 -40.4 83.68 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.242 -0.911 . . . . 0.0 108.709 179.595 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.44 ' N ' HG21 ' A' ' 10' ' ' ILE . . . -62.96 -20.91 62.95 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 108.586 -1.805 . . . . 0.0 108.586 179.319 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.46 ' O ' HG11 ' A' ' 12' ' ' VAL . 49.6 t -88.66 -29.68 5.32 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.425 0 O-C-N 121.621 -0.929 . . . . 0.0 109.069 179.635 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 38.0 t -95.17 -0.63 53.09 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.294 -0.879 . . . . 0.0 109.453 179.827 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.448 ' HB2' ' O ' ' A' ' 10' ' ' ILE . 0.9 OUTLIER -99.26 -16.8 18.38 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.163 -0.961 . . . . 0.0 109.49 179.946 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 29.8 t0 -95.42 -54.82 3.25 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.23 -0.919 . . . . 0.0 109.415 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -52.18 -41.46 62.65 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.167 -0.958 . . . . 0.0 109.012 179.705 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.603 ' CG ' ' N ' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -59.14 -55.7 31.62 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 179.366 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.603 ' N ' ' CG ' ' A' ' 17' ' ' TYR . 9.3 ttm180 -66.96 -6.04 15.18 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 179.652 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . 0.52 ' CD2' HD11 ' A' ' 23' ' ' ILE . 2.4 m-85 -107.59 -16.58 14.32 Favored 'General case' 0 C--N 1.305 -1.336 0 O-C-N 121.341 -0.85 . . . . 0.0 109.873 -179.265 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 1.9 mmt180 -74.78 -21.66 59.2 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.259 -0.9 . . . . 0.0 110.234 -179.323 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 8.5 t -107.71 24.63 12.62 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.036 -1.04 . . . . 0.0 109.997 -179.577 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.528 ' CG1' ' O ' ' A' ' 18' ' ' ARG . 0.1 OUTLIER -146.77 -49.46 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.547 0 O-C-N 121.333 -0.854 . . . . 0.0 109.631 -178.82 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.52 HD11 ' CD2' ' A' ' 19' ' ' TYR . 2.5 mp -100.67 -54.98 6.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 120.977 -1.077 . . . . 0.0 109.409 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 5.3 mttm -82.49 68.97 9.15 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.211 -0.931 . . . . 0.0 109.426 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.565 0 CA-C-O 117.972 -1.013 . . . . 0.0 109.519 179.945 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.647 0 N-CA-C 110.096 -0.335 . . . . 0.0 110.096 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -73.93 -0.65 9.76 Favored 'Trans proline' 0 C--N 1.304 -1.767 0 O-C-N 124.13 1.595 . . . . 0.0 110.633 -179.914 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -87.18 97.55 2.28 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.417 HG21 ' N ' ' A' ' 5' ' ' ILE . 7.3 t -61.41 -27.19 68.36 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.221 -1.164 . . . . 0.0 109.546 -179.938 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.417 ' N ' HG21 ' A' ' 4' ' ' THR . 2.5 mp -62.8 -21.87 28.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.171 -0.956 . . . . 0.0 109.464 -179.943 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 19.9 mmtt -102.96 -41.08 6.24 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.322 -0.861 . . . . 0.0 109.339 179.858 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -67.62 -12.24 59.98 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.241 -0.912 . . . . 0.0 109.459 179.89 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 30.3 t-20 -87.67 -50.53 6.43 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.275 -0.89 . . . . 0.0 109.244 179.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.421 HD11 HG22 ' A' ' 9' ' ' ILE . 24.7 mm -70.69 -18.72 21.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.277 -0.889 . . . . 0.0 109.21 179.765 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.438 ' O ' ' N ' ' A' ' 14' ' ' TYR . 1.9 mm -66.64 -57.3 10.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.312 -0.867 . . . . 0.0 109.058 179.786 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -55.54 -20.45 23.84 Favored Glycine 0 N--CA 1.488 2.146 0 N-CA-C 109.065 -1.614 . . . . 0.0 109.065 179.658 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.456 ' O ' HG11 ' A' ' 12' ' ' VAL . 69.0 t -86.76 -21.64 7.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.303 -1.116 . . . . 0.0 109.484 179.788 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.1 p -116.27 2.14 13.21 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.21 -0.931 . . . . 0.0 109.642 -179.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.438 ' N ' ' O ' ' A' ' 10' ' ' ILE . 0.3 OUTLIER -125.16 -35.36 2.64 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.215 -0.928 . . . . 0.0 109.663 -179.935 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.409 ' O ' ' HB2' ' A' ' 19' ' ' TYR . 1.0 OUTLIER -76.35 -38.97 55.1 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.123 -0.986 . . . . 0.0 109.408 -179.983 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -58.18 -43.46 87.5 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.294 -0.879 . . . . 0.0 109.464 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.632 ' CG ' ' N ' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -62.91 -59.68 4.51 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 179.488 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.632 ' N ' ' CG ' ' A' ' 17' ' ' TYR . 4.8 ttm180 -53.92 -20.48 6.13 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 179.302 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . 0.477 ' HA ' HG11 ' A' ' 22' ' ' VAL . 3.1 m-30 -92.39 -12.46 32.21 Favored 'General case' 0 C--N 1.305 -1.354 0 O-C-N 121.624 -0.673 . . . . 0.0 109.567 -179.725 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.28 -35.13 63.74 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.322 -0.861 . . . . 0.0 110.069 -179.442 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 48.3 t -90.41 21.35 3.93 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.142 -0.974 . . . . 0.0 109.882 -179.621 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.535 ' CG1' ' O ' ' A' ' 18' ' ' ARG . 0.2 OUTLIER -150.09 -43.07 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.556 0 O-C-N 121.371 -0.831 . . . . 0.0 109.541 -178.777 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 3.8 mm -93.2 -64.48 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.172 -0.955 . . . . 0.0 109.597 -179.669 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 60.68 37.45 19.09 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.228 -0.92 . . . . 0.0 109.34 -179.821 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.547 0 CA-C-O 117.985 -1.007 . . . . 0.0 109.514 -179.895 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.2 ttp . . . . . 0 N--CA 1.492 1.646 0 CA-C-O 120.869 0.366 . . . . 0.0 110.323 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . 0.425 ' HG2' HD11 ' A' ' 5' ' ' ILE . 46.5 Cg_endo -73.85 0.09 8.74 Favored 'Trans proline' 0 C--N 1.307 -1.651 0 O-C-N 124.007 1.53 . . . . 0.0 110.633 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 133.48 -110.05 0.86 Allowed Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.648 -1.381 . . . . 0.0 109.648 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.422 ' O ' ' HB2' ' A' ' 8' ' ' ASN . 15.1 t -112.04 -12.54 13.69 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.302 -1.117 . . . . 0.0 109.729 -179.833 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.425 HD11 ' HG2' ' A' ' 2' ' ' PRO . 2.5 mp -51.87 -21.38 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.233 -0.917 . . . . 0.0 109.477 -179.909 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 18.4 ttpt -93.4 -60.1 1.86 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.189 -0.944 . . . . 0.0 109.602 -179.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 7.3 tt0 -58.87 -24.86 62.74 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.237 -0.915 . . . . 0.0 109.753 -179.755 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . 0.422 ' HB2' ' O ' ' A' ' 4' ' ' THR . 6.0 t-20 -61.98 -45.76 92.25 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.092 -1.005 . . . . 0.0 109.555 -179.909 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.461 ' O ' ' N ' ' A' ' 12' ' ' VAL . 19.6 mm -69.52 -49.0 63.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.298 -0.876 . . . . 0.0 109.527 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.476 HG23 HD11 ' A' ' 10' ' ' ILE . 64.1 mt -46.5 -27.56 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.201 -0.937 . . . . 0.0 109.166 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -86.93 -26.88 30.36 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.329 -1.509 . . . . 0.0 109.329 179.809 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.461 ' N ' ' O ' ' A' ' 9' ' ' ILE . 76.5 t -60.03 -47.06 93.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.332 -1.099 . . . . 0.0 109.311 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 7.6 t -77.19 -16.66 59.0 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.263 -0.898 . . . . 0.0 109.283 179.708 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -86.15 -23.77 26.45 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.345 -0.847 . . . . 0.0 109.324 179.805 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.449 ' O ' ' C ' ' A' ' 16' ' ' GLU . 27.7 m-20 -76.44 -55.77 5.23 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.355 -0.841 . . . . 0.0 109.555 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.449 ' C ' ' O ' ' A' ' 15' ' ' ASP . 0.3 OUTLIER -43.77 -32.63 1.08 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.127 -0.983 . . . . 0.0 108.838 179.72 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -65.94 -48.79 70.2 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 108.385 -0.968 . . . . 0.0 108.385 179.116 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.543 ' O ' ' CG1' ' A' ' 22' ' ' VAL . 21.7 ttt180 -73.27 4.11 4.97 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.476 -0.765 . . . . 0.0 109.062 179.199 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 8.3 m-85 -119.78 -4.73 10.19 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.419 -0.8 . . . . 0.0 109.038 -179.297 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 1.7 tpt180 -95.52 -68.14 0.82 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.516 -0.74 . . . . 0.0 111.372 -178.296 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 18.3 t -85.25 20.36 1.99 Allowed 'General case' 0 N--CA 1.496 1.845 0 O-C-N 120.964 -1.085 . . . . 0.0 110.697 -178.406 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.543 ' CG1' ' O ' ' A' ' 18' ' ' ARG . 0.2 OUTLIER -134.04 -63.43 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.783 0 O-C-N 121.347 -0.846 . . . . 0.0 109.032 -179.183 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.406 HD13 HG23 ' A' ' 22' ' ' VAL . 3.3 mt -87.71 -33.12 6.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.238 -0.913 . . . . 0.0 109.288 179.782 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.403 ' C ' ' O ' ' A' ' 23' ' ' ILE . 0.0 OUTLIER 44.61 61.15 2.56 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.296 -0.878 . . . . 0.0 109.539 179.995 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.501 0 CA-C-O 117.97 -1.014 . . . . 0.0 109.469 180.0 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.3 mtp . . . . . 0 N--CA 1.492 1.652 0 CA-C-O 120.725 0.298 . . . . 0.0 110.339 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -80.44 6.37 5.45 Favored 'Trans proline' 0 C--N 1.306 -1.695 0 O-C-N 123.958 1.504 . . . . 0.0 110.495 -179.851 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -119.8 55.97 0.6 Allowed Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.689 -1.364 . . . . 0.0 109.689 -179.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.457 ' O ' ' HB2' ' A' ' 8' ' ' ASN . 15.0 t -148.44 50.63 1.01 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.238 -1.154 . . . . 0.0 109.592 179.93 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 23.0 mm -74.88 -28.88 21.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.318 -0.864 . . . . 0.0 109.25 179.792 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 7.6 mtpt -106.21 -37.06 6.69 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.475 -0.766 . . . . 0.0 109.274 179.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.14 -15.91 62.92 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.313 -0.867 . . . . 0.0 108.992 179.775 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . 0.457 ' HB2' ' O ' ' A' ' 4' ' ' THR . 48.3 t-20 -78.76 -54.71 5.8 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.421 -0.8 . . . . 0.0 109.354 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.489 HD11 HG22 ' A' ' 9' ' ' ILE . 46.8 mm -67.99 -30.64 48.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.205 -0.934 . . . . 0.0 109.276 179.83 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 3.3 mm -50.91 -36.36 15.4 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 O-C-N 121.279 -0.888 . . . . 0.0 109.208 179.755 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -89.99 -32.47 9.84 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 179.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.457 ' HB ' ' HA ' ' A' ' 9' ' ' ILE . 47.4 t -70.48 -37.92 71.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.22 -1.165 . . . . 0.0 109.318 179.942 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -71.38 -13.31 61.81 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.3 -0.875 . . . . 0.0 109.468 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.464 ' O ' ' HB3' ' A' ' 17' ' ' TYR . 2.3 m-85 -77.96 -49.63 13.73 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.206 -0.934 . . . . 0.0 109.406 179.862 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.454 ' OD1' ' CE1' ' A' ' 19' ' ' TYR . 6.3 t0 -56.56 -46.07 80.92 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.182 -0.949 . . . . 0.0 109.1 179.799 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.402 ' C ' ' O ' ' A' ' 15' ' ' ASP . 0.6 OUTLIER -46.73 -39.26 11.28 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 108.204 -1.035 . . . . 0.0 108.204 179.401 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.464 ' HB3' ' O ' ' A' ' 14' ' ' TYR . 0.2 OUTLIER -64.1 -61.54 2.19 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 107.668 -1.234 . . . . 0.0 107.668 178.781 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.553 ' O ' ' CG1' ' A' ' 22' ' ' VAL . 4.0 ttt85 -52.37 -22.36 4.54 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 178.805 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . 0.514 ' HA ' HG11 ' A' ' 22' ' ' VAL . 7.8 m-30 -91.79 -8.94 45.28 Favored 'General case' 0 C--N 1.305 -1.347 0 CA-C-O 121.346 0.593 . . . . 0.0 109.747 -179.637 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.44 ' O ' ' HG2' ' A' ' 20' ' ' ARG . 0.4 OUTLIER -75.14 -28.02 60.0 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.287 -0.883 . . . . 0.0 110.299 -179.121 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 7.4 t -105.48 28.4 7.44 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.981 -1.074 . . . . 0.0 110.047 -179.487 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.553 ' CG1' ' O ' ' A' ' 18' ' ' ARG . 0.2 OUTLIER -155.02 -41.12 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.56 0 O-C-N 121.316 -0.865 . . . . 0.0 109.356 -178.833 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.464 ' CD1' ' CG ' ' A' ' 19' ' ' TYR . 4.6 mt -107.17 -31.07 2.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.259 -0.901 . . . . 0.0 109.13 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.439 ' HG2' ' O ' ' A' ' 20' ' ' ARG . 15.8 mttt 44.98 66.65 0.85 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.336 -0.852 . . . . 0.0 109.538 179.926 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.508 0 CA-C-O 117.971 -1.014 . . . . 0.0 109.473 179.907 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.5 tpp . . . . . 0 N--CA 1.491 1.593 0 N-CA-C 110.072 -0.344 . . . . 0.0 110.072 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -73.76 -0.67 9.71 Favored 'Trans proline' 0 C--N 1.305 -1.712 0 O-C-N 123.866 1.456 . . . . 0.0 110.403 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 102.24 -172.22 22.12 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 12.8 t -100.54 30.81 3.74 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.332 -1.099 . . . . 0.0 109.243 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.464 ' O ' HG12 ' A' ' 9' ' ' ILE . 21.5 mm -76.83 -43.1 33.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.375 -0.828 . . . . 0.0 109.746 -179.784 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.483 ' O ' HG13 ' A' ' 10' ' ' ILE . 0.2 OUTLIER -102.07 -15.16 16.83 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.217 -0.927 . . . . 0.0 109.746 -179.592 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 7.1 mt-10 -70.79 -29.5 65.72 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 120.96 -1.088 . . . . 0.0 109.572 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 41.3 t-20 -94.45 -37.83 11.23 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.162 -0.961 . . . . 0.0 109.701 -179.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.464 HG12 ' O ' ' A' ' 5' ' ' ILE . 18.7 mm -65.53 -41.9 91.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.172 -0.955 . . . . 0.0 109.487 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.483 HG13 ' O ' ' A' ' 6' ' ' LYS . 19.3 mt -49.64 -42.07 17.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.173 -0.954 . . . . 0.0 108.636 179.693 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -68.62 -32.07 74.26 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 108.662 -1.775 . . . . 0.0 108.662 179.14 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 68.3 t -73.1 -33.18 41.63 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 O-C-N 121.437 -1.037 . . . . 0.0 108.89 179.395 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.583 ' O ' ' CD2' ' A' ' 17' ' ' TYR . 0.4 OUTLIER -91.04 17.55 7.86 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.439 -0.788 . . . . 0.0 109.187 179.744 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -118.96 -25.18 6.32 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.385 -0.822 . . . . 0.0 109.301 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.506 ' O ' ' HB2' ' A' ' 19' ' ' TYR . 0.1 OUTLIER -94.58 -50.48 5.17 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.291 -0.88 . . . . 0.0 109.425 179.951 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.402 ' C ' ' HB2' ' A' ' 19' ' ' TYR . 1.2 tt0 -51.57 -33.46 32.63 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.403 -0.81 . . . . 0.0 109.665 179.917 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.627 ' CD1' ' N ' ' A' ' 17' ' ' TYR . 3.8 m-30 -82.11 -59.8 2.44 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.293 -0.879 . . . . 0.0 109.042 -179.872 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.516 ' O ' HG11 ' A' ' 22' ' ' VAL . 1.0 OUTLIER -49.97 -24.51 2.62 Favored 'General case' 0 C--N 1.306 -1.302 0 N-CA-C 106.48 -1.674 . . . . 0.0 106.48 177.555 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . 0.612 ' HA ' ' CG1' ' A' ' 22' ' ' VAL . 0.1 OUTLIER -60.55 -35.71 76.7 Favored 'General case' 0 N--CA 1.484 1.245 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 178.502 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.448 ' N ' ' O ' ' A' ' 17' ' ' TYR . 30.8 mtp180 -68.56 -27.66 66.27 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.277 -0.89 . . . . 0.0 109.462 -179.696 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 5.7 t -92.13 29.37 1.65 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.283 -0.886 . . . . 0.0 109.336 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.612 ' CG1' ' HA ' ' A' ' 19' ' ' TYR . 0.3 OUTLIER -150.34 -40.61 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.298 -1.644 0 O-C-N 121.609 -0.682 . . . . 0.0 109.229 -178.492 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.592 HD13 ' CD1' ' A' ' 19' ' ' TYR . 2.7 mt -85.22 -56.99 4.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.072 -1.018 . . . . 0.0 108.86 179.492 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.485 ' HG2' ' N ' ' A' ' 25' ' ' ALA . 0.1 OUTLIER -61.56 146.85 47.46 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.21 -0.931 . . . . 0.0 109.195 179.788 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.485 ' N ' ' HG2' ' A' ' 24' ' ' LYS . . . . . . . . 0 N--CA 1.489 1.506 0 CA-C-O 117.943 -1.027 . . . . 0.0 109.482 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.455 ' O ' ' CG ' ' A' ' 1' ' ' MET . 0.1 OUTLIER . . . . . 0 N--CA 1.494 1.762 0 CA-C-O 120.737 0.303 . . . . 0.0 110.219 . . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . 0.422 ' O ' ' C ' ' A' ' 3' ' ' GLY . 46.7 Cg_endo -73.21 -11.14 24.88 Favored 'Trans proline' 0 C--N 1.307 -1.65 0 O-C-N 124.062 1.559 . . . . 0.0 110.722 -179.969 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . 0.422 ' C ' ' O ' ' A' ' 2' ' ' PRO . . . 43.04 56.46 4.52 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.796 -1.322 . . . . 0.0 109.796 179.954 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.1 t -116.22 -32.44 5.32 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.099 -1.236 . . . . 0.0 109.583 179.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.417 ' O ' HG12 ' A' ' 9' ' ' ILE . 7.1 mt -70.44 -35.15 60.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.174 -0.954 . . . . 0.0 109.275 179.897 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.47 -27.08 58.71 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.299 -0.875 . . . . 0.0 109.435 179.794 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -65.9 -25.14 67.03 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.269 -0.894 . . . . 0.0 109.382 179.889 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 9.3 t-20 -84.21 -48.65 9.57 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.361 -0.837 . . . . 0.0 109.255 179.768 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.417 HG12 ' O ' ' A' ' 5' ' ' ILE . 37.5 mm -50.03 -38.37 14.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.307 -0.871 . . . . 0.0 108.917 179.719 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 21.7 mt -50.9 -40.81 20.87 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 179.562 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -68.79 -35.72 80.6 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 108.875 -1.69 . . . . 0.0 108.875 179.45 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 71.8 t -74.37 -9.96 13.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.345 -1.091 . . . . 0.0 109.225 179.592 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -103.17 -47.31 4.37 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.451 -0.78 . . . . 0.0 109.578 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -54.61 -41.33 69.85 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.184 -0.947 . . . . 0.0 109.652 -179.817 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 2.2 t0 -68.9 -47.51 65.63 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.228 -0.92 . . . . 0.0 109.116 179.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.448 ' O ' ' HB2' ' A' ' 19' ' ' TYR . 0.2 OUTLIER -47.53 -31.91 4.8 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.268 -0.895 . . . . 0.0 108.828 179.611 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.575 ' CG ' ' N ' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -71.99 -65.84 0.72 Allowed 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 179.425 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.575 ' N ' ' CG ' ' A' ' 17' ' ' TYR . 5.0 ttp180 -47.04 -26.02 0.95 Allowed 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 179.215 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . 0.631 ' CG ' ' CD1' ' A' ' 23' ' ' ILE . 1.6 m-85 -66.5 -48.81 68.61 Favored 'General case' 0 C--N 1.302 -1.462 0 CA-C-O 121.242 0.544 . . . . 0.0 109.733 179.713 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -53.87 -18.94 3.79 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.323 -0.861 . . . . 0.0 109.665 -179.741 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 2.4 t -89.14 -19.5 25.43 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.23 -0.919 . . . . 0.0 110.569 -179.42 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.456 ' CG1' ' O ' ' A' ' 18' ' ' ARG . 0.3 OUTLIER -123.13 -8.4 7.95 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.689 0 O-C-N 121.168 -0.958 . . . . 0.0 110.364 -178.133 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.631 ' CD1' ' CG ' ' A' ' 19' ' ' TYR . 2.5 mp -118.33 -33.24 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 120.923 -1.111 . . . . 0.0 109.923 -179.8 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 20.4 mmtm -98.04 175.64 6.04 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.217 -0.927 . . . . 0.0 109.492 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.497 0 CA-C-O 117.958 -1.02 . . . . 0.0 109.491 -179.939 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.9 mtt . . . . . 0 N--CA 1.492 1.662 0 CA-C-O 120.787 0.327 . . . . 0.0 110.314 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -74.8 1.06 8.04 Favored 'Trans proline' 0 C--N 1.305 -1.733 0 O-C-N 123.976 1.514 . . . . 0.0 110.453 179.92 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -87.04 132.18 11.01 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.704 -1.359 . . . . 0.0 109.704 -179.924 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 10.7 t -126.14 14.54 7.84 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.28 -1.129 . . . . 0.0 109.498 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.446 ' O ' HG12 ' A' ' 9' ' ' ILE . 12.0 mt -82.6 -29.22 8.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.169 -0.957 . . . . 0.0 109.368 -179.961 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.473 ' HB3' ' CD1' ' A' ' 10' ' ' ILE . 4.8 mttm -83.3 -45.01 14.29 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.243 -0.91 . . . . 0.0 109.421 179.941 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -51.8 -20.56 2.25 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.27 -0.894 . . . . 0.0 109.556 179.886 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 10.8 t-20 -87.41 -42.75 12.6 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.195 -0.941 . . . . 0.0 109.462 -179.86 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.446 HG12 ' O ' ' A' ' 5' ' ' ILE . 17.6 mm -78.12 -38.72 24.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.248 -0.907 . . . . 0.0 109.555 -179.923 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.473 ' CD1' ' HB3' ' A' ' 6' ' ' LYS . 1.1 mp -54.15 -42.2 54.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.107 -0.996 . . . . 0.0 109.001 179.946 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.412 ' HA2' ' HB2' ' A' ' 14' ' ' TYR . . . -59.01 -36.28 87.63 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.296 -1.522 . . . . 0.0 109.296 179.828 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.431 ' HB ' ' O ' ' A' ' 9' ' ' ILE . 24.8 t -58.52 -42.41 84.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.282 -1.128 . . . . 0.0 109.419 179.969 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 8.5 t -85.03 -19.32 32.15 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.168 -0.957 . . . . 0.0 109.521 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.412 ' HB2' ' HA2' ' A' ' 11' ' ' GLY . 1.5 m-85 -78.0 -21.74 50.39 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.268 -0.895 . . . . 0.0 109.362 179.917 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.407 ' O ' ' HB2' ' A' ' 19' ' ' TYR . 76.0 m-20 -74.09 -55.8 5.68 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.312 -0.867 . . . . 0.0 109.428 179.917 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.468 ' OE1' ' HA ' ' A' ' 16' ' ' GLU . 0.9 OUTLIER -50.72 -41.27 56.09 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.265 -0.897 . . . . 0.0 109.11 179.949 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.629 ' CG ' ' N ' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -67.11 -62.18 1.56 Allowed 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 179.465 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.629 ' N ' ' CG ' ' A' ' 17' ' ' TYR . 0.3 OUTLIER -51.3 -22.52 2.86 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 179.223 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . 0.499 ' HA ' ' CD1' ' A' ' 23' ' ' ILE . 3.3 m-85 -85.26 -27.48 25.99 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.762 -0.587 . . . . 0.0 109.77 -179.86 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.29 4.95 13.62 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.251 -0.906 . . . . 0.0 109.634 -179.795 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 4.2 t -111.13 -29.99 7.65 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.137 -0.977 . . . . 0.0 110.68 -179.517 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.474 HG12 ' O ' ' A' ' 18' ' ' ARG . 2.0 m -111.83 -38.35 3.12 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.679 0 O-C-N 121.114 -0.991 . . . . 0.0 110.413 -177.81 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.499 ' CD1' ' HA ' ' A' ' 19' ' ' TYR . 3.0 mp -84.41 -45.51 17.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.015 -1.053 . . . . 0.0 109.829 -179.478 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 5.6 mttt -117.02 156.44 27.49 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.24 -0.912 . . . . 0.0 109.635 -179.749 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.574 0 CA-C-O 118.021 -0.99 . . . . 0.0 109.502 -179.869 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.433 ' CG ' ' O ' ' A' ' 1' ' ' MET . 1.2 ptm . . . . . 0 N--CA 1.492 1.639 0 CA-C-O 120.688 0.28 . . . . 0.0 110.37 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . 0.47 ' O ' HG23 ' A' ' 4' ' ' THR . 45.9 Cg_endo -73.76 -5.86 17.73 Favored 'Trans proline' 0 C--N 1.304 -1.805 0 O-C-N 123.986 1.519 . . . . 0.0 110.329 179.885 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . 0.536 ' O ' ' CG2' ' A' ' 4' ' ' THR . . . 57.03 -126.39 41.88 Favored Glycine 0 N--CA 1.493 2.439 0 N-CA-C 109.883 -1.287 . . . . 0.0 109.883 179.82 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.536 ' CG2' ' O ' ' A' ' 3' ' ' GLY . 3.3 t 41.2 34.41 0.31 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.546 -0.973 . . . . 0.0 109.295 -179.703 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 2.5 mp -64.85 -16.67 20.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.581 -0.699 . . . . 0.0 109.802 -179.892 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 12.8 tttt -116.42 -30.43 5.89 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.111 -0.993 . . . . 0.0 109.666 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -78.76 -25.44 44.44 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.197 -0.939 . . . . 0.0 109.582 -179.915 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . 0.428 ' HB2' ' OG1' ' A' ' 4' ' ' THR . 0.4 OUTLIER -83.0 -26.62 31.08 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.238 -0.914 . . . . 0.0 109.478 -179.929 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.479 ' O ' ' N ' ' A' ' 12' ' ' VAL . 24.9 mm -86.01 -48.24 16.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.232 -0.918 . . . . 0.0 109.515 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.488 HD13 HG22 ' A' ' 10' ' ' ILE . 0.4 OUTLIER -48.02 -32.16 3.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.288 -0.883 . . . . 0.0 109.117 -179.851 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.451 ' O ' ' OD2' ' A' ' 15' ' ' ASP . . . -75.25 -27.31 64.17 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 108.964 -1.655 . . . . 0.0 108.964 179.547 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.479 ' N ' ' O ' ' A' ' 9' ' ' ILE . 45.9 t -55.54 -27.27 20.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.345 -1.091 . . . . 0.0 109.141 179.808 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -107.55 -4.47 18.33 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.303 -0.873 . . . . 0.0 109.498 179.906 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.432 ' HB2' ' HA2' ' A' ' 11' ' ' GLY . 0.3 OUTLIER -100.08 -21.28 15.65 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.189 -0.944 . . . . 0.0 109.658 -179.834 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.478 ' OD1' ' N ' ' A' ' 16' ' ' GLU . 2.3 p30 -95.32 -44.71 7.46 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.235 -0.916 . . . . 0.0 109.418 179.874 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.478 ' N ' ' OD1' ' A' ' 15' ' ' ASP . 0.1 OUTLIER -56.96 -45.46 82.85 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.173 -0.954 . . . . 0.0 109.103 179.805 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.661 ' CG ' ' N ' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -59.75 -56.77 17.72 Favored 'General case' 0 N--CA 1.487 1.378 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 179.234 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.661 ' N ' ' CG ' ' A' ' 17' ' ' TYR . 0.0 OUTLIER -53.43 -20.88 5.15 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 178.881 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . 0.529 ' HA ' ' CG1' ' A' ' 22' ' ' VAL . 2.5 m-30 -90.69 -12.91 35.32 Favored 'General case' 0 C--N 1.306 -1.323 0 CA-C-O 121.422 0.63 . . . . 0.0 109.386 179.768 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.438 ' HA ' ' HB2' ' A' ' 24' ' ' LYS . 0.9 OUTLIER -71.76 -31.72 66.94 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.374 -0.829 . . . . 0.0 110.371 -179.208 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 3.1 t -96.17 24.37 5.72 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.031 -1.043 . . . . 0.0 109.796 -179.567 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.529 ' CG1' ' HA ' ' A' ' 19' ' ' TYR . 0.2 OUTLIER -149.82 -40.4 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.299 -1.598 0 O-C-N 121.346 -0.846 . . . . 0.0 109.426 -178.889 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.505 ' CD1' ' CD2' ' A' ' 19' ' ' TYR . 7.7 mt -109.89 -60.26 2.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.26 -0.9 . . . . 0.0 109.299 -179.886 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.438 ' HB2' ' HA ' ' A' ' 20' ' ' ARG . 5.9 mtpp -85.3 -176.93 6.34 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.242 -0.911 . . . . 0.0 109.333 179.905 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.612 0 CA-C-O 117.961 -1.019 . . . . 0.0 109.504 179.962 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.5 ttt . . . . . 0 N--CA 1.492 1.645 0 CA-C-O 120.813 0.339 . . . . 0.0 110.206 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -79.34 11.55 2.62 Favored 'Trans proline' 0 C--N 1.306 -1.66 0 O-C-N 123.98 1.516 . . . . 0.0 110.817 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -86.92 33.54 3.75 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.797 -1.321 . . . . 0.0 109.797 179.932 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.9 t -84.26 -13.39 52.7 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.209 -1.171 . . . . 0.0 109.255 179.89 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.487 HG23 HD11 ' A' ' 5' ' ' ILE . 33.8 mt -99.01 -19.2 5.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.273 -0.892 . . . . 0.0 109.307 179.889 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -102.02 18.71 20.02 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.321 -0.862 . . . . 0.0 109.56 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -136.9 -39.92 0.61 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.106 -0.996 . . . . 0.0 109.563 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 21.5 t-20 -94.52 -53.01 4.06 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.307 -0.87 . . . . 0.0 109.503 -179.863 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.457 HG12 ' HA ' ' A' ' 5' ' ' ILE . 34.8 mm -55.83 -20.86 9.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.245 -0.91 . . . . 0.0 109.329 179.983 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 23.9 mt -68.77 -43.55 82.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.309 -0.869 . . . . 0.0 109.198 179.809 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -65.65 -31.6 80.48 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.358 -1.497 . . . . 0.0 109.358 179.851 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 39.4 t -58.64 -29.02 38.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.262 -1.14 . . . . 0.0 109.448 179.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.577 ' O ' ' CZ ' ' A' ' 17' ' ' TYR . 22.6 m -86.2 -34.07 20.59 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.203 -0.936 . . . . 0.0 109.468 -179.996 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.584 ' HA ' ' CD2' ' A' ' 17' ' ' TYR . 0.3 OUTLIER -75.76 -27.3 58.0 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.256 -0.902 . . . . 0.0 109.434 -179.996 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.464 ' O ' ' CD1' ' A' ' 19' ' ' TYR . 0.7 OUTLIER -61.55 -45.04 95.83 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.287 -0.883 . . . . 0.0 109.31 179.902 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.403 ' O ' ' HB2' ' A' ' 19' ' ' TYR . 0.0 OUTLIER -60.29 -41.34 93.18 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.254 -0.904 . . . . 0.0 109.377 179.896 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.602 ' N ' ' CD1' ' A' ' 17' ' ' TYR . 1.2 m-30 -67.07 -42.15 85.18 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.273 -0.892 . . . . 0.0 108.943 179.978 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.529 ' O ' ' CG1' ' A' ' 22' ' ' VAL . 0.0 OUTLIER -80.58 7.64 9.59 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 108.62 -0.882 . . . . 0.0 108.62 178.725 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . 0.602 ' CG ' ' CD1' ' A' ' 23' ' ' ILE . 3.2 m-30 -103.34 -42.62 5.66 Favored 'General case' 0 C--N 1.309 -1.16 0 O-C-N 121.493 -0.754 . . . . 0.0 109.456 -179.577 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 29.1 mtp180 -56.45 -33.81 66.24 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.441 -0.787 . . . . 0.0 110.276 -179.255 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 23.3 t -84.16 12.38 6.59 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.111 -0.993 . . . . 0.0 110.277 -179.35 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.555 ' CG2' ' N ' ' A' ' 23' ' ' ILE . 0.1 OUTLIER -146.73 -78.55 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.299 -1.601 0 O-C-N 121.184 -0.947 . . . . 0.0 110.094 -178.718 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.602 ' CD1' ' CG ' ' A' ' 19' ' ' TYR . 1.7 mp -44.22 -26.79 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.032 -1.043 . . . . 0.0 109.432 -179.62 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.403 ' N ' ' O ' ' A' ' 22' ' ' VAL . 10.2 mttp -113.85 -88.46 0.55 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.251 -0.906 . . . . 0.0 109.364 179.752 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.611 0 CA-C-O 118.023 -0.989 . . . . 0.0 109.437 -179.983 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.705 ' O ' HG23 ' A' ' 4' ' ' THR . 11.6 t . . . . . 0 N--CA 1.49 1.551 0 CA-C-O 121.379 0.609 . . . . 0.0 109.359 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.463 ' O ' HG12 ' A' ' 9' ' ' ILE . 70.9 mt -93.76 -39.2 10.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.33 -0.856 . . . . 0.0 109.61 -179.858 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.54 -41.89 12.43 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.253 -0.905 . . . . 0.0 109.272 179.912 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.5 ' HA ' HD12 ' A' ' 10' ' ' ILE . 16.6 tp10 -59.41 -15.44 16.96 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.311 -0.868 . . . . 0.0 109.382 179.881 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -87.84 -42.62 12.42 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.25 -0.906 . . . . 0.0 109.388 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.463 HG12 ' O ' ' A' ' 5' ' ' ILE . 23.9 mm -61.64 -40.62 87.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.225 -0.922 . . . . 0.0 109.191 179.827 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.5 HD12 ' HA ' ' A' ' 7' ' ' GLU . 15.2 mt -48.89 -30.95 3.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.235 -0.916 . . . . 0.0 108.882 179.593 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -86.51 -33.78 13.01 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.531 -1.427 . . . . 0.0 109.531 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 44.1 t -70.25 -37.64 71.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.225 -1.162 . . . . 0.0 109.415 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -76.49 -42.8 42.21 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.223 -0.923 . . . . 0.0 109.431 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.405 ' HB2' ' O ' ' A' ' 10' ' ' ILE . 0.2 OUTLIER -49.03 -22.33 0.87 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.304 -0.873 . . . . 0.0 109.397 179.837 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.473 ' O ' ' HB2' ' A' ' 19' ' ' TYR . 1.7 t70 -94.67 -56.89 2.63 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.211 -0.93 . . . . 0.0 109.686 -179.906 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.494 ' O ' ' N ' ' A' ' 20' ' ' ARG . 0.9 OUTLIER -46.12 -39.9 10.19 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.275 -0.89 . . . . 0.0 109.046 -179.943 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.605 ' CG ' ' N ' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -65.82 -56.38 12.2 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 108.674 -0.861 . . . . 0.0 108.674 179.536 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 1.035 ' O ' HG11 ' A' ' 22' ' ' VAL . 2.3 ttt-85 -67.49 -1.55 5.1 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.656 -0.652 . . . . 0.0 109.467 179.66 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.616 ' O ' HD12 ' A' ' 23' ' ' ILE . 6.1 m-85 -119.63 -8.6 9.93 Favored 'General case' 0 C--N 1.308 -1.221 0 CA-C-O 121.616 0.722 . . . . 0.0 109.066 -179.725 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.494 ' N ' ' O ' ' A' ' 16' ' ' GLU . 6.8 ttt-85 -64.34 -45.39 88.05 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.562 -0.712 . . . . 0.0 111.648 -178.19 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 3.5 t -127.85 48.8 2.21 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.697 -1.252 . . . . 0.0 110.609 -178.234 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 1.035 HG11 ' O ' ' A' ' 18' ' ' ARG . 0.6 OUTLIER -138.06 -37.42 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.759 0 O-C-N 121.433 -0.792 . . . . 0.0 109.921 -179.29 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.616 HD12 ' O ' ' A' ' 19' ' ' TYR . 5.1 mt . . . . . 0 N--CA 1.489 1.517 0 O-C-N 121.134 -0.979 . . . . 0.0 109.598 -179.383 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 13.3 t . . . . . 0 N--CA 1.491 1.623 0 CA-C-O 121.18 0.514 . . . . 0.0 109.745 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 20.8 mm -65.25 -16.44 20.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.195 -0.94 . . . . 0.0 109.663 -179.803 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -128.42 -28.11 2.58 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.133 -0.98 . . . . 0.0 109.945 -179.738 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.426 ' HA ' HD12 ' A' ' 10' ' ' ILE . 0.0 OUTLIER -82.62 -29.06 30.37 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.127 -0.983 . . . . 0.0 109.767 -179.805 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 41.4 t30 -67.39 -49.1 65.32 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.107 -0.996 . . . . 0.0 109.238 179.776 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 47.5 mm -57.53 -37.88 60.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.305 -0.872 . . . . 0.0 109.348 179.909 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.426 HD12 ' HA ' ' A' ' 7' ' ' GLU . 56.7 mt -53.5 -44.77 57.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.201 -0.937 . . . . 0.0 108.75 179.662 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.47 ' O ' ' HB2' ' A' ' 15' ' ' ASP . . . -69.32 -13.41 67.58 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 108.943 -1.663 . . . . 0.0 108.943 179.426 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.454 ' O ' HG12 ' A' ' 12' ' ' VAL . 55.1 t -98.32 -12.38 8.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.406 -1.056 . . . . 0.0 109.169 179.675 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.448 ' O ' ' HB3' ' A' ' 17' ' ' TYR . 23.2 p -120.64 -34.48 3.58 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.272 -0.892 . . . . 0.0 109.505 -179.823 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -77.26 -42.78 35.77 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.201 -0.937 . . . . 0.0 109.33 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.47 ' HB2' ' O ' ' A' ' 11' ' ' GLY . 3.1 m-20 -62.13 -54.35 42.49 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.218 -0.926 . . . . 0.0 109.103 179.83 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.45 ' O ' ' N ' ' A' ' 20' ' ' ARG . 1.6 tt0 -54.92 -43.86 73.7 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.204 -0.935 . . . . 0.0 108.891 179.58 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.526 ' CG ' ' N ' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -61.03 -58.31 8.96 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 179.159 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.526 ' N ' ' CG ' ' A' ' 17' ' ' TYR . 5.3 ttm180 -58.78 -14.92 10.03 Favored 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 108.898 -0.779 . . . . 0.0 108.898 179.455 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.656 ' HA ' HG13 ' A' ' 22' ' ' VAL . 3.1 m-85 -97.42 -27.63 14.37 Favored 'General case' 0 C--N 1.307 -1.252 0 O-C-N 121.462 -0.774 . . . . 0.0 109.709 -179.629 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.45 ' N ' ' O ' ' A' ' 16' ' ' GLU . 0.0 OUTLIER -65.96 -10.56 40.39 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.184 -0.948 . . . . 0.0 109.999 -179.353 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 5.5 t -111.16 14.91 21.77 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.032 -1.043 . . . . 0.0 109.436 179.873 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.656 HG13 ' HA ' ' A' ' 19' ' ' TYR . 0.1 OUTLIER -146.75 -39.94 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.594 0 O-C-N 121.549 -0.72 . . . . 0.0 109.447 -178.299 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.405 HG13 ' HB3' ' A' ' 19' ' ' TYR . 5.4 mm . . . . . 0 N--CA 1.488 1.439 0 O-C-N 121.203 -0.935 . . . . 0.0 109.494 -179.677 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 4.2 t . . . . . 0 N--CA 1.493 1.675 0 N-CA-C 109.26 -0.645 . . . . 0.0 109.26 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 52.4 mt -75.06 -16.97 16.1 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.474 0 O-C-N 121.444 -0.785 . . . . 0.0 109.419 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 9.3 pttt -107.02 -30.5 8.78 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.265 -0.897 . . . . 0.0 109.468 179.828 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -62.23 -22.29 65.84 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.19 -0.944 . . . . 0.0 109.195 179.831 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 12.3 t-20 -80.73 -52.25 7.74 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.265 -0.897 . . . . 0.0 109.297 179.864 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.505 ' O ' ' N ' ' A' ' 12' ' ' VAL . 41.2 mm -63.14 -45.93 97.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.307 -0.871 . . . . 0.0 109.481 179.927 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 48.0 mt -47.8 -29.17 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.138 -0.976 . . . . 0.0 109.074 179.883 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -81.63 -23.88 57.23 Favored Glycine 0 N--CA 1.489 2.172 0 N-CA-C 109.157 -1.577 . . . . 0.0 109.157 179.583 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.505 ' N ' ' O ' ' A' ' 9' ' ' ILE . 75.6 t -65.02 -33.85 66.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.45 -1.029 . . . . 0.0 109.335 179.721 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -75.1 -30.76 60.98 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.227 -0.92 . . . . 0.0 109.329 179.77 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -56.76 -45.72 81.86 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.292 -0.88 . . . . 0.0 109.389 179.846 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.573 ' HB3' ' CE2' ' A' ' 19' ' ' TYR . 67.9 m-20 -55.91 -45.65 78.61 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.271 -0.893 . . . . 0.0 109.211 179.809 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -51.16 -42.5 60.84 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.338 -0.851 . . . . 0.0 108.768 179.507 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.533 ' CD1' ' C ' ' A' ' 17' ' ' TYR . 0.0 OUTLIER -64.66 -62.32 1.65 Allowed 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 179.261 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.523 ' N ' ' CG ' ' A' ' 17' ' ' TYR . 0.0 OUTLIER -54.42 -20.08 6.8 Favored 'General case' 0 C--N 1.303 -1.413 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 179.321 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.627 ' HA ' HG13 ' A' ' 22' ' ' VAL . 4.6 m-30 -88.25 -22.32 24.01 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 179.631 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.453 ' O ' ' HG3' ' A' ' 20' ' ' ARG . 24.3 tpp180 -67.18 -18.45 65.27 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.335 -0.853 . . . . 0.0 110.107 -179.439 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 4.1 t -105.8 16.51 25.13 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.993 -1.067 . . . . 0.0 109.832 -179.734 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.627 HG13 ' HA ' ' A' ' 19' ' ' TYR . 0.1 OUTLIER -149.58 -44.83 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.298 -1.639 0 O-C-N 121.333 -0.854 . . . . 0.0 109.837 -178.461 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.501 HG13 ' HB3' ' A' ' 19' ' ' TYR . 11.5 mm . . . . . 0 N--CA 1.487 1.41 0 O-C-N 121.083 -1.011 . . . . 0.0 109.96 -179.431 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 4.1 t . . . . . 0 N--CA 1.491 1.61 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.504 ' N ' HD13 ' A' ' 5' ' ' ILE . 3.3 mm -84.49 -12.08 11.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.32 -0.863 . . . . 0.0 109.547 -179.82 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -113.94 -22.09 10.28 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.27 -0.894 . . . . 0.0 109.436 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 4.9 tm-20 -86.42 -11.77 50.98 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.29 -0.881 . . . . 0.0 109.578 -179.745 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 18.0 t-20 -95.92 -49.18 5.41 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.245 -0.909 . . . . 0.0 109.355 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.409 HD13 ' HA ' ' A' ' 9' ' ' ILE . 49.1 mm -62.13 -34.96 66.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.284 -0.885 . . . . 0.0 109.541 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.402 ' O ' ' HB2' ' A' ' 14' ' ' TYR . 10.4 tt -49.41 -35.1 8.44 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 O-C-N 121.234 -0.916 . . . . 0.0 109.15 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.493 ' O ' ' N ' ' A' ' 15' ' ' ASP . . . -76.21 -39.92 30.5 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 109.059 -1.616 . . . . 0.0 109.059 179.666 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.484 ' O ' ' HB2' ' A' ' 16' ' ' GLU . 55.2 t -54.22 -32.7 23.94 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.319 -1.106 . . . . 0.0 109.066 179.581 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -96.08 -5.47 40.82 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.365 -0.835 . . . . 0.0 109.204 179.762 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.434 ' O ' ' CD2' ' A' ' 17' ' ' TYR . 1.8 m-85 -111.35 -56.32 2.39 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.22 -0.925 . . . . 0.0 109.382 179.917 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.493 ' N ' ' O ' ' A' ' 11' ' ' GLY . 14.3 t70 -58.4 -46.16 86.95 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.054 -1.029 . . . . 0.0 109.176 179.832 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.484 ' HB2' ' O ' ' A' ' 12' ' ' VAL . 1.9 tp10 -56.83 -48.43 78.04 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.268 -0.895 . . . . 0.0 109.221 179.774 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.62 ' CG ' ' N ' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -55.54 -55.8 27.75 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 179.404 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.713 ' O ' HG11 ' A' ' 22' ' ' VAL . 0.0 OUTLIER -58.93 -15.08 11.13 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 108.963 -0.755 . . . . 0.0 108.963 179.59 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.61 ' HA ' ' CG1' ' A' ' 22' ' ' VAL . 3.1 m-85 -102.83 -16.2 16.0 Favored 'General case' 0 C--N 1.305 -1.336 0 O-C-N 121.614 -0.679 . . . . 0.0 110.383 -178.918 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.437 ' N ' ' O ' ' A' ' 16' ' ' GLU . 0.0 OUTLIER -70.68 -21.1 62.62 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.172 -0.955 . . . . 0.0 110.998 -178.657 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 4.9 t -122.51 41.88 3.31 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.705 -1.247 . . . . 0.0 110.23 -179.112 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.713 HG11 ' O ' ' A' ' 18' ' ' ARG . 0.3 OUTLIER -155.35 -37.34 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 O-C-N 121.155 -0.966 . . . . 0.0 110.195 -178.531 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.531 HD11 ' CD2' ' A' ' 19' ' ' TYR . 12.3 mm . . . . . 0 N--CA 1.489 1.486 0 O-C-N 121.061 -1.025 . . . . 0.0 109.72 -179.239 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 11.1 t . . . . . 0 N--CA 1.491 1.585 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 24.4 mm -81.93 -30.96 10.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.34 -0.85 . . . . 0.0 109.627 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 19.5 ttpt -87.56 -29.89 20.94 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.205 -0.934 . . . . 0.0 109.621 -179.863 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.593 ' O ' HG22 ' A' ' 10' ' ' ILE . 0.8 OUTLIER -74.79 -47.29 31.59 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.226 -0.921 . . . . 0.0 109.495 -179.916 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 33.1 t-20 -48.82 -35.08 13.68 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.24 -0.913 . . . . 0.0 109.208 179.898 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 31.9 mm -69.29 -33.42 57.78 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.189 -0.945 . . . . 0.0 109.085 179.694 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.593 HG22 ' O ' ' A' ' 7' ' ' GLU . 2.4 tt -60.28 -40.4 83.68 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.242 -0.911 . . . . 0.0 108.709 179.595 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.419 ' N ' ' CG2' ' A' ' 10' ' ' ILE . . . -62.96 -20.91 62.95 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 108.586 -1.805 . . . . 0.0 108.586 179.319 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 49.6 t -88.66 -29.68 5.32 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.425 0 O-C-N 121.621 -0.929 . . . . 0.0 109.069 179.635 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 38.0 t -95.17 -0.63 53.09 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.294 -0.879 . . . . 0.0 109.453 179.827 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.458 ' HB2' ' O ' ' A' ' 10' ' ' ILE . 0.9 OUTLIER -99.26 -16.8 18.38 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.163 -0.961 . . . . 0.0 109.49 179.946 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 29.8 t0 -95.42 -54.82 3.25 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.23 -0.919 . . . . 0.0 109.415 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -52.18 -41.46 62.65 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.167 -0.958 . . . . 0.0 109.012 179.705 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.603 ' CG ' ' N ' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -59.14 -55.7 31.62 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 179.366 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.603 ' N ' ' CG ' ' A' ' 17' ' ' TYR . 9.3 ttm180 -66.96 -6.04 15.18 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 179.652 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.764 ' CD2' HD13 ' A' ' 23' ' ' ILE . 2.4 m-85 -107.59 -16.58 14.32 Favored 'General case' 0 C--N 1.305 -1.336 0 O-C-N 121.341 -0.85 . . . . 0.0 109.873 -179.265 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 1.9 mmt180 -74.78 -21.66 59.2 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.259 -0.9 . . . . 0.0 110.234 -179.323 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 8.5 t -107.71 24.63 12.62 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.036 -1.04 . . . . 0.0 109.997 -179.577 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.594 HG11 ' O ' ' A' ' 18' ' ' ARG . 0.1 OUTLIER -146.77 -49.46 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.547 0 O-C-N 121.333 -0.854 . . . . 0.0 109.631 -178.82 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.764 HD13 ' CD2' ' A' ' 19' ' ' TYR . 2.5 mp . . . . . 0 N--CA 1.489 1.503 0 O-C-N 120.977 -1.077 . . . . 0.0 109.409 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 7.3 t . . . . . 0 N--CA 1.49 1.538 0 CA-C-O 121.328 0.585 . . . . 0.0 109.546 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 2.5 mp -62.8 -21.87 28.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.171 -0.956 . . . . 0.0 109.464 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 19.9 mmtt -102.96 -41.08 6.24 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.322 -0.861 . . . . 0.0 109.339 179.858 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -67.62 -12.24 59.98 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.241 -0.912 . . . . 0.0 109.459 179.89 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 30.3 t-20 -87.67 -50.53 6.43 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.275 -0.89 . . . . 0.0 109.244 179.865 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 24.7 mm -70.69 -18.72 21.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.277 -0.889 . . . . 0.0 109.21 179.765 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.438 ' O ' ' N ' ' A' ' 14' ' ' TYR . 1.9 mm -66.64 -57.3 10.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.312 -0.867 . . . . 0.0 109.058 179.786 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -55.54 -20.45 23.84 Favored Glycine 0 N--CA 1.488 2.146 0 N-CA-C 109.065 -1.614 . . . . 0.0 109.065 179.658 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 69.0 t -86.76 -21.64 7.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.303 -1.116 . . . . 0.0 109.484 179.788 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.1 p -116.27 2.14 13.21 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.21 -0.931 . . . . 0.0 109.642 -179.885 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.438 ' N ' ' O ' ' A' ' 10' ' ' ILE . 0.3 OUTLIER -125.16 -35.36 2.64 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.215 -0.928 . . . . 0.0 109.663 -179.935 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -76.35 -38.97 55.1 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.123 -0.986 . . . . 0.0 109.408 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -58.18 -43.46 87.5 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.294 -0.879 . . . . 0.0 109.464 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.632 ' CG ' ' N ' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -62.91 -59.68 4.51 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 179.488 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.632 ' N ' ' CG ' ' A' ' 17' ' ' TYR . 4.8 ttm180 -53.92 -20.48 6.13 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 179.302 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.575 ' HA ' HG13 ' A' ' 22' ' ' VAL . 3.1 m-30 -92.39 -12.46 32.21 Favored 'General case' 0 C--N 1.305 -1.354 0 O-C-N 121.624 -0.673 . . . . 0.0 109.567 -179.725 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.28 -35.13 63.74 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.322 -0.861 . . . . 0.0 110.069 -179.442 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 48.3 t -90.41 21.35 3.93 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.142 -0.974 . . . . 0.0 109.882 -179.621 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.575 HG13 ' HA ' ' A' ' 19' ' ' TYR . 0.2 OUTLIER -150.09 -43.07 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.556 0 O-C-N 121.371 -0.831 . . . . 0.0 109.541 -178.777 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.46 HG12 HG13 ' A' ' 22' ' ' VAL . 3.8 mm . . . . . 0 N--CA 1.489 1.491 0 O-C-N 121.172 -0.955 . . . . 0.0 109.597 -179.669 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.434 ' O ' ' HB2' ' A' ' 8' ' ' ASN . 15.1 t . . . . . 0 N--CA 1.49 1.57 0 CA-C-O 121.172 0.51 . . . . 0.0 109.729 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.447 ' H ' HD12 ' A' ' 5' ' ' ILE . 2.5 mp -51.87 -21.38 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.233 -0.917 . . . . 0.0 109.477 -179.909 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 18.4 ttpt -93.4 -60.1 1.86 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.189 -0.944 . . . . 0.0 109.602 -179.923 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 7.3 tt0 -58.87 -24.86 62.74 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.237 -0.915 . . . . 0.0 109.753 -179.755 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' ASN . . . . . 0.434 ' HB2' ' O ' ' A' ' 4' ' ' THR . 6.0 t-20 -61.98 -45.76 92.25 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.092 -1.005 . . . . 0.0 109.555 -179.909 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.461 ' O ' ' N ' ' A' ' 12' ' ' VAL . 19.6 mm -69.52 -49.0 63.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.298 -0.876 . . . . 0.0 109.527 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 64.1 mt -46.5 -27.56 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.201 -0.937 . . . . 0.0 109.166 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -86.93 -26.88 30.36 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.329 -1.509 . . . . 0.0 109.329 179.809 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.461 ' N ' ' O ' ' A' ' 9' ' ' ILE . 76.5 t -60.03 -47.06 93.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.332 -1.099 . . . . 0.0 109.311 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 7.6 t -77.19 -16.66 59.0 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.263 -0.898 . . . . 0.0 109.283 179.708 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -86.15 -23.77 26.45 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.345 -0.847 . . . . 0.0 109.324 179.805 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.449 ' O ' ' C ' ' A' ' 16' ' ' GLU . 27.7 m-20 -76.44 -55.77 5.23 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.355 -0.841 . . . . 0.0 109.555 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.449 ' C ' ' O ' ' A' ' 15' ' ' ASP . 0.3 OUTLIER -43.77 -32.63 1.08 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.127 -0.983 . . . . 0.0 108.838 179.72 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -65.94 -48.79 70.2 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 108.385 -0.968 . . . . 0.0 108.385 179.116 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.572 ' O ' HG11 ' A' ' 22' ' ' VAL . 21.7 ttt180 -73.27 4.11 4.97 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.476 -0.765 . . . . 0.0 109.062 179.199 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.552 ' HA ' HD12 ' A' ' 23' ' ' ILE . 8.3 m-85 -119.78 -4.73 10.19 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.419 -0.8 . . . . 0.0 109.038 -179.297 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 1.7 tpt180 -95.52 -68.14 0.82 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.516 -0.74 . . . . 0.0 111.372 -178.296 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 18.3 t -85.25 20.36 1.99 Allowed 'General case' 0 N--CA 1.496 1.845 0 O-C-N 120.964 -1.085 . . . . 0.0 110.697 -178.406 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.577 HG22 ' N ' ' A' ' 23' ' ' ILE . 0.2 OUTLIER -134.04 -63.43 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.783 0 O-C-N 121.347 -0.846 . . . . 0.0 109.032 -179.183 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.577 ' N ' HG22 ' A' ' 22' ' ' VAL . 3.3 mt . . . . . 0 N--CA 1.489 1.492 0 O-C-N 121.238 -0.913 . . . . 0.0 109.288 179.782 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.659 ' O ' HG23 ' A' ' 4' ' ' THR . 15.0 t . . . . . 0 N--CA 1.49 1.562 0 N-CA-C 109.592 -0.521 . . . . 0.0 109.592 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.421 HD13 ' HA ' ' A' ' 5' ' ' ILE . 23.0 mm -74.88 -28.88 21.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.318 -0.864 . . . . 0.0 109.25 179.792 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 7.6 mtpt -106.21 -37.06 6.69 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.475 -0.766 . . . . 0.0 109.274 179.895 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.14 -15.91 62.92 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.313 -0.867 . . . . 0.0 108.992 179.775 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' ASN . . . . . 0.478 ' HB2' ' O ' ' A' ' 4' ' ' THR . 48.3 t-20 -78.76 -54.71 5.8 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.421 -0.8 . . . . 0.0 109.354 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.476 ' HA ' ' HB ' ' A' ' 12' ' ' VAL . 46.8 mm -67.99 -30.64 48.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.205 -0.934 . . . . 0.0 109.276 179.83 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.402 ' HA ' HD13 ' A' ' 10' ' ' ILE . 3.3 mm -50.91 -36.36 15.4 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 O-C-N 121.279 -0.888 . . . . 0.0 109.208 179.755 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -89.99 -32.47 9.84 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 179.916 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.476 ' HB ' ' HA ' ' A' ' 9' ' ' ILE . 47.4 t -70.48 -37.92 71.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.22 -1.165 . . . . 0.0 109.318 179.942 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -71.38 -13.31 61.81 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.3 -0.875 . . . . 0.0 109.468 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.461 ' O ' ' HB3' ' A' ' 17' ' ' TYR . 2.3 m-85 -77.96 -49.63 13.73 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.206 -0.934 . . . . 0.0 109.406 179.862 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.454 ' OD1' ' CE1' ' A' ' 19' ' ' TYR . 6.3 t0 -56.56 -46.07 80.92 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.182 -0.949 . . . . 0.0 109.1 179.799 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.402 ' C ' ' O ' ' A' ' 15' ' ' ASP . 0.6 OUTLIER -46.73 -39.26 11.28 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 108.204 -1.035 . . . . 0.0 108.204 179.401 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.461 ' HB3' ' O ' ' A' ' 14' ' ' TYR . 0.2 OUTLIER -64.1 -61.54 2.19 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 107.668 -1.234 . . . . 0.0 107.668 178.781 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.553 ' O ' ' CG1' ' A' ' 22' ' ' VAL . 4.0 ttt85 -52.37 -22.36 4.54 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 178.805 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.575 ' HA ' HG13 ' A' ' 22' ' ' VAL . 7.8 m-30 -91.79 -8.94 45.28 Favored 'General case' 0 C--N 1.305 -1.347 0 CA-C-O 121.346 0.593 . . . . 0.0 109.747 -179.637 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.432 ' O ' ' HG2' ' A' ' 20' ' ' ARG . 0.4 OUTLIER -75.14 -28.02 60.0 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.287 -0.883 . . . . 0.0 110.299 -179.121 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 7.4 t -105.48 28.4 7.44 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.981 -1.074 . . . . 0.0 110.047 -179.487 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.575 HG13 ' HA ' ' A' ' 19' ' ' TYR . 0.2 OUTLIER -155.02 -41.12 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.56 0 O-C-N 121.316 -0.865 . . . . 0.0 109.356 -178.833 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.464 ' CD1' ' CG ' ' A' ' 19' ' ' TYR . 4.6 mt . . . . . 0 N--CA 1.491 1.591 0 O-C-N 121.259 -0.901 . . . . 0.0 109.13 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 12.8 t . . . . . 0 N--CA 1.489 1.492 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.488 ' O ' HG12 ' A' ' 9' ' ' ILE . 21.5 mm -76.83 -43.1 33.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.375 -0.828 . . . . 0.0 109.746 -179.784 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.471 ' O ' HG13 ' A' ' 10' ' ' ILE . 0.2 OUTLIER -102.07 -15.16 16.83 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.217 -0.927 . . . . 0.0 109.746 -179.592 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 7.1 mt-10 -70.79 -29.5 65.72 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 120.96 -1.088 . . . . 0.0 109.572 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' ASN . . . . . 0.421 ' O ' HG23 ' A' ' 12' ' ' VAL . 41.3 t-20 -94.45 -37.83 11.23 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.162 -0.961 . . . . 0.0 109.701 -179.884 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.488 HG12 ' O ' ' A' ' 5' ' ' ILE . 18.7 mm -65.53 -41.9 91.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.172 -0.955 . . . . 0.0 109.487 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.471 HG13 ' O ' ' A' ' 6' ' ' LYS . 19.3 mt -49.64 -42.07 17.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.173 -0.954 . . . . 0.0 108.636 179.693 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -68.62 -32.07 74.26 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 108.662 -1.775 . . . . 0.0 108.662 179.14 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.421 HG23 ' O ' ' A' ' 8' ' ' ASN . 68.3 t -73.1 -33.18 41.63 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 O-C-N 121.437 -1.037 . . . . 0.0 108.89 179.395 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.583 ' O ' ' CD2' ' A' ' 17' ' ' TYR . 0.4 OUTLIER -91.04 17.55 7.86 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.439 -0.788 . . . . 0.0 109.187 179.744 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -118.96 -25.18 6.32 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.385 -0.822 . . . . 0.0 109.301 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.496 ' O ' ' HB2' ' A' ' 19' ' ' TYR . 0.1 OUTLIER -94.58 -50.48 5.17 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.291 -0.88 . . . . 0.0 109.425 179.951 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.419 ' C ' ' HB2' ' A' ' 19' ' ' TYR . 1.2 tt0 -51.57 -33.46 32.63 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.403 -0.81 . . . . 0.0 109.665 179.917 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.627 ' CD1' ' N ' ' A' ' 17' ' ' TYR . 3.8 m-30 -82.11 -59.8 2.44 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.293 -0.879 . . . . 0.0 109.042 -179.872 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.846 ' O ' HG12 ' A' ' 22' ' ' VAL . 1.0 OUTLIER -49.97 -24.51 2.62 Favored 'General case' 0 C--N 1.306 -1.302 0 N-CA-C 106.48 -1.674 . . . . 0.0 106.48 177.555 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.774 ' O ' HG13 ' A' ' 22' ' ' VAL . 0.1 OUTLIER -60.55 -35.71 76.7 Favored 'General case' 0 N--CA 1.484 1.245 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 178.502 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.422 ' N ' ' O ' ' A' ' 17' ' ' TYR . 30.8 mtp180 -68.56 -27.66 66.27 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.277 -0.89 . . . . 0.0 109.462 -179.696 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 5.7 t -92.13 29.37 1.65 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.283 -0.886 . . . . 0.0 109.336 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.846 HG12 ' O ' ' A' ' 18' ' ' ARG . 0.3 OUTLIER -150.34 -40.61 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.298 -1.644 0 O-C-N 121.609 -0.682 . . . . 0.0 109.229 -178.492 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.741 HD11 ' CD1' ' A' ' 19' ' ' TYR . 2.7 mt . . . . . 0 N--CA 1.491 1.595 0 O-C-N 121.072 -1.018 . . . . 0.0 108.86 179.492 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.1 t . . . . . 0 N--CA 1.491 1.585 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.43 ' O ' HG12 ' A' ' 9' ' ' ILE . 7.1 mt -70.44 -35.15 60.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.174 -0.954 . . . . 0.0 109.275 179.897 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.47 -27.08 58.71 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.299 -0.875 . . . . 0.0 109.435 179.794 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -65.9 -25.14 67.03 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.269 -0.894 . . . . 0.0 109.382 179.889 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 9.3 t-20 -84.21 -48.65 9.57 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.361 -0.837 . . . . 0.0 109.255 179.768 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.43 HG12 ' O ' ' A' ' 5' ' ' ILE . 37.5 mm -50.03 -38.37 14.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.307 -0.871 . . . . 0.0 108.917 179.719 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 21.7 mt -50.9 -40.81 20.87 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 179.562 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -68.79 -35.72 80.6 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 108.875 -1.69 . . . . 0.0 108.875 179.45 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.477 ' O ' HG12 ' A' ' 12' ' ' VAL . 71.8 t -74.37 -9.96 13.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.345 -1.091 . . . . 0.0 109.225 179.592 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -103.17 -47.31 4.37 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.451 -0.78 . . . . 0.0 109.578 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -54.61 -41.33 69.85 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.184 -0.947 . . . . 0.0 109.652 -179.817 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 2.2 t0 -68.9 -47.51 65.63 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.228 -0.92 . . . . 0.0 109.116 179.915 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.467 ' O ' ' HB2' ' A' ' 19' ' ' TYR . 0.2 OUTLIER -47.53 -31.91 4.8 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.268 -0.895 . . . . 0.0 108.828 179.611 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.575 ' CG ' ' N ' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -71.99 -65.84 0.72 Allowed 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 179.425 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.575 ' N ' ' CG ' ' A' ' 17' ' ' TYR . 5.0 ttp180 -47.04 -26.02 0.95 Allowed 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 179.215 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.738 ' CD2' HD13 ' A' ' 23' ' ' ILE . 1.6 m-85 -66.5 -48.81 68.61 Favored 'General case' 0 C--N 1.302 -1.462 0 CA-C-O 121.242 0.544 . . . . 0.0 109.733 179.713 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -53.87 -18.94 3.79 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.323 -0.861 . . . . 0.0 109.665 -179.741 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 2.4 t -89.14 -19.5 25.43 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.23 -0.919 . . . . 0.0 110.569 -179.42 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.456 ' CG1' ' O ' ' A' ' 18' ' ' ARG . 0.3 OUTLIER -123.13 -8.4 7.95 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.689 0 O-C-N 121.168 -0.958 . . . . 0.0 110.364 -178.133 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.738 HD13 ' CD2' ' A' ' 19' ' ' TYR . 2.5 mp . . . . . 0 N--CA 1.492 1.649 0 O-C-N 120.923 -1.111 . . . . 0.0 109.923 -179.8 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 10.7 t . . . . . 0 N--CA 1.49 1.542 0 CA-C-O 121.276 0.56 . . . . 0.0 109.498 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.459 ' O ' HG12 ' A' ' 9' ' ' ILE . 12.0 mt -82.6 -29.22 8.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.169 -0.957 . . . . 0.0 109.368 -179.961 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.775 ' O ' HD12 ' A' ' 10' ' ' ILE . 4.8 mttm -83.3 -45.01 14.29 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.243 -0.91 . . . . 0.0 109.421 179.941 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -51.8 -20.56 2.25 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.27 -0.894 . . . . 0.0 109.556 179.886 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 10.8 t-20 -87.41 -42.75 12.6 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.195 -0.941 . . . . 0.0 109.462 -179.86 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.459 HG12 ' O ' ' A' ' 5' ' ' ILE . 17.6 mm -78.12 -38.72 24.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.248 -0.907 . . . . 0.0 109.555 -179.923 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.775 HD12 ' O ' ' A' ' 6' ' ' LYS . 1.1 mp -54.15 -42.2 54.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.107 -0.996 . . . . 0.0 109.001 179.946 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.421 ' HA2' ' HB2' ' A' ' 14' ' ' TYR . . . -59.01 -36.28 87.63 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.296 -1.522 . . . . 0.0 109.296 179.828 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.439 ' HB ' ' O ' ' A' ' 9' ' ' ILE . 24.8 t -58.52 -42.41 84.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.282 -1.128 . . . . 0.0 109.419 179.969 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 8.5 t -85.03 -19.32 32.15 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.168 -0.957 . . . . 0.0 109.521 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.421 ' HB2' ' HA2' ' A' ' 11' ' ' GLY . 1.5 m-85 -78.0 -21.74 50.39 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.268 -0.895 . . . . 0.0 109.362 179.917 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 76.0 m-20 -74.09 -55.8 5.68 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.312 -0.867 . . . . 0.0 109.428 179.917 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.479 ' OE1' ' HA ' ' A' ' 16' ' ' GLU . 0.9 OUTLIER -50.72 -41.27 56.09 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.265 -0.897 . . . . 0.0 109.11 179.949 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.629 ' CG ' ' N ' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -67.11 -62.18 1.56 Allowed 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 179.465 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.629 ' N ' ' CG ' ' A' ' 17' ' ' TYR . 0.3 OUTLIER -51.3 -22.52 2.86 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 179.223 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.673 ' CD2' HD13 ' A' ' 23' ' ' ILE . 3.3 m-85 -85.26 -27.48 25.99 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.762 -0.587 . . . . 0.0 109.77 -179.86 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.29 4.95 13.62 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.251 -0.906 . . . . 0.0 109.634 -179.795 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 4.2 t -111.13 -29.99 7.65 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.137 -0.977 . . . . 0.0 110.68 -179.517 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.484 HG13 ' O ' ' A' ' 18' ' ' ARG . 2.0 m -111.83 -38.35 3.12 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.679 0 O-C-N 121.114 -0.991 . . . . 0.0 110.413 -177.81 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.673 HD13 ' CD2' ' A' ' 19' ' ' TYR . 3.0 mp . . . . . 0 N--CA 1.491 1.61 0 O-C-N 121.015 -1.053 . . . . 0.0 109.829 -179.478 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.426 ' OG1' ' HB2' ' A' ' 8' ' ' ASN . 3.3 t . . . . . 0 N--CA 1.492 1.671 0 CA-C-O 121.536 0.684 . . . . 0.0 109.295 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 2.5 mp -64.85 -16.67 20.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.581 -0.699 . . . . 0.0 109.802 -179.892 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 12.8 tttt -116.42 -30.43 5.89 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.111 -0.993 . . . . 0.0 109.666 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -78.76 -25.44 44.44 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.197 -0.939 . . . . 0.0 109.582 -179.915 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 8' ' ' ASN . . . . . 0.426 ' HB2' ' OG1' ' A' ' 4' ' ' THR . 0.4 OUTLIER -83.0 -26.62 31.08 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.238 -0.914 . . . . 0.0 109.478 -179.929 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.479 ' O ' ' N ' ' A' ' 12' ' ' VAL . 24.9 mm -86.01 -48.24 16.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.232 -0.918 . . . . 0.0 109.515 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -48.02 -32.16 3.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.288 -0.883 . . . . 0.0 109.117 -179.851 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.451 ' O ' ' OD2' ' A' ' 15' ' ' ASP . . . -75.25 -27.31 64.17 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 108.964 -1.655 . . . . 0.0 108.964 179.547 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.479 ' N ' ' O ' ' A' ' 9' ' ' ILE . 45.9 t -55.54 -27.27 20.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.345 -1.091 . . . . 0.0 109.141 179.808 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -107.55 -4.47 18.33 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.303 -0.873 . . . . 0.0 109.498 179.906 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.449 ' HB2' ' HA2' ' A' ' 11' ' ' GLY . 0.3 OUTLIER -100.08 -21.28 15.65 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.189 -0.944 . . . . 0.0 109.658 -179.834 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.478 ' OD1' ' N ' ' A' ' 16' ' ' GLU . 2.3 p30 -95.32 -44.71 7.46 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.235 -0.916 . . . . 0.0 109.418 179.874 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.478 ' N ' ' OD1' ' A' ' 15' ' ' ASP . 0.1 OUTLIER -56.96 -45.46 82.85 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.173 -0.954 . . . . 0.0 109.103 179.805 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.661 ' CG ' ' N ' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -59.75 -56.77 17.72 Favored 'General case' 0 N--CA 1.487 1.378 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 179.234 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.661 ' N ' ' CG ' ' A' ' 17' ' ' TYR . 0.0 OUTLIER -53.43 -20.88 5.15 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 178.881 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.565 ' HA ' HG13 ' A' ' 22' ' ' VAL . 2.5 m-30 -90.69 -12.91 35.32 Favored 'General case' 0 C--N 1.306 -1.323 0 CA-C-O 121.422 0.63 . . . . 0.0 109.386 179.768 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -71.76 -31.72 66.94 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.374 -0.829 . . . . 0.0 110.371 -179.208 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 3.1 t -96.17 24.37 5.72 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.031 -1.043 . . . . 0.0 109.796 -179.567 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.567 HG22 HG13 ' A' ' 23' ' ' ILE . 0.2 OUTLIER -149.82 -40.4 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.299 -1.598 0 O-C-N 121.346 -0.846 . . . . 0.0 109.426 -178.889 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.567 HG13 HG22 ' A' ' 22' ' ' VAL . 7.7 mt . . . . . 0 N--CA 1.489 1.523 0 O-C-N 121.26 -0.9 . . . . 0.0 109.299 -179.886 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.9 t . . . . . 0 N--CA 1.491 1.587 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.61 HG23 HG13 ' A' ' 9' ' ' ILE . 33.8 mt -99.01 -19.2 5.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.273 -0.892 . . . . 0.0 109.307 179.889 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.517 ' O ' HD12 ' A' ' 10' ' ' ILE . 0.7 OUTLIER -102.02 18.71 20.02 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.321 -0.862 . . . . 0.0 109.56 179.991 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -136.9 -39.92 0.61 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.106 -0.996 . . . . 0.0 109.563 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 21.5 t-20 -94.52 -53.01 4.06 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.307 -0.87 . . . . 0.0 109.503 -179.863 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.61 HG13 HG23 ' A' ' 5' ' ' ILE . 34.8 mm -55.83 -20.86 9.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.245 -0.91 . . . . 0.0 109.329 179.983 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.517 HD12 ' O ' ' A' ' 6' ' ' LYS . 23.9 mt -68.77 -43.55 82.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.309 -0.869 . . . . 0.0 109.198 179.809 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -65.65 -31.6 80.48 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.358 -1.497 . . . . 0.0 109.358 179.851 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 39.4 t -58.64 -29.02 38.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.262 -1.14 . . . . 0.0 109.448 179.943 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.577 ' O ' ' CZ ' ' A' ' 17' ' ' TYR . 22.6 m -86.2 -34.07 20.59 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.203 -0.936 . . . . 0.0 109.468 -179.996 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.593 ' HA ' ' CD2' ' A' ' 17' ' ' TYR . 0.3 OUTLIER -75.76 -27.3 58.0 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.256 -0.902 . . . . 0.0 109.434 -179.996 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.464 ' O ' ' CD1' ' A' ' 19' ' ' TYR . 0.7 OUTLIER -61.55 -45.04 95.83 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.287 -0.883 . . . . 0.0 109.31 179.902 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.412 ' O ' ' HB2' ' A' ' 19' ' ' TYR . 0.0 OUTLIER -60.29 -41.34 93.18 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.254 -0.904 . . . . 0.0 109.377 179.896 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.602 ' CD1' ' N ' ' A' ' 17' ' ' TYR . 1.2 m-30 -67.07 -42.15 85.18 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.273 -0.892 . . . . 0.0 108.943 179.978 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.529 ' O ' ' CG1' ' A' ' 22' ' ' VAL . 0.0 OUTLIER -80.58 7.64 9.59 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 108.62 -0.882 . . . . 0.0 108.62 178.725 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.715 ' CG ' HD13 ' A' ' 23' ' ' ILE . 3.2 m-30 -103.34 -42.62 5.66 Favored 'General case' 0 C--N 1.309 -1.16 0 O-C-N 121.493 -0.754 . . . . 0.0 109.456 -179.577 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 29.1 mtp180 -56.45 -33.81 66.24 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.441 -0.787 . . . . 0.0 110.276 -179.255 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 23.3 t -84.16 12.38 6.59 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.111 -0.993 . . . . 0.0 110.277 -179.35 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.802 HG22 ' N ' ' A' ' 23' ' ' ILE . 0.1 OUTLIER -146.73 -78.55 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.299 -1.601 0 O-C-N 121.184 -0.947 . . . . 0.0 110.094 -178.718 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.802 ' N ' HG22 ' A' ' 22' ' ' VAL . 1.7 mp . . . . . 0 N--CA 1.49 1.575 0 O-C-N 121.032 -1.043 . . . . 0.0 109.432 -179.62 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.501 ' HA ' HG22 ' A' ' 4' ' ' THR . 0.1 OUTLIER . . . . . 0 N--CA 1.493 1.694 0 CA-C-O 120.775 0.322 . . . . 0.0 110.28 . . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -75.43 -1.2 11.02 Favored 'Trans proline' 0 C--N 1.305 -1.736 0 O-C-N 123.984 1.518 . . . . 0.0 110.569 -179.852 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -166.45 34.89 0.23 Allowed Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.651 -1.379 . . . . 0.0 109.651 -179.848 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.705 ' O ' HG23 ' A' ' 4' ' ' THR . 11.6 t -147.92 47.58 1.08 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.262 -1.14 . . . . 0.0 109.359 179.84 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.463 ' O ' HG12 ' A' ' 9' ' ' ILE . 70.9 mt -93.76 -39.2 10.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.33 -0.856 . . . . 0.0 109.61 -179.858 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.54 -41.89 12.43 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.253 -0.905 . . . . 0.0 109.272 179.912 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.5 ' HA ' HD12 ' A' ' 10' ' ' ILE . 16.6 tp10 -59.41 -15.44 16.96 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.311 -0.868 . . . . 0.0 109.382 179.881 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -87.84 -42.62 12.42 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.25 -0.906 . . . . 0.0 109.388 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.463 HG12 ' O ' ' A' ' 5' ' ' ILE . 23.9 mm -61.64 -40.62 87.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.225 -0.922 . . . . 0.0 109.191 179.827 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.5 HD12 ' HA ' ' A' ' 7' ' ' GLU . 15.2 mt -48.89 -30.95 3.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.235 -0.916 . . . . 0.0 108.882 179.593 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -86.51 -33.78 13.01 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.531 -1.427 . . . . 0.0 109.531 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 44.1 t -70.25 -37.64 71.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.225 -1.162 . . . . 0.0 109.415 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -76.49 -42.8 42.21 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.223 -0.923 . . . . 0.0 109.431 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.405 ' HB2' ' O ' ' A' ' 10' ' ' ILE . 0.2 OUTLIER -49.03 -22.33 0.87 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.304 -0.873 . . . . 0.0 109.397 179.837 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.473 ' O ' ' HB2' ' A' ' 19' ' ' TYR . 1.7 t70 -94.67 -56.89 2.63 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.211 -0.93 . . . . 0.0 109.686 -179.906 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.494 ' O ' ' N ' ' A' ' 20' ' ' ARG . 0.9 OUTLIER -46.12 -39.9 10.19 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.275 -0.89 . . . . 0.0 109.046 -179.943 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.605 ' CG ' ' N ' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -65.82 -56.38 12.2 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 108.674 -0.861 . . . . 0.0 108.674 179.536 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 1.035 ' O ' HG11 ' A' ' 22' ' ' VAL . 2.3 ttt-85 -67.49 -1.55 5.1 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.656 -0.652 . . . . 0.0 109.467 179.66 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.616 ' O ' HD12 ' A' ' 23' ' ' ILE . 6.1 m-85 -119.63 -8.6 9.93 Favored 'General case' 0 C--N 1.308 -1.221 0 CA-C-O 121.616 0.722 . . . . 0.0 109.066 -179.725 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.494 ' N ' ' O ' ' A' ' 16' ' ' GLU . 6.8 ttt-85 -64.34 -45.39 88.05 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.562 -0.712 . . . . 0.0 111.648 -178.19 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 3.5 t -127.85 48.8 2.21 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.697 -1.252 . . . . 0.0 110.609 -178.234 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 1.035 HG11 ' O ' ' A' ' 18' ' ' ARG . 0.6 OUTLIER -138.06 -37.42 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.759 0 O-C-N 121.433 -0.792 . . . . 0.0 109.921 -179.29 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.616 HD12 ' O ' ' A' ' 19' ' ' TYR . 5.1 mt -60.02 -46.76 93.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.134 -0.979 . . . . 0.0 109.598 -179.383 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.435 ' O ' ' HG2' ' A' ' 24' ' ' LYS . 3.4 ttmm -52.8 91.87 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.24 -0.913 . . . . 0.0 109.342 179.805 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.482 ' N ' ' O ' ' A' ' 23' ' ' ILE . . . . . . . . 0 N--CA 1.49 1.535 0 CA-C-O 118.0 -1.0 . . . . 0.0 109.488 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.622 0 CA-C-O 120.798 0.333 . . . . 0.0 110.185 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -74.73 1.38 7.64 Favored 'Trans proline' 0 C--N 1.306 -1.673 0 O-C-N 124.058 1.557 . . . . 0.0 110.52 -179.874 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' GLY . . . . . 0.475 ' O ' ' HB2' ' A' ' 7' ' ' GLU . . . -83.71 -21.4 57.95 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 13.3 t -129.12 -31.7 2.09 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.342 -1.093 . . . . 0.0 109.745 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 20.8 mm -65.25 -16.44 20.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.195 -0.94 . . . . 0.0 109.663 -179.803 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -128.42 -28.11 2.58 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.133 -0.98 . . . . 0.0 109.945 -179.738 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.475 ' HB2' ' O ' ' A' ' 3' ' ' GLY . 0.0 OUTLIER -82.62 -29.06 30.37 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.127 -0.983 . . . . 0.0 109.767 -179.805 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 41.4 t30 -67.39 -49.1 65.32 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.107 -0.996 . . . . 0.0 109.238 179.776 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 47.5 mm -57.53 -37.88 60.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.305 -0.872 . . . . 0.0 109.348 179.909 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.426 HD12 ' HA ' ' A' ' 7' ' ' GLU . 56.7 mt -53.5 -44.77 57.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.201 -0.937 . . . . 0.0 108.75 179.662 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.47 ' O ' ' HB2' ' A' ' 15' ' ' ASP . . . -69.32 -13.41 67.58 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 108.943 -1.663 . . . . 0.0 108.943 179.426 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.454 ' O ' HG12 ' A' ' 12' ' ' VAL . 55.1 t -98.32 -12.38 8.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.406 -1.056 . . . . 0.0 109.169 179.675 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.448 ' O ' ' HB3' ' A' ' 17' ' ' TYR . 23.2 p -120.64 -34.48 3.58 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.272 -0.892 . . . . 0.0 109.505 -179.823 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -77.26 -42.78 35.77 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.201 -0.937 . . . . 0.0 109.33 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.47 ' HB2' ' O ' ' A' ' 11' ' ' GLY . 3.1 m-20 -62.13 -54.35 42.49 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.218 -0.926 . . . . 0.0 109.103 179.83 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.45 ' O ' ' N ' ' A' ' 20' ' ' ARG . 1.6 tt0 -54.92 -43.86 73.7 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.204 -0.935 . . . . 0.0 108.891 179.58 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.526 ' CG ' ' N ' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -61.03 -58.31 8.96 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 179.159 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.526 ' N ' ' CG ' ' A' ' 17' ' ' TYR . 5.3 ttm180 -58.78 -14.92 10.03 Favored 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 108.898 -0.779 . . . . 0.0 108.898 179.455 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.656 ' HA ' HG13 ' A' ' 22' ' ' VAL . 3.1 m-85 -97.42 -27.63 14.37 Favored 'General case' 0 C--N 1.307 -1.252 0 O-C-N 121.462 -0.774 . . . . 0.0 109.709 -179.629 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.45 ' N ' ' O ' ' A' ' 16' ' ' GLU . 0.0 OUTLIER -65.96 -10.56 40.39 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.184 -0.948 . . . . 0.0 109.999 -179.353 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 5.5 t -111.16 14.91 21.77 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.032 -1.043 . . . . 0.0 109.436 179.873 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.656 HG13 ' HA ' ' A' ' 19' ' ' TYR . 0.1 OUTLIER -146.75 -39.94 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.594 0 O-C-N 121.549 -0.72 . . . . 0.0 109.447 -178.299 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.405 HG13 ' HB3' ' A' ' 19' ' ' TYR . 5.4 mm -86.35 -69.82 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 O-C-N 121.203 -0.935 . . . . 0.0 109.494 -179.677 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -69.39 -177.51 1.17 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.163 -0.961 . . . . 0.0 109.393 179.876 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.597 0 CA-C-O 117.98 -1.01 . . . . 0.0 109.481 -179.959 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.3 ttp . . . . . 0 N--CA 1.491 1.581 0 CA-C-O 120.817 0.342 . . . . 0.0 110.187 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -74.17 1.95 6.68 Favored 'Trans proline' 0 C--N 1.305 -1.713 0 O-C-N 124.079 1.568 . . . . 0.0 110.626 179.818 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' GLY . . . . . 0.536 ' O ' ' CG2' ' A' ' 4' ' ' THR . . . 135.87 -113.22 1.06 Allowed Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 179.905 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.536 ' CG2' ' O ' ' A' ' 3' ' ' GLY . 4.2 t 40.59 29.2 0.06 Allowed 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.617 -0.931 . . . . 0.0 109.26 -179.846 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.45 ' N ' ' O ' ' A' ' 3' ' ' GLY . 52.4 mt -75.06 -16.97 16.1 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.474 0 O-C-N 121.444 -0.785 . . . . 0.0 109.419 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 9.3 pttt -107.02 -30.5 8.78 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.265 -0.897 . . . . 0.0 109.468 179.828 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -62.23 -22.29 65.84 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.19 -0.944 . . . . 0.0 109.195 179.831 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 12.3 t-20 -80.73 -52.25 7.74 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.265 -0.897 . . . . 0.0 109.297 179.864 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.505 ' O ' ' N ' ' A' ' 12' ' ' VAL . 41.2 mm -63.14 -45.93 97.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.307 -0.871 . . . . 0.0 109.481 179.927 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 48.0 mt -47.8 -29.17 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.138 -0.976 . . . . 0.0 109.074 179.883 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -81.63 -23.88 57.23 Favored Glycine 0 N--CA 1.489 2.172 0 N-CA-C 109.157 -1.577 . . . . 0.0 109.157 179.583 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.505 ' N ' ' O ' ' A' ' 9' ' ' ILE . 75.6 t -65.02 -33.85 66.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.45 -1.029 . . . . 0.0 109.335 179.721 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -75.1 -30.76 60.98 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.227 -0.92 . . . . 0.0 109.329 179.77 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -56.76 -45.72 81.86 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.292 -0.88 . . . . 0.0 109.389 179.846 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.573 ' HB3' ' CE2' ' A' ' 19' ' ' TYR . 67.9 m-20 -55.91 -45.65 78.61 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.271 -0.893 . . . . 0.0 109.211 179.809 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -51.16 -42.5 60.84 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.338 -0.851 . . . . 0.0 108.768 179.507 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.533 ' CD1' ' C ' ' A' ' 17' ' ' TYR . 0.0 OUTLIER -64.66 -62.32 1.65 Allowed 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 179.261 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.523 ' N ' ' CG ' ' A' ' 17' ' ' TYR . 0.0 OUTLIER -54.42 -20.08 6.8 Favored 'General case' 0 C--N 1.303 -1.413 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 179.321 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.627 ' HA ' HG13 ' A' ' 22' ' ' VAL . 4.6 m-30 -88.25 -22.32 24.01 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 179.631 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.453 ' O ' ' HG3' ' A' ' 20' ' ' ARG . 24.3 tpp180 -67.18 -18.45 65.27 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.335 -0.853 . . . . 0.0 110.107 -179.439 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 4.1 t -105.8 16.51 25.13 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.993 -1.067 . . . . 0.0 109.832 -179.734 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.627 HG13 ' HA ' ' A' ' 19' ' ' TYR . 0.1 OUTLIER -149.58 -44.83 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.298 -1.639 0 O-C-N 121.333 -0.854 . . . . 0.0 109.837 -178.461 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.501 HG13 ' HB3' ' A' ' 19' ' ' TYR . 11.5 mm -79.46 -65.61 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.41 0 O-C-N 121.083 -1.011 . . . . 0.0 109.96 -179.431 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.411 ' O ' ' HG2' ' A' ' 24' ' ' LYS . 0.1 OUTLIER -79.92 -10.8 59.81 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.173 -0.954 . . . . 0.0 109.637 -179.951 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.579 0 CA-C-O 117.977 -1.011 . . . . 0.0 109.555 179.979 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.481 ' N ' ' HD3' ' A' ' 2' ' ' PRO . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.752 0 N-CA-C 110.141 -0.318 . . . . 0.0 110.141 . . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 2' ' ' PRO . . . . . 0.481 ' HD3' ' N ' ' A' ' 1' ' ' MET . 50.3 Cg_endo -80.17 13.5 2.18 Favored 'Trans proline' 0 C--N 1.306 -1.681 0 O-C-N 124.086 1.572 . . . . 0.0 110.875 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -49.16 119.78 6.52 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.697 -1.361 . . . . 0.0 109.697 -179.925 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 4.1 t -111.9 36.86 3.14 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.283 -1.128 . . . . 0.0 109.378 179.735 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.504 ' N ' HD13 ' A' ' 5' ' ' ILE . 3.3 mm -84.49 -12.08 11.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.32 -0.863 . . . . 0.0 109.547 -179.82 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -113.94 -22.09 10.28 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.27 -0.894 . . . . 0.0 109.436 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 4.9 tm-20 -86.42 -11.77 50.98 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.29 -0.881 . . . . 0.0 109.578 -179.745 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 18.0 t-20 -95.92 -49.18 5.41 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.245 -0.909 . . . . 0.0 109.355 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.409 HD13 ' HA ' ' A' ' 9' ' ' ILE . 49.1 mm -62.13 -34.96 66.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.284 -0.885 . . . . 0.0 109.541 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.402 ' O ' ' HB2' ' A' ' 14' ' ' TYR . 10.4 tt -49.41 -35.1 8.44 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 O-C-N 121.234 -0.916 . . . . 0.0 109.15 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.493 ' O ' ' N ' ' A' ' 15' ' ' ASP . . . -76.21 -39.92 30.5 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 109.059 -1.616 . . . . 0.0 109.059 179.666 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.484 ' O ' ' HB2' ' A' ' 16' ' ' GLU . 55.2 t -54.22 -32.7 23.94 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.319 -1.106 . . . . 0.0 109.066 179.581 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -96.08 -5.47 40.82 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.365 -0.835 . . . . 0.0 109.204 179.762 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.434 ' O ' ' CD2' ' A' ' 17' ' ' TYR . 1.8 m-85 -111.35 -56.32 2.39 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.22 -0.925 . . . . 0.0 109.382 179.917 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.493 ' N ' ' O ' ' A' ' 11' ' ' GLY . 14.3 t70 -58.4 -46.16 86.95 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.054 -1.029 . . . . 0.0 109.176 179.832 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.484 ' HB2' ' O ' ' A' ' 12' ' ' VAL . 1.9 tp10 -56.83 -48.43 78.04 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.268 -0.895 . . . . 0.0 109.221 179.774 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.62 ' CG ' ' N ' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -55.54 -55.8 27.75 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 179.404 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.713 ' O ' HG11 ' A' ' 22' ' ' VAL . 0.0 OUTLIER -58.93 -15.08 11.13 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 108.963 -0.755 . . . . 0.0 108.963 179.59 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.61 ' HA ' ' CG1' ' A' ' 22' ' ' VAL . 3.1 m-85 -102.83 -16.2 16.0 Favored 'General case' 0 C--N 1.305 -1.336 0 O-C-N 121.614 -0.679 . . . . 0.0 110.383 -178.918 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.437 ' N ' ' O ' ' A' ' 16' ' ' GLU . 0.0 OUTLIER -70.68 -21.1 62.62 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.172 -0.955 . . . . 0.0 110.998 -178.657 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 4.9 t -122.51 41.88 3.31 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.705 -1.247 . . . . 0.0 110.23 -179.112 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.713 HG11 ' O ' ' A' ' 18' ' ' ARG . 0.3 OUTLIER -155.35 -37.34 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 O-C-N 121.155 -0.966 . . . . 0.0 110.195 -178.531 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.531 HD11 ' CD2' ' A' ' 19' ' ' TYR . 12.3 mm -71.31 -60.08 2.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.061 -1.025 . . . . 0.0 109.72 -179.239 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -177.64 -73.68 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.288 -0.883 . . . . 0.0 109.545 -179.936 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.548 0 CA-C-O 118.028 -0.987 . . . . 0.0 109.392 179.963 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.6 mtp . . . . . 0 N--CA 1.491 1.618 0 CA-C-O 120.719 0.295 . . . . 0.0 110.26 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -73.81 -0.78 9.88 Favored 'Trans proline' 0 C--N 1.305 -1.728 0 O-C-N 124.112 1.585 . . . . 0.0 110.485 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -102.0 -161.45 26.59 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 -179.854 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 11.1 t -124.92 35.13 4.84 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.255 -1.144 . . . . 0.0 109.47 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 24.4 mm -81.93 -30.96 10.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.34 -0.85 . . . . 0.0 109.627 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 19.5 ttpt -87.56 -29.89 20.94 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.205 -0.934 . . . . 0.0 109.621 -179.863 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.593 ' O ' HG22 ' A' ' 10' ' ' ILE . 0.8 OUTLIER -74.79 -47.29 31.59 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.226 -0.921 . . . . 0.0 109.495 -179.916 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 33.1 t-20 -48.82 -35.08 13.68 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.24 -0.913 . . . . 0.0 109.208 179.898 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 31.9 mm -69.29 -33.42 57.78 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.189 -0.945 . . . . 0.0 109.085 179.694 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.593 HG22 ' O ' ' A' ' 7' ' ' GLU . 2.4 tt -60.28 -40.4 83.68 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.242 -0.911 . . . . 0.0 108.709 179.595 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.419 ' N ' ' CG2' ' A' ' 10' ' ' ILE . . . -62.96 -20.91 62.95 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 108.586 -1.805 . . . . 0.0 108.586 179.319 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 49.6 t -88.66 -29.68 5.32 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.425 0 O-C-N 121.621 -0.929 . . . . 0.0 109.069 179.635 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 38.0 t -95.17 -0.63 53.09 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.294 -0.879 . . . . 0.0 109.453 179.827 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.458 ' HB2' ' O ' ' A' ' 10' ' ' ILE . 0.9 OUTLIER -99.26 -16.8 18.38 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.163 -0.961 . . . . 0.0 109.49 179.946 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 29.8 t0 -95.42 -54.82 3.25 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.23 -0.919 . . . . 0.0 109.415 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -52.18 -41.46 62.65 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.167 -0.958 . . . . 0.0 109.012 179.705 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.603 ' CG ' ' N ' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -59.14 -55.7 31.62 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 179.366 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.603 ' N ' ' CG ' ' A' ' 17' ' ' TYR . 9.3 ttm180 -66.96 -6.04 15.18 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 179.652 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.764 ' CD2' HD13 ' A' ' 23' ' ' ILE . 2.4 m-85 -107.59 -16.58 14.32 Favored 'General case' 0 C--N 1.305 -1.336 0 O-C-N 121.341 -0.85 . . . . 0.0 109.873 -179.265 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 1.9 mmt180 -74.78 -21.66 59.2 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.259 -0.9 . . . . 0.0 110.234 -179.323 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 8.5 t -107.71 24.63 12.62 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.036 -1.04 . . . . 0.0 109.997 -179.577 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.594 HG11 ' O ' ' A' ' 18' ' ' ARG . 0.1 OUTLIER -146.77 -49.46 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.547 0 O-C-N 121.333 -0.854 . . . . 0.0 109.631 -178.82 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.764 HD13 ' CD2' ' A' ' 19' ' ' TYR . 2.5 mp -100.67 -54.98 6.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 120.977 -1.077 . . . . 0.0 109.409 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 5.3 mttm -82.49 68.97 9.15 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.211 -0.931 . . . . 0.0 109.426 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.565 0 CA-C-O 117.972 -1.013 . . . . 0.0 109.519 179.945 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.647 0 N-CA-C 110.096 -0.335 . . . . 0.0 110.096 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -73.93 -0.65 9.76 Favored 'Trans proline' 0 C--N 1.304 -1.767 0 O-C-N 124.13 1.595 . . . . 0.0 110.633 -179.914 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -87.18 97.55 2.28 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 7.3 t -61.41 -27.19 68.36 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.221 -1.164 . . . . 0.0 109.546 -179.938 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 2.5 mp -62.8 -21.87 28.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.171 -0.956 . . . . 0.0 109.464 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 19.9 mmtt -102.96 -41.08 6.24 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.322 -0.861 . . . . 0.0 109.339 179.858 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -67.62 -12.24 59.98 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.241 -0.912 . . . . 0.0 109.459 179.89 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 30.3 t-20 -87.67 -50.53 6.43 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.275 -0.89 . . . . 0.0 109.244 179.865 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 24.7 mm -70.69 -18.72 21.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.277 -0.889 . . . . 0.0 109.21 179.765 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.438 ' O ' ' N ' ' A' ' 14' ' ' TYR . 1.9 mm -66.64 -57.3 10.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.312 -0.867 . . . . 0.0 109.058 179.786 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -55.54 -20.45 23.84 Favored Glycine 0 N--CA 1.488 2.146 0 N-CA-C 109.065 -1.614 . . . . 0.0 109.065 179.658 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 69.0 t -86.76 -21.64 7.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.303 -1.116 . . . . 0.0 109.484 179.788 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.1 p -116.27 2.14 13.21 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.21 -0.931 . . . . 0.0 109.642 -179.885 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.438 ' N ' ' O ' ' A' ' 10' ' ' ILE . 0.3 OUTLIER -125.16 -35.36 2.64 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.215 -0.928 . . . . 0.0 109.663 -179.935 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -76.35 -38.97 55.1 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.123 -0.986 . . . . 0.0 109.408 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -58.18 -43.46 87.5 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.294 -0.879 . . . . 0.0 109.464 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.632 ' CG ' ' N ' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -62.91 -59.68 4.51 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 179.488 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.632 ' N ' ' CG ' ' A' ' 17' ' ' TYR . 4.8 ttm180 -53.92 -20.48 6.13 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 179.302 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.575 ' HA ' HG13 ' A' ' 22' ' ' VAL . 3.1 m-30 -92.39 -12.46 32.21 Favored 'General case' 0 C--N 1.305 -1.354 0 O-C-N 121.624 -0.673 . . . . 0.0 109.567 -179.725 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.28 -35.13 63.74 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.322 -0.861 . . . . 0.0 110.069 -179.442 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 48.3 t -90.41 21.35 3.93 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.142 -0.974 . . . . 0.0 109.882 -179.621 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.575 HG13 ' HA ' ' A' ' 19' ' ' TYR . 0.2 OUTLIER -150.09 -43.07 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.556 0 O-C-N 121.371 -0.831 . . . . 0.0 109.541 -178.777 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.46 HG12 HG13 ' A' ' 22' ' ' VAL . 3.8 mm -93.2 -64.48 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.172 -0.955 . . . . 0.0 109.597 -179.669 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 60.68 37.45 19.09 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.228 -0.92 . . . . 0.0 109.34 -179.821 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.547 0 CA-C-O 117.985 -1.007 . . . . 0.0 109.514 -179.895 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.2 ttp . . . . . 0 N--CA 1.492 1.646 0 CA-C-O 120.869 0.366 . . . . 0.0 110.323 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' PRO . . . . . 0.515 ' HB2' HD13 ' A' ' 5' ' ' ILE . 46.5 Cg_endo -73.85 0.09 8.74 Favored 'Trans proline' 0 C--N 1.307 -1.651 0 O-C-N 124.007 1.53 . . . . 0.0 110.633 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 133.48 -110.05 0.86 Allowed Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.648 -1.381 . . . . 0.0 109.648 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.434 ' O ' ' HB2' ' A' ' 8' ' ' ASN . 15.1 t -112.04 -12.54 13.69 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.302 -1.117 . . . . 0.0 109.729 -179.833 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.515 HD13 ' HB2' ' A' ' 2' ' ' PRO . 2.5 mp -51.87 -21.38 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.233 -0.917 . . . . 0.0 109.477 -179.909 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 18.4 ttpt -93.4 -60.1 1.86 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.189 -0.944 . . . . 0.0 109.602 -179.923 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 7.3 tt0 -58.87 -24.86 62.74 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.237 -0.915 . . . . 0.0 109.753 -179.755 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.434 ' HB2' ' O ' ' A' ' 4' ' ' THR . 6.0 t-20 -61.98 -45.76 92.25 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.092 -1.005 . . . . 0.0 109.555 -179.909 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.461 ' O ' ' N ' ' A' ' 12' ' ' VAL . 19.6 mm -69.52 -49.0 63.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.298 -0.876 . . . . 0.0 109.527 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 64.1 mt -46.5 -27.56 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.201 -0.937 . . . . 0.0 109.166 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -86.93 -26.88 30.36 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.329 -1.509 . . . . 0.0 109.329 179.809 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.461 ' N ' ' O ' ' A' ' 9' ' ' ILE . 76.5 t -60.03 -47.06 93.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.332 -1.099 . . . . 0.0 109.311 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 7.6 t -77.19 -16.66 59.0 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.263 -0.898 . . . . 0.0 109.283 179.708 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -86.15 -23.77 26.45 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.345 -0.847 . . . . 0.0 109.324 179.805 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.449 ' O ' ' C ' ' A' ' 16' ' ' GLU . 27.7 m-20 -76.44 -55.77 5.23 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.355 -0.841 . . . . 0.0 109.555 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.449 ' C ' ' O ' ' A' ' 15' ' ' ASP . 0.3 OUTLIER -43.77 -32.63 1.08 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.127 -0.983 . . . . 0.0 108.838 179.72 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -65.94 -48.79 70.2 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 108.385 -0.968 . . . . 0.0 108.385 179.116 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.572 ' O ' HG11 ' A' ' 22' ' ' VAL . 21.7 ttt180 -73.27 4.11 4.97 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.476 -0.765 . . . . 0.0 109.062 179.199 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.552 ' HA ' HD12 ' A' ' 23' ' ' ILE . 8.3 m-85 -119.78 -4.73 10.19 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.419 -0.8 . . . . 0.0 109.038 -179.297 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 1.7 tpt180 -95.52 -68.14 0.82 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.516 -0.74 . . . . 0.0 111.372 -178.296 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 18.3 t -85.25 20.36 1.99 Allowed 'General case' 0 N--CA 1.496 1.845 0 O-C-N 120.964 -1.085 . . . . 0.0 110.697 -178.406 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.577 HG22 ' N ' ' A' ' 23' ' ' ILE . 0.2 OUTLIER -134.04 -63.43 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.783 0 O-C-N 121.347 -0.846 . . . . 0.0 109.032 -179.183 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.577 ' N ' HG22 ' A' ' 22' ' ' VAL . 3.3 mt -87.71 -33.12 6.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.238 -0.913 . . . . 0.0 109.288 179.782 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.548 ' O ' ' HB2' ' A' ' 25' ' ' ALA . 0.0 OUTLIER 44.61 61.15 2.56 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.296 -0.878 . . . . 0.0 109.539 179.995 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.548 ' HB2' ' O ' ' A' ' 24' ' ' LYS . . . . . . . . 0 N--CA 1.489 1.501 0 CA-C-O 117.97 -1.014 . . . . 0.0 109.469 180.0 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.3 mtp . . . . . 0 N--CA 1.492 1.652 0 CA-C-O 120.725 0.298 . . . . 0.0 110.339 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -80.44 6.37 5.45 Favored 'Trans proline' 0 C--N 1.306 -1.695 0 O-C-N 123.958 1.504 . . . . 0.0 110.495 -179.851 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -119.8 55.97 0.6 Allowed Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.689 -1.364 . . . . 0.0 109.689 -179.887 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.659 ' O ' HG23 ' A' ' 4' ' ' THR . 15.0 t -148.44 50.63 1.01 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.238 -1.154 . . . . 0.0 109.592 179.93 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.421 HD13 ' HA ' ' A' ' 5' ' ' ILE . 23.0 mm -74.88 -28.88 21.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.318 -0.864 . . . . 0.0 109.25 179.792 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 7.6 mtpt -106.21 -37.06 6.69 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.475 -0.766 . . . . 0.0 109.274 179.895 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.14 -15.91 62.92 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.313 -0.867 . . . . 0.0 108.992 179.775 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.478 ' HB2' ' O ' ' A' ' 4' ' ' THR . 48.3 t-20 -78.76 -54.71 5.8 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.421 -0.8 . . . . 0.0 109.354 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.476 ' HA ' ' HB ' ' A' ' 12' ' ' VAL . 46.8 mm -67.99 -30.64 48.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.205 -0.934 . . . . 0.0 109.276 179.83 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.402 ' HA ' HD13 ' A' ' 10' ' ' ILE . 3.3 mm -50.91 -36.36 15.4 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 O-C-N 121.279 -0.888 . . . . 0.0 109.208 179.755 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -89.99 -32.47 9.84 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 179.916 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.476 ' HB ' ' HA ' ' A' ' 9' ' ' ILE . 47.4 t -70.48 -37.92 71.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.22 -1.165 . . . . 0.0 109.318 179.942 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -71.38 -13.31 61.81 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.3 -0.875 . . . . 0.0 109.468 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.461 ' O ' ' HB3' ' A' ' 17' ' ' TYR . 2.3 m-85 -77.96 -49.63 13.73 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.206 -0.934 . . . . 0.0 109.406 179.862 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.454 ' OD1' ' CE1' ' A' ' 19' ' ' TYR . 6.3 t0 -56.56 -46.07 80.92 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.182 -0.949 . . . . 0.0 109.1 179.799 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.402 ' C ' ' O ' ' A' ' 15' ' ' ASP . 0.6 OUTLIER -46.73 -39.26 11.28 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 108.204 -1.035 . . . . 0.0 108.204 179.401 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.461 ' HB3' ' O ' ' A' ' 14' ' ' TYR . 0.2 OUTLIER -64.1 -61.54 2.19 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 107.668 -1.234 . . . . 0.0 107.668 178.781 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.553 ' O ' ' CG1' ' A' ' 22' ' ' VAL . 4.0 ttt85 -52.37 -22.36 4.54 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 178.805 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.575 ' HA ' HG13 ' A' ' 22' ' ' VAL . 7.8 m-30 -91.79 -8.94 45.28 Favored 'General case' 0 C--N 1.305 -1.347 0 CA-C-O 121.346 0.593 . . . . 0.0 109.747 -179.637 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.46 ' O ' ' HG2' ' A' ' 24' ' ' LYS . 0.4 OUTLIER -75.14 -28.02 60.0 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.287 -0.883 . . . . 0.0 110.299 -179.121 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 7.4 t -105.48 28.4 7.44 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.981 -1.074 . . . . 0.0 110.047 -179.487 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.575 HG13 ' HA ' ' A' ' 19' ' ' TYR . 0.2 OUTLIER -155.02 -41.12 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.56 0 O-C-N 121.316 -0.865 . . . . 0.0 109.356 -178.833 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.464 ' CD1' ' CG ' ' A' ' 19' ' ' TYR . 4.6 mt -107.17 -31.07 2.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.259 -0.901 . . . . 0.0 109.13 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.46 ' HG2' ' O ' ' A' ' 20' ' ' ARG . 15.8 mttt 44.98 66.65 0.85 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.336 -0.852 . . . . 0.0 109.538 179.926 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.508 0 CA-C-O 117.971 -1.014 . . . . 0.0 109.473 179.907 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.5 tpp . . . . . 0 N--CA 1.491 1.593 0 N-CA-C 110.072 -0.344 . . . . 0.0 110.072 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -73.76 -0.67 9.71 Favored 'Trans proline' 0 C--N 1.305 -1.712 0 O-C-N 123.866 1.456 . . . . 0.0 110.403 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 102.24 -172.22 22.12 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 12.8 t -100.54 30.81 3.74 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.332 -1.099 . . . . 0.0 109.243 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.488 ' O ' HG12 ' A' ' 9' ' ' ILE . 21.5 mm -76.83 -43.1 33.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.375 -0.828 . . . . 0.0 109.746 -179.784 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.471 ' O ' HG13 ' A' ' 10' ' ' ILE . 0.2 OUTLIER -102.07 -15.16 16.83 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.217 -0.927 . . . . 0.0 109.746 -179.592 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 7.1 mt-10 -70.79 -29.5 65.72 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 120.96 -1.088 . . . . 0.0 109.572 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.421 ' O ' HG23 ' A' ' 12' ' ' VAL . 41.3 t-20 -94.45 -37.83 11.23 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.162 -0.961 . . . . 0.0 109.701 -179.884 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.488 HG12 ' O ' ' A' ' 5' ' ' ILE . 18.7 mm -65.53 -41.9 91.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.172 -0.955 . . . . 0.0 109.487 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.471 HG13 ' O ' ' A' ' 6' ' ' LYS . 19.3 mt -49.64 -42.07 17.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.173 -0.954 . . . . 0.0 108.636 179.693 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -68.62 -32.07 74.26 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 108.662 -1.775 . . . . 0.0 108.662 179.14 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.421 HG23 ' O ' ' A' ' 8' ' ' ASN . 68.3 t -73.1 -33.18 41.63 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 O-C-N 121.437 -1.037 . . . . 0.0 108.89 179.395 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.583 ' O ' ' CD2' ' A' ' 17' ' ' TYR . 0.4 OUTLIER -91.04 17.55 7.86 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.439 -0.788 . . . . 0.0 109.187 179.744 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -118.96 -25.18 6.32 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.385 -0.822 . . . . 0.0 109.301 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.496 ' O ' ' HB2' ' A' ' 19' ' ' TYR . 0.1 OUTLIER -94.58 -50.48 5.17 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.291 -0.88 . . . . 0.0 109.425 179.951 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.419 ' C ' ' HB2' ' A' ' 19' ' ' TYR . 1.2 tt0 -51.57 -33.46 32.63 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.403 -0.81 . . . . 0.0 109.665 179.917 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.627 ' CD1' ' N ' ' A' ' 17' ' ' TYR . 3.8 m-30 -82.11 -59.8 2.44 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.293 -0.879 . . . . 0.0 109.042 -179.872 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.846 ' O ' HG12 ' A' ' 22' ' ' VAL . 1.0 OUTLIER -49.97 -24.51 2.62 Favored 'General case' 0 C--N 1.306 -1.302 0 N-CA-C 106.48 -1.674 . . . . 0.0 106.48 177.555 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.774 ' O ' HG13 ' A' ' 22' ' ' VAL . 0.1 OUTLIER -60.55 -35.71 76.7 Favored 'General case' 0 N--CA 1.484 1.245 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 178.502 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.422 ' N ' ' O ' ' A' ' 17' ' ' TYR . 30.8 mtp180 -68.56 -27.66 66.27 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.277 -0.89 . . . . 0.0 109.462 -179.696 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 5.7 t -92.13 29.37 1.65 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.283 -0.886 . . . . 0.0 109.336 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.846 HG12 ' O ' ' A' ' 18' ' ' ARG . 0.3 OUTLIER -150.34 -40.61 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.298 -1.644 0 O-C-N 121.609 -0.682 . . . . 0.0 109.229 -178.492 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.741 HD11 ' CD1' ' A' ' 19' ' ' TYR . 2.7 mt -85.22 -56.99 4.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.072 -1.018 . . . . 0.0 108.86 179.492 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.476 ' HG2' ' N ' ' A' ' 25' ' ' ALA . 0.1 OUTLIER -61.56 146.85 47.46 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.21 -0.931 . . . . 0.0 109.195 179.788 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.476 ' N ' ' HG2' ' A' ' 24' ' ' LYS . . . . . . . . 0 N--CA 1.489 1.506 0 CA-C-O 117.943 -1.027 . . . . 0.0 109.482 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.455 ' O ' ' CG ' ' A' ' 1' ' ' MET . 0.1 OUTLIER . . . . . 0 N--CA 1.494 1.762 0 CA-C-O 120.737 0.303 . . . . 0.0 110.219 . . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 2' ' ' PRO . . . . . 0.422 ' O ' ' C ' ' A' ' 3' ' ' GLY . 46.7 Cg_endo -73.21 -11.14 24.88 Favored 'Trans proline' 0 C--N 1.307 -1.65 0 O-C-N 124.062 1.559 . . . . 0.0 110.722 -179.969 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' GLY . . . . . 0.422 ' C ' ' O ' ' A' ' 2' ' ' PRO . . . 43.04 56.46 4.52 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.796 -1.322 . . . . 0.0 109.796 179.954 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.1 t -116.22 -32.44 5.32 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.099 -1.236 . . . . 0.0 109.583 179.892 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.43 ' O ' HG12 ' A' ' 9' ' ' ILE . 7.1 mt -70.44 -35.15 60.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.174 -0.954 . . . . 0.0 109.275 179.897 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.47 -27.08 58.71 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.299 -0.875 . . . . 0.0 109.435 179.794 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -65.9 -25.14 67.03 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.269 -0.894 . . . . 0.0 109.382 179.889 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 9.3 t-20 -84.21 -48.65 9.57 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.361 -0.837 . . . . 0.0 109.255 179.768 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.43 HG12 ' O ' ' A' ' 5' ' ' ILE . 37.5 mm -50.03 -38.37 14.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.307 -0.871 . . . . 0.0 108.917 179.719 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 21.7 mt -50.9 -40.81 20.87 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 179.562 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -68.79 -35.72 80.6 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 108.875 -1.69 . . . . 0.0 108.875 179.45 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.477 ' O ' HG12 ' A' ' 12' ' ' VAL . 71.8 t -74.37 -9.96 13.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.345 -1.091 . . . . 0.0 109.225 179.592 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -103.17 -47.31 4.37 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.451 -0.78 . . . . 0.0 109.578 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -54.61 -41.33 69.85 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.184 -0.947 . . . . 0.0 109.652 -179.817 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 2.2 t0 -68.9 -47.51 65.63 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.228 -0.92 . . . . 0.0 109.116 179.915 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.467 ' O ' ' HB2' ' A' ' 19' ' ' TYR . 0.2 OUTLIER -47.53 -31.91 4.8 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.268 -0.895 . . . . 0.0 108.828 179.611 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.575 ' CG ' ' N ' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -71.99 -65.84 0.72 Allowed 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 179.425 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.575 ' N ' ' CG ' ' A' ' 17' ' ' TYR . 5.0 ttp180 -47.04 -26.02 0.95 Allowed 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 179.215 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.738 ' CD2' HD13 ' A' ' 23' ' ' ILE . 1.6 m-85 -66.5 -48.81 68.61 Favored 'General case' 0 C--N 1.302 -1.462 0 CA-C-O 121.242 0.544 . . . . 0.0 109.733 179.713 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -53.87 -18.94 3.79 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.323 -0.861 . . . . 0.0 109.665 -179.741 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 2.4 t -89.14 -19.5 25.43 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.23 -0.919 . . . . 0.0 110.569 -179.42 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.456 ' CG1' ' O ' ' A' ' 18' ' ' ARG . 0.3 OUTLIER -123.13 -8.4 7.95 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.689 0 O-C-N 121.168 -0.958 . . . . 0.0 110.364 -178.133 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.738 HD13 ' CD2' ' A' ' 19' ' ' TYR . 2.5 mp -118.33 -33.24 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 120.923 -1.111 . . . . 0.0 109.923 -179.8 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.424 ' O ' ' HB3' ' A' ' 25' ' ' ALA . 20.4 mmtm -98.04 175.64 6.04 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.217 -0.927 . . . . 0.0 109.492 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.424 ' HB3' ' O ' ' A' ' 24' ' ' LYS . . . . . . . . 0 N--CA 1.489 1.497 0 CA-C-O 117.958 -1.02 . . . . 0.0 109.491 -179.939 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.9 mtt . . . . . 0 N--CA 1.492 1.662 0 CA-C-O 120.787 0.327 . . . . 0.0 110.314 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -74.8 1.06 8.04 Favored 'Trans proline' 0 C--N 1.305 -1.733 0 O-C-N 123.976 1.514 . . . . 0.0 110.453 179.92 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -87.04 132.18 11.01 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.704 -1.359 . . . . 0.0 109.704 -179.924 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 10.7 t -126.14 14.54 7.84 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.28 -1.129 . . . . 0.0 109.498 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.459 ' O ' HG12 ' A' ' 9' ' ' ILE . 12.0 mt -82.6 -29.22 8.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.169 -0.957 . . . . 0.0 109.368 -179.961 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.775 ' O ' HD12 ' A' ' 10' ' ' ILE . 4.8 mttm -83.3 -45.01 14.29 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.243 -0.91 . . . . 0.0 109.421 179.941 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -51.8 -20.56 2.25 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.27 -0.894 . . . . 0.0 109.556 179.886 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 10.8 t-20 -87.41 -42.75 12.6 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.195 -0.941 . . . . 0.0 109.462 -179.86 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.459 HG12 ' O ' ' A' ' 5' ' ' ILE . 17.6 mm -78.12 -38.72 24.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.248 -0.907 . . . . 0.0 109.555 -179.923 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.775 HD12 ' O ' ' A' ' 6' ' ' LYS . 1.1 mp -54.15 -42.2 54.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.107 -0.996 . . . . 0.0 109.001 179.946 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.421 ' HA2' ' HB2' ' A' ' 14' ' ' TYR . . . -59.01 -36.28 87.63 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.296 -1.522 . . . . 0.0 109.296 179.828 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.439 ' HB ' ' O ' ' A' ' 9' ' ' ILE . 24.8 t -58.52 -42.41 84.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.282 -1.128 . . . . 0.0 109.419 179.969 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 8.5 t -85.03 -19.32 32.15 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.168 -0.957 . . . . 0.0 109.521 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.421 ' HB2' ' HA2' ' A' ' 11' ' ' GLY . 1.5 m-85 -78.0 -21.74 50.39 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.268 -0.895 . . . . 0.0 109.362 179.917 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 76.0 m-20 -74.09 -55.8 5.68 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.312 -0.867 . . . . 0.0 109.428 179.917 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.479 ' OE1' ' HA ' ' A' ' 16' ' ' GLU . 0.9 OUTLIER -50.72 -41.27 56.09 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.265 -0.897 . . . . 0.0 109.11 179.949 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.629 ' CG ' ' N ' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -67.11 -62.18 1.56 Allowed 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 179.465 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.629 ' N ' ' CG ' ' A' ' 17' ' ' TYR . 0.3 OUTLIER -51.3 -22.52 2.86 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 179.223 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.673 ' CD2' HD13 ' A' ' 23' ' ' ILE . 3.3 m-85 -85.26 -27.48 25.99 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.762 -0.587 . . . . 0.0 109.77 -179.86 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.29 4.95 13.62 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.251 -0.906 . . . . 0.0 109.634 -179.795 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 4.2 t -111.13 -29.99 7.65 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.137 -0.977 . . . . 0.0 110.68 -179.517 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.484 HG13 ' O ' ' A' ' 18' ' ' ARG . 2.0 m -111.83 -38.35 3.12 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.679 0 O-C-N 121.114 -0.991 . . . . 0.0 110.413 -177.81 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.673 HD13 ' CD2' ' A' ' 19' ' ' TYR . 3.0 mp -84.41 -45.51 17.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.015 -1.053 . . . . 0.0 109.829 -179.478 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 5.6 mttt -117.02 156.44 27.49 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.24 -0.912 . . . . 0.0 109.635 -179.749 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.574 0 CA-C-O 118.021 -0.99 . . . . 0.0 109.502 -179.869 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.433 ' CG ' ' O ' ' A' ' 1' ' ' MET . 1.2 ptm . . . . . 0 N--CA 1.492 1.639 0 CA-C-O 120.688 0.28 . . . . 0.0 110.37 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 2' ' ' PRO . . . . . 0.461 ' O ' HG22 ' A' ' 4' ' ' THR . 45.9 Cg_endo -73.76 -5.86 17.73 Favored 'Trans proline' 0 C--N 1.304 -1.805 0 O-C-N 123.986 1.519 . . . . 0.0 110.329 179.885 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 3' ' ' GLY . . . . . 0.536 ' O ' ' CG2' ' A' ' 4' ' ' THR . . . 57.03 -126.39 41.88 Favored Glycine 0 N--CA 1.493 2.439 0 N-CA-C 109.883 -1.287 . . . . 0.0 109.883 179.82 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.536 ' CG2' ' O ' ' A' ' 3' ' ' GLY . 3.3 t 41.2 34.41 0.31 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.546 -0.973 . . . . 0.0 109.295 -179.703 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 2.5 mp -64.85 -16.67 20.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.581 -0.699 . . . . 0.0 109.802 -179.892 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 12.8 tttt -116.42 -30.43 5.89 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.111 -0.993 . . . . 0.0 109.666 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -78.76 -25.44 44.44 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.197 -0.939 . . . . 0.0 109.582 -179.915 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.426 ' HB2' ' OG1' ' A' ' 4' ' ' THR . 0.4 OUTLIER -83.0 -26.62 31.08 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.238 -0.914 . . . . 0.0 109.478 -179.929 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.479 ' O ' ' N ' ' A' ' 12' ' ' VAL . 24.9 mm -86.01 -48.24 16.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.232 -0.918 . . . . 0.0 109.515 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -48.02 -32.16 3.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.288 -0.883 . . . . 0.0 109.117 -179.851 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.451 ' O ' ' OD2' ' A' ' 15' ' ' ASP . . . -75.25 -27.31 64.17 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 108.964 -1.655 . . . . 0.0 108.964 179.547 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.479 ' N ' ' O ' ' A' ' 9' ' ' ILE . 45.9 t -55.54 -27.27 20.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.345 -1.091 . . . . 0.0 109.141 179.808 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -107.55 -4.47 18.33 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.303 -0.873 . . . . 0.0 109.498 179.906 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.449 ' HB2' ' HA2' ' A' ' 11' ' ' GLY . 0.3 OUTLIER -100.08 -21.28 15.65 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.189 -0.944 . . . . 0.0 109.658 -179.834 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.478 ' OD1' ' N ' ' A' ' 16' ' ' GLU . 2.3 p30 -95.32 -44.71 7.46 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.235 -0.916 . . . . 0.0 109.418 179.874 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.478 ' N ' ' OD1' ' A' ' 15' ' ' ASP . 0.1 OUTLIER -56.96 -45.46 82.85 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.173 -0.954 . . . . 0.0 109.103 179.805 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.661 ' CG ' ' N ' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -59.75 -56.77 17.72 Favored 'General case' 0 N--CA 1.487 1.378 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 179.234 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.661 ' N ' ' CG ' ' A' ' 17' ' ' TYR . 0.0 OUTLIER -53.43 -20.88 5.15 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 178.881 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.565 ' HA ' HG13 ' A' ' 22' ' ' VAL . 2.5 m-30 -90.69 -12.91 35.32 Favored 'General case' 0 C--N 1.306 -1.323 0 CA-C-O 121.422 0.63 . . . . 0.0 109.386 179.768 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.454 ' HA ' ' HB2' ' A' ' 24' ' ' LYS . 0.9 OUTLIER -71.76 -31.72 66.94 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.374 -0.829 . . . . 0.0 110.371 -179.208 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 3.1 t -96.17 24.37 5.72 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.031 -1.043 . . . . 0.0 109.796 -179.567 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.567 HG22 HG13 ' A' ' 23' ' ' ILE . 0.2 OUTLIER -149.82 -40.4 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.299 -1.598 0 O-C-N 121.346 -0.846 . . . . 0.0 109.426 -178.889 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.567 HG13 HG22 ' A' ' 22' ' ' VAL . 7.7 mt -109.89 -60.26 2.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.26 -0.9 . . . . 0.0 109.299 -179.886 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.454 ' HB2' ' HA ' ' A' ' 20' ' ' ARG . 5.9 mtpp -85.3 -176.93 6.34 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.242 -0.911 . . . . 0.0 109.333 179.905 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.612 0 CA-C-O 117.961 -1.019 . . . . 0.0 109.504 179.962 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.5 ttt . . . . . 0 N--CA 1.492 1.645 0 CA-C-O 120.813 0.339 . . . . 0.0 110.206 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -79.34 11.55 2.62 Favored 'Trans proline' 0 C--N 1.306 -1.66 0 O-C-N 123.98 1.516 . . . . 0.0 110.817 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -86.92 33.54 3.75 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.797 -1.321 . . . . 0.0 109.797 179.932 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.9 t -84.26 -13.39 52.7 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.209 -1.171 . . . . 0.0 109.255 179.89 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.61 HG23 HG13 ' A' ' 9' ' ' ILE . 33.8 mt -99.01 -19.2 5.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.273 -0.892 . . . . 0.0 109.307 179.889 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.517 ' O ' HD12 ' A' ' 10' ' ' ILE . 0.7 OUTLIER -102.02 18.71 20.02 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.321 -0.862 . . . . 0.0 109.56 179.991 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -136.9 -39.92 0.61 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.106 -0.996 . . . . 0.0 109.563 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 21.5 t-20 -94.52 -53.01 4.06 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.307 -0.87 . . . . 0.0 109.503 -179.863 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.61 HG13 HG23 ' A' ' 5' ' ' ILE . 34.8 mm -55.83 -20.86 9.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.245 -0.91 . . . . 0.0 109.329 179.983 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.517 HD12 ' O ' ' A' ' 6' ' ' LYS . 23.9 mt -68.77 -43.55 82.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.309 -0.869 . . . . 0.0 109.198 179.809 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -65.65 -31.6 80.48 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.358 -1.497 . . . . 0.0 109.358 179.851 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 39.4 t -58.64 -29.02 38.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.262 -1.14 . . . . 0.0 109.448 179.943 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.577 ' O ' ' CZ ' ' A' ' 17' ' ' TYR . 22.6 m -86.2 -34.07 20.59 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.203 -0.936 . . . . 0.0 109.468 -179.996 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.593 ' HA ' ' CD2' ' A' ' 17' ' ' TYR . 0.3 OUTLIER -75.76 -27.3 58.0 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.256 -0.902 . . . . 0.0 109.434 -179.996 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.464 ' O ' ' CD1' ' A' ' 19' ' ' TYR . 0.7 OUTLIER -61.55 -45.04 95.83 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.287 -0.883 . . . . 0.0 109.31 179.902 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.412 ' O ' ' HB2' ' A' ' 19' ' ' TYR . 0.0 OUTLIER -60.29 -41.34 93.18 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.254 -0.904 . . . . 0.0 109.377 179.896 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.602 ' CD1' ' N ' ' A' ' 17' ' ' TYR . 1.2 m-30 -67.07 -42.15 85.18 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.273 -0.892 . . . . 0.0 108.943 179.978 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.529 ' O ' ' CG1' ' A' ' 22' ' ' VAL . 0.0 OUTLIER -80.58 7.64 9.59 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 108.62 -0.882 . . . . 0.0 108.62 178.725 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.715 ' CG ' HD13 ' A' ' 23' ' ' ILE . 3.2 m-30 -103.34 -42.62 5.66 Favored 'General case' 0 C--N 1.309 -1.16 0 O-C-N 121.493 -0.754 . . . . 0.0 109.456 -179.577 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 29.1 mtp180 -56.45 -33.81 66.24 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.441 -0.787 . . . . 0.0 110.276 -179.255 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 23.3 t -84.16 12.38 6.59 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.111 -0.993 . . . . 0.0 110.277 -179.35 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.802 HG22 ' N ' ' A' ' 23' ' ' ILE . 0.1 OUTLIER -146.73 -78.55 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.299 -1.601 0 O-C-N 121.184 -0.947 . . . . 0.0 110.094 -178.718 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.802 ' N ' HG22 ' A' ' 22' ' ' VAL . 1.7 mp -44.22 -26.79 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.032 -1.043 . . . . 0.0 109.432 -179.62 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.403 ' N ' ' O ' ' A' ' 22' ' ' VAL . 10.2 mttp -113.85 -88.46 0.55 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.251 -0.906 . . . . 0.0 109.364 179.752 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.611 0 CA-C-O 118.023 -0.989 . . . . 0.0 109.437 -179.983 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.705 HG23 ' O ' ' A' ' 4' ' ' THR . 11.6 t . . . . . 0 N--CA 1.49 1.551 0 CA-C-O 121.379 0.609 . . . . 0.0 109.359 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.463 ' O ' HG12 ' A' ' 9' ' ' ILE . 70.9 mt -93.76 -39.2 10.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.33 -0.856 . . . . 0.0 109.61 -179.858 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.54 -41.89 12.43 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.253 -0.905 . . . . 0.0 109.272 179.912 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.5 ' HA ' HD12 ' A' ' 10' ' ' ILE . 16.6 tp10 -59.41 -15.44 16.96 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.311 -0.868 . . . . 0.0 109.382 179.881 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -87.84 -42.62 12.42 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.25 -0.906 . . . . 0.0 109.388 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.463 HG12 ' O ' ' A' ' 5' ' ' ILE . 23.9 mm -61.64 -40.62 87.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.225 -0.922 . . . . 0.0 109.191 179.827 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.5 HD12 ' HA ' ' A' ' 7' ' ' GLU . 15.2 mt -48.89 -30.95 3.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.235 -0.916 . . . . 0.0 108.882 179.593 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -86.51 -33.78 13.01 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.531 -1.427 . . . . 0.0 109.531 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 44.1 t -70.25 -37.64 71.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.225 -1.162 . . . . 0.0 109.415 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -76.49 -42.8 42.21 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.223 -0.923 . . . . 0.0 109.431 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.405 ' HB2' ' O ' ' A' ' 10' ' ' ILE . 0.2 OUTLIER -49.03 -22.33 0.87 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.304 -0.873 . . . . 0.0 109.397 179.837 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.473 ' O ' ' HB2' ' A' ' 19' ' ' TYR . 1.7 t70 -94.67 -56.89 2.63 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.211 -0.93 . . . . 0.0 109.686 -179.906 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.494 ' O ' ' N ' ' A' ' 20' ' ' ARG . 0.9 OUTLIER -46.12 -39.9 10.19 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.275 -0.89 . . . . 0.0 109.046 -179.943 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.605 ' CG ' ' N ' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -65.82 -56.38 12.2 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 108.674 -0.861 . . . . 0.0 108.674 179.536 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 1.035 ' O ' HG11 ' A' ' 22' ' ' VAL . 2.3 ttt-85 -67.49 -1.55 5.1 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.656 -0.652 . . . . 0.0 109.467 179.66 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.616 ' O ' HD12 ' A' ' 23' ' ' ILE . 6.1 m-85 -119.63 -8.6 9.93 Favored 'General case' 0 C--N 1.308 -1.221 0 CA-C-O 121.616 0.722 . . . . 0.0 109.066 -179.725 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.494 ' N ' ' O ' ' A' ' 16' ' ' GLU . 6.8 ttt-85 -64.34 -45.39 88.05 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.562 -0.712 . . . . 0.0 111.648 -178.19 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 3.5 t -127.85 48.8 2.21 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.697 -1.252 . . . . 0.0 110.609 -178.234 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 1.035 HG11 ' O ' ' A' ' 18' ' ' ARG . 0.6 OUTLIER -138.06 -37.42 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.759 0 O-C-N 121.433 -0.792 . . . . 0.0 109.921 -179.29 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.616 HD12 ' O ' ' A' ' 19' ' ' TYR . 5.1 mt . . . . . 0 N--CA 1.489 1.517 0 O-C-N 121.134 -0.979 . . . . 0.0 109.598 -179.383 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 13.3 t . . . . . 0 N--CA 1.491 1.623 0 CA-C-O 121.18 0.514 . . . . 0.0 109.745 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 20.8 mm -65.25 -16.44 20.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.195 -0.94 . . . . 0.0 109.663 -179.803 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -128.42 -28.11 2.58 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.133 -0.98 . . . . 0.0 109.945 -179.738 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.426 ' HA ' HD12 ' A' ' 10' ' ' ILE . 0.0 OUTLIER -82.62 -29.06 30.37 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.127 -0.983 . . . . 0.0 109.767 -179.805 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 4.3 t-20 -67.39 -49.1 65.32 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.107 -0.996 . . . . 0.0 109.238 179.776 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 47.5 mm -57.53 -37.88 60.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.305 -0.872 . . . . 0.0 109.348 179.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.426 HD12 ' HA ' ' A' ' 7' ' ' GLU . 56.7 mt -53.5 -44.77 57.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.201 -0.937 . . . . 0.0 108.75 179.662 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.47 ' O ' ' HB2' ' A' ' 15' ' ' ASP . . . -69.32 -13.41 67.58 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 108.943 -1.663 . . . . 0.0 108.943 179.426 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.454 HG12 ' O ' ' A' ' 12' ' ' VAL . 55.1 t -98.32 -12.38 8.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.406 -1.056 . . . . 0.0 109.169 179.675 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.448 ' O ' ' HB3' ' A' ' 17' ' ' TYR . 23.2 p -120.64 -34.48 3.58 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.272 -0.892 . . . . 0.0 109.505 -179.823 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -77.26 -42.78 35.77 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.201 -0.937 . . . . 0.0 109.33 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.47 ' HB2' ' O ' ' A' ' 11' ' ' GLY . 3.1 m-20 -62.13 -54.35 42.49 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.218 -0.926 . . . . 0.0 109.103 179.83 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.45 ' O ' ' N ' ' A' ' 20' ' ' ARG . 1.6 tt0 -54.92 -43.86 73.7 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.204 -0.935 . . . . 0.0 108.891 179.58 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.526 ' CG ' ' N ' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -61.03 -58.31 8.96 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 179.159 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.526 ' N ' ' CG ' ' A' ' 17' ' ' TYR . 5.3 ttm180 -58.78 -14.92 10.03 Favored 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 108.898 -0.779 . . . . 0.0 108.898 179.455 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.656 ' HA ' HG13 ' A' ' 22' ' ' VAL . 3.1 m-85 -97.42 -27.63 14.37 Favored 'General case' 0 C--N 1.307 -1.252 0 O-C-N 121.462 -0.774 . . . . 0.0 109.709 -179.629 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.45 ' N ' ' O ' ' A' ' 16' ' ' GLU . 0.0 OUTLIER -65.96 -10.56 40.39 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.184 -0.948 . . . . 0.0 109.999 -179.353 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 5.5 t -111.16 14.91 21.77 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.032 -1.043 . . . . 0.0 109.436 179.873 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.656 HG13 ' HA ' ' A' ' 19' ' ' TYR . 0.1 OUTLIER -146.75 -39.94 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.594 0 O-C-N 121.549 -0.72 . . . . 0.0 109.447 -178.299 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.405 HG13 ' HB3' ' A' ' 19' ' ' TYR . 5.4 mm . . . . . 0 N--CA 1.488 1.439 0 O-C-N 121.203 -0.935 . . . . 0.0 109.494 -179.677 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 4.2 t . . . . . 0 N--CA 1.493 1.675 0 N-CA-C 109.26 -0.645 . . . . 0.0 109.26 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 52.4 mt -75.06 -16.97 16.1 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.474 0 O-C-N 121.444 -0.785 . . . . 0.0 109.419 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 9.3 pttt -107.02 -30.5 8.78 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.265 -0.897 . . . . 0.0 109.468 179.828 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -62.23 -22.29 65.84 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.19 -0.944 . . . . 0.0 109.195 179.831 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 12.3 t-20 -80.73 -52.25 7.74 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.265 -0.897 . . . . 0.0 109.297 179.864 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.505 ' O ' ' N ' ' A' ' 12' ' ' VAL . 41.2 mm -63.14 -45.93 97.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.307 -0.871 . . . . 0.0 109.481 179.927 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 48.0 mt -47.8 -29.17 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.138 -0.976 . . . . 0.0 109.074 179.883 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -81.63 -23.88 57.23 Favored Glycine 0 N--CA 1.489 2.172 0 N-CA-C 109.157 -1.577 . . . . 0.0 109.157 179.583 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.505 ' N ' ' O ' ' A' ' 9' ' ' ILE . 75.6 t -65.02 -33.85 66.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.45 -1.029 . . . . 0.0 109.335 179.721 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -75.1 -30.76 60.98 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.227 -0.92 . . . . 0.0 109.329 179.77 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -56.76 -45.72 81.86 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.292 -0.88 . . . . 0.0 109.389 179.846 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.573 ' HB3' ' CE2' ' A' ' 19' ' ' TYR . 67.9 m-20 -55.91 -45.65 78.61 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.271 -0.893 . . . . 0.0 109.211 179.809 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -51.16 -42.5 60.84 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.338 -0.851 . . . . 0.0 108.768 179.507 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.533 ' CD1' ' C ' ' A' ' 17' ' ' TYR . 0.0 OUTLIER -64.66 -62.32 1.65 Allowed 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 179.261 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.523 ' N ' ' CG ' ' A' ' 17' ' ' TYR . 0.0 OUTLIER -54.42 -20.08 6.8 Favored 'General case' 0 C--N 1.303 -1.413 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 179.321 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.627 ' HA ' HG13 ' A' ' 22' ' ' VAL . 4.6 m-30 -88.25 -22.32 24.01 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 179.631 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.453 ' HG3' ' O ' ' A' ' 20' ' ' ARG . 24.3 tpp180 -67.18 -18.45 65.27 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.335 -0.853 . . . . 0.0 110.107 -179.439 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 4.1 t -105.8 16.51 25.13 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.993 -1.067 . . . . 0.0 109.832 -179.734 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.627 HG13 ' HA ' ' A' ' 19' ' ' TYR . 0.1 OUTLIER -149.58 -44.83 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.298 -1.639 0 O-C-N 121.333 -0.854 . . . . 0.0 109.837 -178.461 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.501 HG13 ' HB3' ' A' ' 19' ' ' TYR . 11.5 mm . . . . . 0 N--CA 1.487 1.41 0 O-C-N 121.083 -1.011 . . . . 0.0 109.96 -179.431 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 4.1 t . . . . . 0 N--CA 1.491 1.61 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.504 ' N ' HD13 ' A' ' 5' ' ' ILE . 3.3 mm -84.49 -12.08 11.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.32 -0.863 . . . . 0.0 109.547 -179.82 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -113.94 -22.09 10.28 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.27 -0.894 . . . . 0.0 109.436 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 4.9 tm-20 -86.42 -11.77 50.98 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.29 -0.881 . . . . 0.0 109.578 -179.745 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 18.0 t-20 -95.92 -49.18 5.41 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.245 -0.909 . . . . 0.0 109.355 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.409 HD13 ' HA ' ' A' ' 9' ' ' ILE . 49.1 mm -62.13 -34.96 66.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.284 -0.885 . . . . 0.0 109.541 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.402 ' O ' ' HB2' ' A' ' 14' ' ' TYR . 10.4 tt -49.41 -35.1 8.44 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 O-C-N 121.234 -0.916 . . . . 0.0 109.15 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.493 ' O ' ' N ' ' A' ' 15' ' ' ASP . . . -76.21 -39.92 30.5 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 109.059 -1.616 . . . . 0.0 109.059 179.666 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.484 ' O ' ' HB2' ' A' ' 16' ' ' GLU . 55.2 t -54.22 -32.7 23.94 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.319 -1.106 . . . . 0.0 109.066 179.581 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -96.08 -5.47 40.82 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.365 -0.835 . . . . 0.0 109.204 179.762 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.434 ' O ' ' CD2' ' A' ' 17' ' ' TYR . 1.8 m-85 -111.35 -56.32 2.39 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.22 -0.925 . . . . 0.0 109.382 179.917 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.493 ' N ' ' O ' ' A' ' 11' ' ' GLY . 14.3 t70 -58.4 -46.16 86.95 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.054 -1.029 . . . . 0.0 109.176 179.832 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.484 ' HB2' ' O ' ' A' ' 12' ' ' VAL . 1.9 tp10 -56.83 -48.43 78.04 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.268 -0.895 . . . . 0.0 109.221 179.774 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.62 ' CG ' ' N ' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -55.54 -55.8 27.75 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 179.404 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.713 ' O ' HG11 ' A' ' 22' ' ' VAL . 0.0 OUTLIER -58.93 -15.08 11.13 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 108.963 -0.755 . . . . 0.0 108.963 179.59 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.61 ' HA ' ' CG1' ' A' ' 22' ' ' VAL . 3.1 m-85 -102.83 -16.2 16.0 Favored 'General case' 0 C--N 1.305 -1.336 0 O-C-N 121.614 -0.679 . . . . 0.0 110.383 -178.918 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.437 ' N ' ' O ' ' A' ' 16' ' ' GLU . 0.0 OUTLIER -70.68 -21.1 62.62 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.172 -0.955 . . . . 0.0 110.998 -178.657 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 4.9 t -122.51 41.88 3.31 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.705 -1.247 . . . . 0.0 110.23 -179.112 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.713 HG11 ' O ' ' A' ' 18' ' ' ARG . 0.3 OUTLIER -155.35 -37.34 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 O-C-N 121.155 -0.966 . . . . 0.0 110.195 -178.531 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.531 HD11 ' CD2' ' A' ' 19' ' ' TYR . 12.3 mm . . . . . 0 N--CA 1.489 1.486 0 O-C-N 121.061 -1.025 . . . . 0.0 109.72 -179.239 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 11.1 t . . . . . 0 N--CA 1.491 1.585 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 24.4 mm -81.93 -30.96 10.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.34 -0.85 . . . . 0.0 109.627 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 19.5 ttpt -87.56 -29.89 20.94 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.205 -0.934 . . . . 0.0 109.621 -179.863 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.593 ' O ' HG22 ' A' ' 10' ' ' ILE . 0.8 OUTLIER -74.79 -47.29 31.59 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.226 -0.921 . . . . 0.0 109.495 -179.916 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 33.1 t-20 -48.82 -35.08 13.68 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.24 -0.913 . . . . 0.0 109.208 179.898 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 31.9 mm -69.29 -33.42 57.78 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.189 -0.945 . . . . 0.0 109.085 179.694 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.593 HG22 ' O ' ' A' ' 7' ' ' GLU . 2.4 tt -60.28 -40.4 83.68 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.242 -0.911 . . . . 0.0 108.709 179.595 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.419 ' N ' ' CG2' ' A' ' 10' ' ' ILE . . . -62.96 -20.91 62.95 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 108.586 -1.805 . . . . 0.0 108.586 179.319 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 49.6 t -88.66 -29.68 5.32 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.425 0 O-C-N 121.621 -0.929 . . . . 0.0 109.069 179.635 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 38.0 t -95.17 -0.63 53.09 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.294 -0.879 . . . . 0.0 109.453 179.827 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.458 ' HB2' ' O ' ' A' ' 10' ' ' ILE . 0.9 OUTLIER -99.26 -16.8 18.38 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.163 -0.961 . . . . 0.0 109.49 179.946 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 29.8 t0 -95.42 -54.82 3.25 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.23 -0.919 . . . . 0.0 109.415 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -52.18 -41.46 62.65 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.167 -0.958 . . . . 0.0 109.012 179.705 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.603 ' CG ' ' N ' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -59.14 -55.7 31.62 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 179.366 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.603 ' N ' ' CG ' ' A' ' 17' ' ' TYR . 9.3 ttm180 -66.96 -6.04 15.18 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 179.652 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.764 ' CD2' HD13 ' A' ' 23' ' ' ILE . 2.4 m-85 -107.59 -16.58 14.32 Favored 'General case' 0 C--N 1.305 -1.336 0 O-C-N 121.341 -0.85 . . . . 0.0 109.873 -179.265 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 1.9 mmt180 -74.78 -21.66 59.2 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.259 -0.9 . . . . 0.0 110.234 -179.323 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 8.5 t -107.71 24.63 12.62 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.036 -1.04 . . . . 0.0 109.997 -179.577 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.594 HG11 ' O ' ' A' ' 18' ' ' ARG . 0.1 OUTLIER -146.77 -49.46 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.547 0 O-C-N 121.333 -0.854 . . . . 0.0 109.631 -178.82 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.764 HD13 ' CD2' ' A' ' 19' ' ' TYR . 2.5 mp . . . . . 0 N--CA 1.489 1.503 0 O-C-N 120.977 -1.077 . . . . 0.0 109.409 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 7.3 t . . . . . 0 N--CA 1.49 1.538 0 CA-C-O 121.328 0.585 . . . . 0.0 109.546 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 2.5 mp -62.8 -21.87 28.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.171 -0.956 . . . . 0.0 109.464 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 19.9 mmtt -102.96 -41.08 6.24 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.322 -0.861 . . . . 0.0 109.339 179.858 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -67.62 -12.24 59.98 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.241 -0.912 . . . . 0.0 109.459 179.89 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 30.3 t-20 -87.67 -50.53 6.43 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.275 -0.89 . . . . 0.0 109.244 179.865 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 24.7 mm -70.69 -18.72 21.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.277 -0.889 . . . . 0.0 109.21 179.765 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.438 ' O ' ' N ' ' A' ' 14' ' ' TYR . 1.9 mm -66.64 -57.3 10.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.312 -0.867 . . . . 0.0 109.058 179.786 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -55.54 -20.45 23.84 Favored Glycine 0 N--CA 1.488 2.146 0 N-CA-C 109.065 -1.614 . . . . 0.0 109.065 179.658 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 69.0 t -86.76 -21.64 7.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.303 -1.116 . . . . 0.0 109.484 179.788 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.1 p -116.27 2.14 13.21 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.21 -0.931 . . . . 0.0 109.642 -179.885 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.438 ' N ' ' O ' ' A' ' 10' ' ' ILE . 0.3 OUTLIER -125.16 -35.36 2.64 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.215 -0.928 . . . . 0.0 109.663 -179.935 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -76.35 -38.97 55.1 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.123 -0.986 . . . . 0.0 109.408 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -58.18 -43.46 87.5 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.294 -0.879 . . . . 0.0 109.464 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.632 ' CG ' ' N ' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -62.91 -59.68 4.51 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 179.488 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.632 ' N ' ' CG ' ' A' ' 17' ' ' TYR . 4.8 ttm180 -53.92 -20.48 6.13 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 179.302 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.575 ' HA ' HG13 ' A' ' 22' ' ' VAL . 3.1 m-30 -92.39 -12.46 32.21 Favored 'General case' 0 C--N 1.305 -1.354 0 O-C-N 121.624 -0.673 . . . . 0.0 109.567 -179.725 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.28 -35.13 63.74 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.322 -0.861 . . . . 0.0 110.069 -179.442 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 48.3 t -90.41 21.35 3.93 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.142 -0.974 . . . . 0.0 109.882 -179.621 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.575 HG13 ' HA ' ' A' ' 19' ' ' TYR . 0.2 OUTLIER -150.09 -43.07 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.556 0 O-C-N 121.371 -0.831 . . . . 0.0 109.541 -178.777 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.46 HG12 HG13 ' A' ' 22' ' ' VAL . 3.8 mm . . . . . 0 N--CA 1.489 1.491 0 O-C-N 121.172 -0.955 . . . . 0.0 109.597 -179.669 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.434 ' O ' ' HB2' ' A' ' 8' ' ' ASN . 15.1 t . . . . . 0 N--CA 1.49 1.57 0 CA-C-O 121.172 0.51 . . . . 0.0 109.729 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.447 HD12 ' H ' ' A' ' 5' ' ' ILE . 2.5 mp -51.87 -21.38 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.233 -0.917 . . . . 0.0 109.477 -179.909 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 18.4 ttpt -93.4 -60.1 1.86 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.189 -0.944 . . . . 0.0 109.602 -179.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 7.3 tt0 -58.87 -24.86 62.74 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.237 -0.915 . . . . 0.0 109.753 -179.755 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . 0.434 ' HB2' ' O ' ' A' ' 4' ' ' THR . 6.0 t-20 -61.98 -45.76 92.25 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.092 -1.005 . . . . 0.0 109.555 -179.909 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.461 ' O ' ' N ' ' A' ' 12' ' ' VAL . 19.6 mm -69.52 -49.0 63.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.298 -0.876 . . . . 0.0 109.527 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 64.1 mt -46.5 -27.56 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.201 -0.937 . . . . 0.0 109.166 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -86.93 -26.88 30.36 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.329 -1.509 . . . . 0.0 109.329 179.809 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.461 ' N ' ' O ' ' A' ' 9' ' ' ILE . 76.5 t -60.03 -47.06 93.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.332 -1.099 . . . . 0.0 109.311 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 7.6 t -77.19 -16.66 59.0 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.263 -0.898 . . . . 0.0 109.283 179.708 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -86.15 -23.77 26.45 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.345 -0.847 . . . . 0.0 109.324 179.805 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.449 ' O ' ' C ' ' A' ' 16' ' ' GLU . 27.7 m-20 -76.44 -55.77 5.23 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.355 -0.841 . . . . 0.0 109.555 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.449 ' C ' ' O ' ' A' ' 15' ' ' ASP . 0.3 OUTLIER -43.77 -32.63 1.08 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.127 -0.983 . . . . 0.0 108.838 179.72 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -65.94 -48.79 70.2 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 108.385 -0.968 . . . . 0.0 108.385 179.116 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.572 ' O ' HG11 ' A' ' 22' ' ' VAL . 21.7 ttt180 -73.27 4.11 4.97 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.476 -0.765 . . . . 0.0 109.062 179.199 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.552 ' HA ' HD12 ' A' ' 23' ' ' ILE . 8.3 m-85 -119.78 -4.73 10.19 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.419 -0.8 . . . . 0.0 109.038 -179.297 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 1.7 tpt180 -95.52 -68.14 0.82 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.516 -0.74 . . . . 0.0 111.372 -178.296 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 18.3 t -85.25 20.36 1.99 Allowed 'General case' 0 N--CA 1.496 1.845 0 O-C-N 120.964 -1.085 . . . . 0.0 110.697 -178.406 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.577 HG22 ' N ' ' A' ' 23' ' ' ILE . 0.2 OUTLIER -134.04 -63.43 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.783 0 O-C-N 121.347 -0.846 . . . . 0.0 109.032 -179.183 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.577 ' N ' HG22 ' A' ' 22' ' ' VAL . 3.3 mt . . . . . 0 N--CA 1.489 1.492 0 O-C-N 121.238 -0.913 . . . . 0.0 109.288 179.782 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.659 HG23 ' O ' ' A' ' 4' ' ' THR . 15.0 t . . . . . 0 N--CA 1.49 1.562 0 N-CA-C 109.592 -0.521 . . . . 0.0 109.592 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.421 HD13 ' HA ' ' A' ' 5' ' ' ILE . 23.0 mm -74.88 -28.88 21.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.318 -0.864 . . . . 0.0 109.25 179.792 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 7.6 mtpt -106.21 -37.06 6.69 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.475 -0.766 . . . . 0.0 109.274 179.895 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.14 -15.91 62.92 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.313 -0.867 . . . . 0.0 108.992 179.775 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . 0.478 ' HB2' ' O ' ' A' ' 4' ' ' THR . 48.3 t-20 -78.76 -54.71 5.8 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.421 -0.8 . . . . 0.0 109.354 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.476 ' HA ' ' HB ' ' A' ' 12' ' ' VAL . 46.8 mm -67.99 -30.64 48.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.205 -0.934 . . . . 0.0 109.276 179.83 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.402 ' HA ' HD13 ' A' ' 10' ' ' ILE . 3.3 mm -50.91 -36.36 15.4 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 O-C-N 121.279 -0.888 . . . . 0.0 109.208 179.755 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -89.99 -32.47 9.84 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 179.916 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.476 ' HB ' ' HA ' ' A' ' 9' ' ' ILE . 47.4 t -70.48 -37.92 71.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.22 -1.165 . . . . 0.0 109.318 179.942 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -71.38 -13.31 61.81 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.3 -0.875 . . . . 0.0 109.468 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.461 ' O ' ' HB3' ' A' ' 17' ' ' TYR . 2.3 m-85 -77.96 -49.63 13.73 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.206 -0.934 . . . . 0.0 109.406 179.862 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.454 ' OD1' ' CE1' ' A' ' 19' ' ' TYR . 6.3 t0 -56.56 -46.07 80.92 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.182 -0.949 . . . . 0.0 109.1 179.799 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.402 ' C ' ' O ' ' A' ' 15' ' ' ASP . 0.6 OUTLIER -46.73 -39.26 11.28 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 108.204 -1.035 . . . . 0.0 108.204 179.401 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.461 ' HB3' ' O ' ' A' ' 14' ' ' TYR . 0.2 OUTLIER -64.1 -61.54 2.19 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 107.668 -1.234 . . . . 0.0 107.668 178.781 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.553 ' O ' ' CG1' ' A' ' 22' ' ' VAL . 4.0 ttt85 -52.37 -22.36 4.54 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 178.805 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.575 ' HA ' HG13 ' A' ' 22' ' ' VAL . 7.8 m-30 -91.79 -8.94 45.28 Favored 'General case' 0 C--N 1.305 -1.347 0 CA-C-O 121.346 0.593 . . . . 0.0 109.747 -179.637 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.432 ' HG2' ' O ' ' A' ' 20' ' ' ARG . 0.4 OUTLIER -75.14 -28.02 60.0 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.287 -0.883 . . . . 0.0 110.299 -179.121 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 7.4 t -105.48 28.4 7.44 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.981 -1.074 . . . . 0.0 110.047 -179.487 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.575 HG13 ' HA ' ' A' ' 19' ' ' TYR . 0.2 OUTLIER -155.02 -41.12 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.56 0 O-C-N 121.316 -0.865 . . . . 0.0 109.356 -178.833 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.464 ' CD1' ' CG ' ' A' ' 19' ' ' TYR . 4.6 mt . . . . . 0 N--CA 1.491 1.591 0 O-C-N 121.259 -0.901 . . . . 0.0 109.13 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 12.8 t . . . . . 0 N--CA 1.489 1.492 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.488 ' O ' HG12 ' A' ' 9' ' ' ILE . 21.5 mm -76.83 -43.1 33.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.375 -0.828 . . . . 0.0 109.746 -179.784 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.471 ' O ' HG13 ' A' ' 10' ' ' ILE . 0.2 OUTLIER -102.07 -15.16 16.83 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.217 -0.927 . . . . 0.0 109.746 -179.592 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 7.1 mt-10 -70.79 -29.5 65.72 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 120.96 -1.088 . . . . 0.0 109.572 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . 0.421 ' O ' HG23 ' A' ' 12' ' ' VAL . 41.3 t-20 -94.45 -37.83 11.23 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.162 -0.961 . . . . 0.0 109.701 -179.884 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.488 HG12 ' O ' ' A' ' 5' ' ' ILE . 18.7 mm -65.53 -41.9 91.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.172 -0.955 . . . . 0.0 109.487 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.471 HG13 ' O ' ' A' ' 6' ' ' LYS . 19.3 mt -49.64 -42.07 17.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.173 -0.954 . . . . 0.0 108.636 179.693 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -68.62 -32.07 74.26 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 108.662 -1.775 . . . . 0.0 108.662 179.14 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.421 HG23 ' O ' ' A' ' 8' ' ' ASN . 68.3 t -73.1 -33.18 41.63 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 O-C-N 121.437 -1.037 . . . . 0.0 108.89 179.395 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.583 ' O ' ' CD2' ' A' ' 17' ' ' TYR . 0.4 OUTLIER -91.04 17.55 7.86 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.439 -0.788 . . . . 0.0 109.187 179.744 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -118.96 -25.18 6.32 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.385 -0.822 . . . . 0.0 109.301 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.496 ' O ' ' HB2' ' A' ' 19' ' ' TYR . 0.1 OUTLIER -94.58 -50.48 5.17 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.291 -0.88 . . . . 0.0 109.425 179.951 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.419 ' C ' ' HB2' ' A' ' 19' ' ' TYR . 1.2 tt0 -51.57 -33.46 32.63 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.403 -0.81 . . . . 0.0 109.665 179.917 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.627 ' N ' ' CD1' ' A' ' 17' ' ' TYR . 3.8 m-30 -82.11 -59.8 2.44 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.293 -0.879 . . . . 0.0 109.042 -179.872 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.846 ' O ' HG12 ' A' ' 22' ' ' VAL . 1.0 OUTLIER -49.97 -24.51 2.62 Favored 'General case' 0 C--N 1.306 -1.302 0 N-CA-C 106.48 -1.674 . . . . 0.0 106.48 177.555 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.774 ' O ' HG13 ' A' ' 22' ' ' VAL . 0.1 OUTLIER -60.55 -35.71 76.7 Favored 'General case' 0 N--CA 1.484 1.245 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 178.502 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.422 ' N ' ' O ' ' A' ' 17' ' ' TYR . 30.8 mtp180 -68.56 -27.66 66.27 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.277 -0.89 . . . . 0.0 109.462 -179.696 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 5.7 t -92.13 29.37 1.65 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.283 -0.886 . . . . 0.0 109.336 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.846 HG12 ' O ' ' A' ' 18' ' ' ARG . 0.3 OUTLIER -150.34 -40.61 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.298 -1.644 0 O-C-N 121.609 -0.682 . . . . 0.0 109.229 -178.492 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.741 HD11 ' CD1' ' A' ' 19' ' ' TYR . 2.7 mt . . . . . 0 N--CA 1.491 1.595 0 O-C-N 121.072 -1.018 . . . . 0.0 108.86 179.492 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.1 t . . . . . 0 N--CA 1.491 1.585 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.43 ' O ' HG12 ' A' ' 9' ' ' ILE . 7.1 mt -70.44 -35.15 60.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.174 -0.954 . . . . 0.0 109.275 179.897 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.47 -27.08 58.71 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.299 -0.875 . . . . 0.0 109.435 179.794 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -65.9 -25.14 67.03 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.269 -0.894 . . . . 0.0 109.382 179.889 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 9.3 t-20 -84.21 -48.65 9.57 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.361 -0.837 . . . . 0.0 109.255 179.768 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.43 HG12 ' O ' ' A' ' 5' ' ' ILE . 37.5 mm -50.03 -38.37 14.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.307 -0.871 . . . . 0.0 108.917 179.719 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 21.7 mt -50.9 -40.81 20.87 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 179.562 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -68.79 -35.72 80.6 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 108.875 -1.69 . . . . 0.0 108.875 179.45 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.477 HG12 ' O ' ' A' ' 12' ' ' VAL . 71.8 t -74.37 -9.96 13.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.345 -1.091 . . . . 0.0 109.225 179.592 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -103.17 -47.31 4.37 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.451 -0.78 . . . . 0.0 109.578 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -54.61 -41.33 69.85 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.184 -0.947 . . . . 0.0 109.652 -179.817 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 2.2 t0 -68.9 -47.51 65.63 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.228 -0.92 . . . . 0.0 109.116 179.915 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.467 ' O ' ' HB2' ' A' ' 19' ' ' TYR . 0.2 OUTLIER -47.53 -31.91 4.8 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.268 -0.895 . . . . 0.0 108.828 179.611 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.575 ' CG ' ' N ' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -71.99 -65.84 0.72 Allowed 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 179.425 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.575 ' N ' ' CG ' ' A' ' 17' ' ' TYR . 5.0 ttp180 -47.04 -26.02 0.95 Allowed 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 179.215 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.738 ' CD2' HD13 ' A' ' 23' ' ' ILE . 1.6 m-85 -66.5 -48.81 68.61 Favored 'General case' 0 C--N 1.302 -1.462 0 CA-C-O 121.242 0.544 . . . . 0.0 109.733 179.713 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -53.87 -18.94 3.79 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.323 -0.861 . . . . 0.0 109.665 -179.741 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 2.4 t -89.14 -19.5 25.43 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.23 -0.919 . . . . 0.0 110.569 -179.42 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.456 ' CG1' ' O ' ' A' ' 18' ' ' ARG . 0.3 OUTLIER -123.13 -8.4 7.95 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.689 0 O-C-N 121.168 -0.958 . . . . 0.0 110.364 -178.133 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.738 HD13 ' CD2' ' A' ' 19' ' ' TYR . 2.5 mp . . . . . 0 N--CA 1.492 1.649 0 O-C-N 120.923 -1.111 . . . . 0.0 109.923 -179.8 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 10.7 t . . . . . 0 N--CA 1.49 1.542 0 CA-C-O 121.276 0.56 . . . . 0.0 109.498 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.459 ' O ' HG12 ' A' ' 9' ' ' ILE . 12.0 mt -82.6 -29.22 8.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.169 -0.957 . . . . 0.0 109.368 -179.961 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.775 ' O ' HD12 ' A' ' 10' ' ' ILE . 4.8 mttm -83.3 -45.01 14.29 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.243 -0.91 . . . . 0.0 109.421 179.941 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -51.8 -20.56 2.25 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.27 -0.894 . . . . 0.0 109.556 179.886 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 10.8 t-20 -87.41 -42.75 12.6 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.195 -0.941 . . . . 0.0 109.462 -179.86 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.459 HG12 ' O ' ' A' ' 5' ' ' ILE . 17.6 mm -78.12 -38.72 24.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.248 -0.907 . . . . 0.0 109.555 -179.923 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.775 HD12 ' O ' ' A' ' 6' ' ' LYS . 1.1 mp -54.15 -42.2 54.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.107 -0.996 . . . . 0.0 109.001 179.946 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.421 ' HA2' ' HB2' ' A' ' 14' ' ' TYR . . . -59.01 -36.28 87.63 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.296 -1.522 . . . . 0.0 109.296 179.828 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.439 ' HB ' ' O ' ' A' ' 9' ' ' ILE . 24.8 t -58.52 -42.41 84.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.282 -1.128 . . . . 0.0 109.419 179.969 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 8.5 t -85.03 -19.32 32.15 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.168 -0.957 . . . . 0.0 109.521 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.421 ' HB2' ' HA2' ' A' ' 11' ' ' GLY . 1.5 m-85 -78.0 -21.74 50.39 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.268 -0.895 . . . . 0.0 109.362 179.917 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 76.0 m-20 -74.09 -55.8 5.68 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.312 -0.867 . . . . 0.0 109.428 179.917 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.479 ' HA ' ' OE1' ' A' ' 16' ' ' GLU . 0.9 OUTLIER -50.72 -41.27 56.09 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.265 -0.897 . . . . 0.0 109.11 179.949 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.629 ' CG ' ' N ' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -67.11 -62.18 1.56 Allowed 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 179.465 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.629 ' N ' ' CG ' ' A' ' 17' ' ' TYR . 0.3 OUTLIER -51.3 -22.52 2.86 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 179.223 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.673 ' CD2' HD13 ' A' ' 23' ' ' ILE . 3.3 m-85 -85.26 -27.48 25.99 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.762 -0.587 . . . . 0.0 109.77 -179.86 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.29 4.95 13.62 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.251 -0.906 . . . . 0.0 109.634 -179.795 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 4.2 t -111.13 -29.99 7.65 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.137 -0.977 . . . . 0.0 110.68 -179.517 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.484 HG13 ' O ' ' A' ' 18' ' ' ARG . 2.0 m -111.83 -38.35 3.12 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.679 0 O-C-N 121.114 -0.991 . . . . 0.0 110.413 -177.81 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.673 HD13 ' CD2' ' A' ' 19' ' ' TYR . 3.0 mp . . . . . 0 N--CA 1.491 1.61 0 O-C-N 121.015 -1.053 . . . . 0.0 109.829 -179.478 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.426 ' OG1' ' HB2' ' A' ' 8' ' ' ASN . 3.3 t . . . . . 0 N--CA 1.492 1.671 0 CA-C-O 121.536 0.684 . . . . 0.0 109.295 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 2.5 mp -64.85 -16.67 20.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.581 -0.699 . . . . 0.0 109.802 -179.892 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 12.8 tttt -116.42 -30.43 5.89 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.111 -0.993 . . . . 0.0 109.666 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -78.76 -25.44 44.44 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.197 -0.939 . . . . 0.0 109.582 -179.915 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . 0.426 ' HB2' ' OG1' ' A' ' 4' ' ' THR . 0.4 OUTLIER -83.0 -26.62 31.08 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.238 -0.914 . . . . 0.0 109.478 -179.929 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.479 ' O ' ' N ' ' A' ' 12' ' ' VAL . 24.9 mm -86.01 -48.24 16.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.232 -0.918 . . . . 0.0 109.515 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -48.02 -32.16 3.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.288 -0.883 . . . . 0.0 109.117 -179.851 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.451 ' O ' ' OD2' ' A' ' 15' ' ' ASP . . . -75.25 -27.31 64.17 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 108.964 -1.655 . . . . 0.0 108.964 179.547 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.479 ' N ' ' O ' ' A' ' 9' ' ' ILE . 45.9 t -55.54 -27.27 20.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.345 -1.091 . . . . 0.0 109.141 179.808 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -107.55 -4.47 18.33 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.303 -0.873 . . . . 0.0 109.498 179.906 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.449 ' HB2' ' HA2' ' A' ' 11' ' ' GLY . 0.3 OUTLIER -100.08 -21.28 15.65 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.189 -0.944 . . . . 0.0 109.658 -179.834 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.478 ' OD1' ' N ' ' A' ' 16' ' ' GLU . 2.3 p30 -95.32 -44.71 7.46 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.235 -0.916 . . . . 0.0 109.418 179.874 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.478 ' N ' ' OD1' ' A' ' 15' ' ' ASP . 0.1 OUTLIER -56.96 -45.46 82.85 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.173 -0.954 . . . . 0.0 109.103 179.805 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.661 ' CG ' ' N ' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -59.75 -56.77 17.72 Favored 'General case' 0 N--CA 1.487 1.378 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 179.234 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.661 ' N ' ' CG ' ' A' ' 17' ' ' TYR . 0.0 OUTLIER -53.43 -20.88 5.15 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 178.881 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.565 ' HA ' HG13 ' A' ' 22' ' ' VAL . 2.5 m-30 -90.69 -12.91 35.32 Favored 'General case' 0 C--N 1.306 -1.323 0 CA-C-O 121.422 0.63 . . . . 0.0 109.386 179.768 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -71.76 -31.72 66.94 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.374 -0.829 . . . . 0.0 110.371 -179.208 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 3.1 t -96.17 24.37 5.72 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.031 -1.043 . . . . 0.0 109.796 -179.567 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.567 HG22 HG13 ' A' ' 23' ' ' ILE . 0.2 OUTLIER -149.82 -40.4 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.299 -1.598 0 O-C-N 121.346 -0.846 . . . . 0.0 109.426 -178.889 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.567 HG13 HG22 ' A' ' 22' ' ' VAL . 7.7 mt . . . . . 0 N--CA 1.489 1.523 0 O-C-N 121.26 -0.9 . . . . 0.0 109.299 -179.886 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.9 t . . . . . 0 N--CA 1.491 1.587 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.61 HG23 HG13 ' A' ' 9' ' ' ILE . 33.8 mt -99.01 -19.2 5.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.273 -0.892 . . . . 0.0 109.307 179.889 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.517 ' O ' HD12 ' A' ' 10' ' ' ILE . 0.7 OUTLIER -102.02 18.71 20.02 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.321 -0.862 . . . . 0.0 109.56 179.991 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -136.9 -39.92 0.61 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.106 -0.996 . . . . 0.0 109.563 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 21.5 t-20 -94.52 -53.01 4.06 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.307 -0.87 . . . . 0.0 109.503 -179.863 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.61 HG13 HG23 ' A' ' 5' ' ' ILE . 34.8 mm -55.83 -20.86 9.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.245 -0.91 . . . . 0.0 109.329 179.983 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.517 HD12 ' O ' ' A' ' 6' ' ' LYS . 23.9 mt -68.77 -43.55 82.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.309 -0.869 . . . . 0.0 109.198 179.809 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -65.65 -31.6 80.48 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.358 -1.497 . . . . 0.0 109.358 179.851 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 39.4 t -58.64 -29.02 38.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.262 -1.14 . . . . 0.0 109.448 179.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.577 ' O ' ' CZ ' ' A' ' 17' ' ' TYR . 22.6 m -86.2 -34.07 20.59 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.203 -0.936 . . . . 0.0 109.468 -179.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.593 ' HA ' ' CD2' ' A' ' 17' ' ' TYR . 0.3 OUTLIER -75.76 -27.3 58.0 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.256 -0.902 . . . . 0.0 109.434 -179.996 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.464 ' O ' ' CD1' ' A' ' 19' ' ' TYR . 0.7 OUTLIER -61.55 -45.04 95.83 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.287 -0.883 . . . . 0.0 109.31 179.902 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.412 ' O ' ' HB2' ' A' ' 19' ' ' TYR . 0.0 OUTLIER -60.29 -41.34 93.18 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.254 -0.904 . . . . 0.0 109.377 179.896 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.602 ' N ' ' CD1' ' A' ' 17' ' ' TYR . 1.2 m-30 -67.07 -42.15 85.18 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.273 -0.892 . . . . 0.0 108.943 179.978 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.529 ' O ' ' CG1' ' A' ' 22' ' ' VAL . 0.0 OUTLIER -80.58 7.64 9.59 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 108.62 -0.882 . . . . 0.0 108.62 178.725 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.715 ' CG ' HD13 ' A' ' 23' ' ' ILE . 3.2 m-30 -103.34 -42.62 5.66 Favored 'General case' 0 C--N 1.309 -1.16 0 O-C-N 121.493 -0.754 . . . . 0.0 109.456 -179.577 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 29.1 mtp180 -56.45 -33.81 66.24 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.441 -0.787 . . . . 0.0 110.276 -179.255 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 23.3 t -84.16 12.38 6.59 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.111 -0.993 . . . . 0.0 110.277 -179.35 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.802 HG22 ' N ' ' A' ' 23' ' ' ILE . 0.1 OUTLIER -146.73 -78.55 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.299 -1.601 0 O-C-N 121.184 -0.947 . . . . 0.0 110.094 -178.718 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.802 ' N ' HG22 ' A' ' 22' ' ' VAL . 1.7 mp . . . . . 0 N--CA 1.49 1.575 0 O-C-N 121.032 -1.043 . . . . 0.0 109.432 -179.62 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.501 ' HA ' HG22 ' A' ' 4' ' ' THR . 0.1 OUTLIER . . . . . 0 N--CA 1.493 1.694 0 CA-C-O 120.775 0.322 . . . . 0.0 110.28 . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -75.43 -1.2 11.02 Favored 'Trans proline' 0 C--N 1.305 -1.736 0 O-C-N 123.984 1.518 . . . . 0.0 110.569 -179.852 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -166.45 34.89 0.23 Allowed Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.651 -1.379 . . . . 0.0 109.651 -179.848 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.705 HG23 ' O ' ' A' ' 4' ' ' THR . 11.6 t -147.92 47.58 1.08 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.262 -1.14 . . . . 0.0 109.359 179.84 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.463 ' O ' HG12 ' A' ' 9' ' ' ILE . 70.9 mt -93.76 -39.2 10.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.33 -0.856 . . . . 0.0 109.61 -179.858 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.54 -41.89 12.43 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.253 -0.905 . . . . 0.0 109.272 179.912 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.5 ' HA ' HD12 ' A' ' 10' ' ' ILE . 16.6 tp10 -59.41 -15.44 16.96 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.311 -0.868 . . . . 0.0 109.382 179.881 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -87.84 -42.62 12.42 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.25 -0.906 . . . . 0.0 109.388 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.463 HG12 ' O ' ' A' ' 5' ' ' ILE . 23.9 mm -61.64 -40.62 87.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.225 -0.922 . . . . 0.0 109.191 179.827 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.5 HD12 ' HA ' ' A' ' 7' ' ' GLU . 15.2 mt -48.89 -30.95 3.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.235 -0.916 . . . . 0.0 108.882 179.593 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -86.51 -33.78 13.01 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.531 -1.427 . . . . 0.0 109.531 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 44.1 t -70.25 -37.64 71.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.225 -1.162 . . . . 0.0 109.415 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -76.49 -42.8 42.21 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.223 -0.923 . . . . 0.0 109.431 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.405 ' HB2' ' O ' ' A' ' 10' ' ' ILE . 0.2 OUTLIER -49.03 -22.33 0.87 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.304 -0.873 . . . . 0.0 109.397 179.837 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.473 ' O ' ' HB2' ' A' ' 19' ' ' TYR . 1.7 t70 -94.67 -56.89 2.63 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.211 -0.93 . . . . 0.0 109.686 -179.906 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.494 ' O ' ' N ' ' A' ' 20' ' ' ARG . 0.9 OUTLIER -46.12 -39.9 10.19 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.275 -0.89 . . . . 0.0 109.046 -179.943 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.605 ' CG ' ' N ' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -65.82 -56.38 12.2 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 108.674 -0.861 . . . . 0.0 108.674 179.536 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 1.035 ' O ' HG11 ' A' ' 22' ' ' VAL . 2.3 ttt-85 -67.49 -1.55 5.1 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.656 -0.652 . . . . 0.0 109.467 179.66 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.616 ' O ' HD12 ' A' ' 23' ' ' ILE . 6.1 m-85 -119.63 -8.6 9.93 Favored 'General case' 0 C--N 1.308 -1.221 0 CA-C-O 121.616 0.722 . . . . 0.0 109.066 -179.725 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.494 ' N ' ' O ' ' A' ' 16' ' ' GLU . 6.8 ttt-85 -64.34 -45.39 88.05 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.562 -0.712 . . . . 0.0 111.648 -178.19 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 3.5 t -127.85 48.8 2.21 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.697 -1.252 . . . . 0.0 110.609 -178.234 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 1.035 HG11 ' O ' ' A' ' 18' ' ' ARG . 0.6 OUTLIER -138.06 -37.42 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.759 0 O-C-N 121.433 -0.792 . . . . 0.0 109.921 -179.29 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.616 HD12 ' O ' ' A' ' 19' ' ' TYR . 5.1 mt -60.02 -46.76 93.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.134 -0.979 . . . . 0.0 109.598 -179.383 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.435 ' O ' ' HG2' ' A' ' 24' ' ' LYS . 3.4 ttmm -52.8 91.87 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.24 -0.913 . . . . 0.0 109.342 179.805 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.482 ' N ' ' O ' ' A' ' 23' ' ' ILE . . . . . . . . 0 N--CA 1.49 1.535 0 CA-C-O 118.0 -1.0 . . . . 0.0 109.488 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.622 0 CA-C-O 120.798 0.333 . . . . 0.0 110.185 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -74.73 1.38 7.64 Favored 'Trans proline' 0 C--N 1.306 -1.673 0 O-C-N 124.058 1.557 . . . . 0.0 110.52 -179.874 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . 0.475 ' O ' ' HB2' ' A' ' 7' ' ' GLU . . . -83.71 -21.4 57.95 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 13.3 t -129.12 -31.7 2.09 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.342 -1.093 . . . . 0.0 109.745 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 20.8 mm -65.25 -16.44 20.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.195 -0.94 . . . . 0.0 109.663 -179.803 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -128.42 -28.11 2.58 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.133 -0.98 . . . . 0.0 109.945 -179.738 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.475 ' HB2' ' O ' ' A' ' 3' ' ' GLY . 0.0 OUTLIER -82.62 -29.06 30.37 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.127 -0.983 . . . . 0.0 109.767 -179.805 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 4.3 t-20 -67.39 -49.1 65.32 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.107 -0.996 . . . . 0.0 109.238 179.776 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 47.5 mm -57.53 -37.88 60.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.305 -0.872 . . . . 0.0 109.348 179.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.426 HD12 ' HA ' ' A' ' 7' ' ' GLU . 56.7 mt -53.5 -44.77 57.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.201 -0.937 . . . . 0.0 108.75 179.662 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.47 ' O ' ' HB2' ' A' ' 15' ' ' ASP . . . -69.32 -13.41 67.58 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 108.943 -1.663 . . . . 0.0 108.943 179.426 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.454 HG12 ' O ' ' A' ' 12' ' ' VAL . 55.1 t -98.32 -12.38 8.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.406 -1.056 . . . . 0.0 109.169 179.675 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.448 ' O ' ' HB3' ' A' ' 17' ' ' TYR . 23.2 p -120.64 -34.48 3.58 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.272 -0.892 . . . . 0.0 109.505 -179.823 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -77.26 -42.78 35.77 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.201 -0.937 . . . . 0.0 109.33 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.47 ' HB2' ' O ' ' A' ' 11' ' ' GLY . 3.1 m-20 -62.13 -54.35 42.49 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.218 -0.926 . . . . 0.0 109.103 179.83 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.45 ' O ' ' N ' ' A' ' 20' ' ' ARG . 1.6 tt0 -54.92 -43.86 73.7 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.204 -0.935 . . . . 0.0 108.891 179.58 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.526 ' CG ' ' N ' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -61.03 -58.31 8.96 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 179.159 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.526 ' N ' ' CG ' ' A' ' 17' ' ' TYR . 5.3 ttm180 -58.78 -14.92 10.03 Favored 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 108.898 -0.779 . . . . 0.0 108.898 179.455 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.656 ' HA ' HG13 ' A' ' 22' ' ' VAL . 3.1 m-85 -97.42 -27.63 14.37 Favored 'General case' 0 C--N 1.307 -1.252 0 O-C-N 121.462 -0.774 . . . . 0.0 109.709 -179.629 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.45 ' N ' ' O ' ' A' ' 16' ' ' GLU . 0.0 OUTLIER -65.96 -10.56 40.39 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.184 -0.948 . . . . 0.0 109.999 -179.353 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 5.5 t -111.16 14.91 21.77 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.032 -1.043 . . . . 0.0 109.436 179.873 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.656 HG13 ' HA ' ' A' ' 19' ' ' TYR . 0.1 OUTLIER -146.75 -39.94 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.594 0 O-C-N 121.549 -0.72 . . . . 0.0 109.447 -178.299 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.405 HG13 ' HB3' ' A' ' 19' ' ' TYR . 5.4 mm -86.35 -69.82 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 O-C-N 121.203 -0.935 . . . . 0.0 109.494 -179.677 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -69.39 -177.51 1.17 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.163 -0.961 . . . . 0.0 109.393 179.876 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.597 0 CA-C-O 117.98 -1.01 . . . . 0.0 109.481 -179.959 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.3 ttp . . . . . 0 N--CA 1.491 1.581 0 CA-C-O 120.817 0.342 . . . . 0.0 110.187 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -74.17 1.95 6.68 Favored 'Trans proline' 0 C--N 1.305 -1.713 0 O-C-N 124.079 1.568 . . . . 0.0 110.626 179.818 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . 0.536 ' O ' ' CG2' ' A' ' 4' ' ' THR . . . 135.87 -113.22 1.06 Allowed Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 179.905 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.536 ' CG2' ' O ' ' A' ' 3' ' ' GLY . 4.2 t 40.59 29.2 0.06 Allowed 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.617 -0.931 . . . . 0.0 109.26 -179.846 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.45 ' N ' ' O ' ' A' ' 3' ' ' GLY . 52.4 mt -75.06 -16.97 16.1 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.474 0 O-C-N 121.444 -0.785 . . . . 0.0 109.419 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 9.3 pttt -107.02 -30.5 8.78 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.265 -0.897 . . . . 0.0 109.468 179.828 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -62.23 -22.29 65.84 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.19 -0.944 . . . . 0.0 109.195 179.831 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 12.3 t-20 -80.73 -52.25 7.74 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.265 -0.897 . . . . 0.0 109.297 179.864 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.505 ' O ' ' N ' ' A' ' 12' ' ' VAL . 41.2 mm -63.14 -45.93 97.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.307 -0.871 . . . . 0.0 109.481 179.927 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 48.0 mt -47.8 -29.17 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.138 -0.976 . . . . 0.0 109.074 179.883 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -81.63 -23.88 57.23 Favored Glycine 0 N--CA 1.489 2.172 0 N-CA-C 109.157 -1.577 . . . . 0.0 109.157 179.583 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.505 ' N ' ' O ' ' A' ' 9' ' ' ILE . 75.6 t -65.02 -33.85 66.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.45 -1.029 . . . . 0.0 109.335 179.721 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -75.1 -30.76 60.98 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.227 -0.92 . . . . 0.0 109.329 179.77 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -56.76 -45.72 81.86 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.292 -0.88 . . . . 0.0 109.389 179.846 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.573 ' HB3' ' CE2' ' A' ' 19' ' ' TYR . 67.9 m-20 -55.91 -45.65 78.61 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.271 -0.893 . . . . 0.0 109.211 179.809 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -51.16 -42.5 60.84 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.338 -0.851 . . . . 0.0 108.768 179.507 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.533 ' CD1' ' C ' ' A' ' 17' ' ' TYR . 0.0 OUTLIER -64.66 -62.32 1.65 Allowed 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 179.261 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.523 ' N ' ' CG ' ' A' ' 17' ' ' TYR . 0.0 OUTLIER -54.42 -20.08 6.8 Favored 'General case' 0 C--N 1.303 -1.413 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 179.321 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.627 ' HA ' HG13 ' A' ' 22' ' ' VAL . 4.6 m-30 -88.25 -22.32 24.01 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 179.631 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.453 ' HG3' ' O ' ' A' ' 20' ' ' ARG . 24.3 tpp180 -67.18 -18.45 65.27 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.335 -0.853 . . . . 0.0 110.107 -179.439 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 4.1 t -105.8 16.51 25.13 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.993 -1.067 . . . . 0.0 109.832 -179.734 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.627 HG13 ' HA ' ' A' ' 19' ' ' TYR . 0.1 OUTLIER -149.58 -44.83 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.298 -1.639 0 O-C-N 121.333 -0.854 . . . . 0.0 109.837 -178.461 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.501 HG13 ' HB3' ' A' ' 19' ' ' TYR . 11.5 mm -79.46 -65.61 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.41 0 O-C-N 121.083 -1.011 . . . . 0.0 109.96 -179.431 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.411 ' O ' ' HG2' ' A' ' 24' ' ' LYS . 0.1 OUTLIER -79.92 -10.8 59.81 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.173 -0.954 . . . . 0.0 109.637 -179.951 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.579 0 CA-C-O 117.977 -1.011 . . . . 0.0 109.555 179.979 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.481 ' N ' ' HD3' ' A' ' 2' ' ' PRO . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.752 0 N-CA-C 110.141 -0.318 . . . . 0.0 110.141 . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . 0.481 ' HD3' ' N ' ' A' ' 1' ' ' MET . 50.3 Cg_endo -80.17 13.5 2.18 Favored 'Trans proline' 0 C--N 1.306 -1.681 0 O-C-N 124.086 1.572 . . . . 0.0 110.875 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -49.16 119.78 6.52 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.697 -1.361 . . . . 0.0 109.697 -179.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 4.1 t -111.9 36.86 3.14 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.283 -1.128 . . . . 0.0 109.378 179.735 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.504 ' N ' HD13 ' A' ' 5' ' ' ILE . 3.3 mm -84.49 -12.08 11.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.32 -0.863 . . . . 0.0 109.547 -179.82 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -113.94 -22.09 10.28 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.27 -0.894 . . . . 0.0 109.436 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 4.9 tm-20 -86.42 -11.77 50.98 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.29 -0.881 . . . . 0.0 109.578 -179.745 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 18.0 t-20 -95.92 -49.18 5.41 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.245 -0.909 . . . . 0.0 109.355 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.409 HD13 ' HA ' ' A' ' 9' ' ' ILE . 49.1 mm -62.13 -34.96 66.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.284 -0.885 . . . . 0.0 109.541 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.402 ' O ' ' HB2' ' A' ' 14' ' ' TYR . 10.4 tt -49.41 -35.1 8.44 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 O-C-N 121.234 -0.916 . . . . 0.0 109.15 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.493 ' O ' ' N ' ' A' ' 15' ' ' ASP . . . -76.21 -39.92 30.5 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 109.059 -1.616 . . . . 0.0 109.059 179.666 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.484 ' O ' ' HB2' ' A' ' 16' ' ' GLU . 55.2 t -54.22 -32.7 23.94 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.319 -1.106 . . . . 0.0 109.066 179.581 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -96.08 -5.47 40.82 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.365 -0.835 . . . . 0.0 109.204 179.762 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.434 ' O ' ' CD2' ' A' ' 17' ' ' TYR . 1.8 m-85 -111.35 -56.32 2.39 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.22 -0.925 . . . . 0.0 109.382 179.917 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.493 ' N ' ' O ' ' A' ' 11' ' ' GLY . 14.3 t70 -58.4 -46.16 86.95 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.054 -1.029 . . . . 0.0 109.176 179.832 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.484 ' HB2' ' O ' ' A' ' 12' ' ' VAL . 1.9 tp10 -56.83 -48.43 78.04 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.268 -0.895 . . . . 0.0 109.221 179.774 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.62 ' CG ' ' N ' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -55.54 -55.8 27.75 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 179.404 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.713 ' O ' HG11 ' A' ' 22' ' ' VAL . 0.0 OUTLIER -58.93 -15.08 11.13 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 108.963 -0.755 . . . . 0.0 108.963 179.59 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.61 ' HA ' ' CG1' ' A' ' 22' ' ' VAL . 3.1 m-85 -102.83 -16.2 16.0 Favored 'General case' 0 C--N 1.305 -1.336 0 O-C-N 121.614 -0.679 . . . . 0.0 110.383 -178.918 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.437 ' N ' ' O ' ' A' ' 16' ' ' GLU . 0.0 OUTLIER -70.68 -21.1 62.62 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.172 -0.955 . . . . 0.0 110.998 -178.657 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 4.9 t -122.51 41.88 3.31 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.705 -1.247 . . . . 0.0 110.23 -179.112 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.713 HG11 ' O ' ' A' ' 18' ' ' ARG . 0.3 OUTLIER -155.35 -37.34 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 O-C-N 121.155 -0.966 . . . . 0.0 110.195 -178.531 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.531 HD11 ' CD2' ' A' ' 19' ' ' TYR . 12.3 mm -71.31 -60.08 2.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.061 -1.025 . . . . 0.0 109.72 -179.239 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -177.64 -73.68 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.288 -0.883 . . . . 0.0 109.545 -179.936 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.548 0 CA-C-O 118.028 -0.987 . . . . 0.0 109.392 179.963 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.6 mtp . . . . . 0 N--CA 1.491 1.618 0 CA-C-O 120.719 0.295 . . . . 0.0 110.26 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -73.81 -0.78 9.88 Favored 'Trans proline' 0 C--N 1.305 -1.728 0 O-C-N 124.112 1.585 . . . . 0.0 110.485 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -102.0 -161.45 26.59 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 -179.854 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 11.1 t -124.92 35.13 4.84 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.255 -1.144 . . . . 0.0 109.47 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 24.4 mm -81.93 -30.96 10.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.34 -0.85 . . . . 0.0 109.627 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 19.5 ttpt -87.56 -29.89 20.94 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.205 -0.934 . . . . 0.0 109.621 -179.863 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.593 ' O ' HG22 ' A' ' 10' ' ' ILE . 0.8 OUTLIER -74.79 -47.29 31.59 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.226 -0.921 . . . . 0.0 109.495 -179.916 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 33.1 t-20 -48.82 -35.08 13.68 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.24 -0.913 . . . . 0.0 109.208 179.898 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 31.9 mm -69.29 -33.42 57.78 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.189 -0.945 . . . . 0.0 109.085 179.694 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.593 HG22 ' O ' ' A' ' 7' ' ' GLU . 2.4 tt -60.28 -40.4 83.68 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.242 -0.911 . . . . 0.0 108.709 179.595 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.419 ' N ' ' CG2' ' A' ' 10' ' ' ILE . . . -62.96 -20.91 62.95 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 108.586 -1.805 . . . . 0.0 108.586 179.319 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 49.6 t -88.66 -29.68 5.32 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.425 0 O-C-N 121.621 -0.929 . . . . 0.0 109.069 179.635 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 38.0 t -95.17 -0.63 53.09 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.294 -0.879 . . . . 0.0 109.453 179.827 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.458 ' HB2' ' O ' ' A' ' 10' ' ' ILE . 0.9 OUTLIER -99.26 -16.8 18.38 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.163 -0.961 . . . . 0.0 109.49 179.946 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 29.8 t0 -95.42 -54.82 3.25 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.23 -0.919 . . . . 0.0 109.415 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -52.18 -41.46 62.65 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.167 -0.958 . . . . 0.0 109.012 179.705 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.603 ' CG ' ' N ' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -59.14 -55.7 31.62 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 179.366 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.603 ' N ' ' CG ' ' A' ' 17' ' ' TYR . 9.3 ttm180 -66.96 -6.04 15.18 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 179.652 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.764 ' CD2' HD13 ' A' ' 23' ' ' ILE . 2.4 m-85 -107.59 -16.58 14.32 Favored 'General case' 0 C--N 1.305 -1.336 0 O-C-N 121.341 -0.85 . . . . 0.0 109.873 -179.265 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 1.9 mmt180 -74.78 -21.66 59.2 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.259 -0.9 . . . . 0.0 110.234 -179.323 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 8.5 t -107.71 24.63 12.62 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.036 -1.04 . . . . 0.0 109.997 -179.577 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.594 HG11 ' O ' ' A' ' 18' ' ' ARG . 0.1 OUTLIER -146.77 -49.46 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.547 0 O-C-N 121.333 -0.854 . . . . 0.0 109.631 -178.82 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.764 HD13 ' CD2' ' A' ' 19' ' ' TYR . 2.5 mp -100.67 -54.98 6.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 120.977 -1.077 . . . . 0.0 109.409 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 5.3 mttm -82.49 68.97 9.15 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.211 -0.931 . . . . 0.0 109.426 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.565 0 CA-C-O 117.972 -1.013 . . . . 0.0 109.519 179.945 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.647 0 N-CA-C 110.096 -0.335 . . . . 0.0 110.096 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -73.93 -0.65 9.76 Favored 'Trans proline' 0 C--N 1.304 -1.767 0 O-C-N 124.13 1.595 . . . . 0.0 110.633 -179.914 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -87.18 97.55 2.28 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 7.3 t -61.41 -27.19 68.36 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.221 -1.164 . . . . 0.0 109.546 -179.938 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 2.5 mp -62.8 -21.87 28.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.171 -0.956 . . . . 0.0 109.464 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 19.9 mmtt -102.96 -41.08 6.24 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.322 -0.861 . . . . 0.0 109.339 179.858 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -67.62 -12.24 59.98 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.241 -0.912 . . . . 0.0 109.459 179.89 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 30.3 t-20 -87.67 -50.53 6.43 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.275 -0.89 . . . . 0.0 109.244 179.865 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 24.7 mm -70.69 -18.72 21.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.277 -0.889 . . . . 0.0 109.21 179.765 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.438 ' O ' ' N ' ' A' ' 14' ' ' TYR . 1.9 mm -66.64 -57.3 10.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.312 -0.867 . . . . 0.0 109.058 179.786 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -55.54 -20.45 23.84 Favored Glycine 0 N--CA 1.488 2.146 0 N-CA-C 109.065 -1.614 . . . . 0.0 109.065 179.658 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 69.0 t -86.76 -21.64 7.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.303 -1.116 . . . . 0.0 109.484 179.788 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.1 p -116.27 2.14 13.21 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.21 -0.931 . . . . 0.0 109.642 -179.885 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.438 ' N ' ' O ' ' A' ' 10' ' ' ILE . 0.3 OUTLIER -125.16 -35.36 2.64 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.215 -0.928 . . . . 0.0 109.663 -179.935 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -76.35 -38.97 55.1 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.123 -0.986 . . . . 0.0 109.408 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -58.18 -43.46 87.5 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.294 -0.879 . . . . 0.0 109.464 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.632 ' CG ' ' N ' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -62.91 -59.68 4.51 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 179.488 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.632 ' N ' ' CG ' ' A' ' 17' ' ' TYR . 4.8 ttm180 -53.92 -20.48 6.13 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 179.302 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.575 ' HA ' HG13 ' A' ' 22' ' ' VAL . 3.1 m-30 -92.39 -12.46 32.21 Favored 'General case' 0 C--N 1.305 -1.354 0 O-C-N 121.624 -0.673 . . . . 0.0 109.567 -179.725 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.28 -35.13 63.74 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.322 -0.861 . . . . 0.0 110.069 -179.442 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 48.3 t -90.41 21.35 3.93 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.142 -0.974 . . . . 0.0 109.882 -179.621 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.575 HG13 ' HA ' ' A' ' 19' ' ' TYR . 0.2 OUTLIER -150.09 -43.07 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.556 0 O-C-N 121.371 -0.831 . . . . 0.0 109.541 -178.777 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.46 HG12 HG13 ' A' ' 22' ' ' VAL . 3.8 mm -93.2 -64.48 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.172 -0.955 . . . . 0.0 109.597 -179.669 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 60.68 37.45 19.09 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.228 -0.92 . . . . 0.0 109.34 -179.821 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.547 0 CA-C-O 117.985 -1.007 . . . . 0.0 109.514 -179.895 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.2 ttp . . . . . 0 N--CA 1.492 1.646 0 CA-C-O 120.869 0.366 . . . . 0.0 110.323 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . 0.515 ' HB2' HD13 ' A' ' 5' ' ' ILE . 46.5 Cg_endo -73.85 0.09 8.74 Favored 'Trans proline' 0 C--N 1.307 -1.651 0 O-C-N 124.007 1.53 . . . . 0.0 110.633 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 133.48 -110.05 0.86 Allowed Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.648 -1.381 . . . . 0.0 109.648 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.434 ' O ' ' HB2' ' A' ' 8' ' ' ASN . 15.1 t -112.04 -12.54 13.69 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.302 -1.117 . . . . 0.0 109.729 -179.833 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.515 HD13 ' HB2' ' A' ' 2' ' ' PRO . 2.5 mp -51.87 -21.38 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.233 -0.917 . . . . 0.0 109.477 -179.909 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 18.4 ttpt -93.4 -60.1 1.86 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.189 -0.944 . . . . 0.0 109.602 -179.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 7.3 tt0 -58.87 -24.86 62.74 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.237 -0.915 . . . . 0.0 109.753 -179.755 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.434 ' HB2' ' O ' ' A' ' 4' ' ' THR . 6.0 t-20 -61.98 -45.76 92.25 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.092 -1.005 . . . . 0.0 109.555 -179.909 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.461 ' O ' ' N ' ' A' ' 12' ' ' VAL . 19.6 mm -69.52 -49.0 63.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.298 -0.876 . . . . 0.0 109.527 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 64.1 mt -46.5 -27.56 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.201 -0.937 . . . . 0.0 109.166 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -86.93 -26.88 30.36 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.329 -1.509 . . . . 0.0 109.329 179.809 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.461 ' N ' ' O ' ' A' ' 9' ' ' ILE . 76.5 t -60.03 -47.06 93.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.332 -1.099 . . . . 0.0 109.311 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 7.6 t -77.19 -16.66 59.0 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.263 -0.898 . . . . 0.0 109.283 179.708 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -86.15 -23.77 26.45 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.345 -0.847 . . . . 0.0 109.324 179.805 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.449 ' O ' ' C ' ' A' ' 16' ' ' GLU . 27.7 m-20 -76.44 -55.77 5.23 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.355 -0.841 . . . . 0.0 109.555 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.449 ' C ' ' O ' ' A' ' 15' ' ' ASP . 0.3 OUTLIER -43.77 -32.63 1.08 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.127 -0.983 . . . . 0.0 108.838 179.72 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -65.94 -48.79 70.2 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 108.385 -0.968 . . . . 0.0 108.385 179.116 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.572 ' O ' HG11 ' A' ' 22' ' ' VAL . 21.7 ttt180 -73.27 4.11 4.97 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.476 -0.765 . . . . 0.0 109.062 179.199 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.552 ' HA ' HD12 ' A' ' 23' ' ' ILE . 8.3 m-85 -119.78 -4.73 10.19 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.419 -0.8 . . . . 0.0 109.038 -179.297 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 1.7 tpt180 -95.52 -68.14 0.82 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.516 -0.74 . . . . 0.0 111.372 -178.296 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 18.3 t -85.25 20.36 1.99 Allowed 'General case' 0 N--CA 1.496 1.845 0 O-C-N 120.964 -1.085 . . . . 0.0 110.697 -178.406 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.577 HG22 ' N ' ' A' ' 23' ' ' ILE . 0.2 OUTLIER -134.04 -63.43 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.783 0 O-C-N 121.347 -0.846 . . . . 0.0 109.032 -179.183 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.577 ' N ' HG22 ' A' ' 22' ' ' VAL . 3.3 mt -87.71 -33.12 6.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.238 -0.913 . . . . 0.0 109.288 179.782 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.548 ' O ' ' HB2' ' A' ' 25' ' ' ALA . 0.0 OUTLIER 44.61 61.15 2.56 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.296 -0.878 . . . . 0.0 109.539 179.995 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.548 ' HB2' ' O ' ' A' ' 24' ' ' LYS . . . . . . . . 0 N--CA 1.489 1.501 0 CA-C-O 117.97 -1.014 . . . . 0.0 109.469 180.0 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.3 mtp . . . . . 0 N--CA 1.492 1.652 0 CA-C-O 120.725 0.298 . . . . 0.0 110.339 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -80.44 6.37 5.45 Favored 'Trans proline' 0 C--N 1.306 -1.695 0 O-C-N 123.958 1.504 . . . . 0.0 110.495 -179.851 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -119.8 55.97 0.6 Allowed Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.689 -1.364 . . . . 0.0 109.689 -179.887 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.659 HG23 ' O ' ' A' ' 4' ' ' THR . 15.0 t -148.44 50.63 1.01 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.238 -1.154 . . . . 0.0 109.592 179.93 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.421 HD13 ' HA ' ' A' ' 5' ' ' ILE . 23.0 mm -74.88 -28.88 21.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.318 -0.864 . . . . 0.0 109.25 179.792 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 7.6 mtpt -106.21 -37.06 6.69 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.475 -0.766 . . . . 0.0 109.274 179.895 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.14 -15.91 62.92 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.313 -0.867 . . . . 0.0 108.992 179.775 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.478 ' HB2' ' O ' ' A' ' 4' ' ' THR . 48.3 t-20 -78.76 -54.71 5.8 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.421 -0.8 . . . . 0.0 109.354 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.476 ' HA ' ' HB ' ' A' ' 12' ' ' VAL . 46.8 mm -67.99 -30.64 48.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.205 -0.934 . . . . 0.0 109.276 179.83 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.402 ' HA ' HD13 ' A' ' 10' ' ' ILE . 3.3 mm -50.91 -36.36 15.4 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 O-C-N 121.279 -0.888 . . . . 0.0 109.208 179.755 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -89.99 -32.47 9.84 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 179.916 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.476 ' HB ' ' HA ' ' A' ' 9' ' ' ILE . 47.4 t -70.48 -37.92 71.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.22 -1.165 . . . . 0.0 109.318 179.942 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -71.38 -13.31 61.81 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.3 -0.875 . . . . 0.0 109.468 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.461 ' O ' ' HB3' ' A' ' 17' ' ' TYR . 2.3 m-85 -77.96 -49.63 13.73 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.206 -0.934 . . . . 0.0 109.406 179.862 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.454 ' OD1' ' CE1' ' A' ' 19' ' ' TYR . 6.3 t0 -56.56 -46.07 80.92 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.182 -0.949 . . . . 0.0 109.1 179.799 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.402 ' C ' ' O ' ' A' ' 15' ' ' ASP . 0.6 OUTLIER -46.73 -39.26 11.28 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 108.204 -1.035 . . . . 0.0 108.204 179.401 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.461 ' HB3' ' O ' ' A' ' 14' ' ' TYR . 0.2 OUTLIER -64.1 -61.54 2.19 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 107.668 -1.234 . . . . 0.0 107.668 178.781 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.553 ' O ' ' CG1' ' A' ' 22' ' ' VAL . 4.0 ttt85 -52.37 -22.36 4.54 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 178.805 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.575 ' HA ' HG13 ' A' ' 22' ' ' VAL . 7.8 m-30 -91.79 -8.94 45.28 Favored 'General case' 0 C--N 1.305 -1.347 0 CA-C-O 121.346 0.593 . . . . 0.0 109.747 -179.637 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.46 ' O ' ' HG2' ' A' ' 24' ' ' LYS . 0.4 OUTLIER -75.14 -28.02 60.0 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.287 -0.883 . . . . 0.0 110.299 -179.121 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 7.4 t -105.48 28.4 7.44 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.981 -1.074 . . . . 0.0 110.047 -179.487 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.575 HG13 ' HA ' ' A' ' 19' ' ' TYR . 0.2 OUTLIER -155.02 -41.12 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.56 0 O-C-N 121.316 -0.865 . . . . 0.0 109.356 -178.833 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.464 ' CD1' ' CG ' ' A' ' 19' ' ' TYR . 4.6 mt -107.17 -31.07 2.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.259 -0.901 . . . . 0.0 109.13 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.46 ' HG2' ' O ' ' A' ' 20' ' ' ARG . 15.8 mttt 44.98 66.65 0.85 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.336 -0.852 . . . . 0.0 109.538 179.926 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.508 0 CA-C-O 117.971 -1.014 . . . . 0.0 109.473 179.907 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.5 tpp . . . . . 0 N--CA 1.491 1.593 0 N-CA-C 110.072 -0.344 . . . . 0.0 110.072 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -73.76 -0.67 9.71 Favored 'Trans proline' 0 C--N 1.305 -1.712 0 O-C-N 123.866 1.456 . . . . 0.0 110.403 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 102.24 -172.22 22.12 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 12.8 t -100.54 30.81 3.74 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.332 -1.099 . . . . 0.0 109.243 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.488 ' O ' HG12 ' A' ' 9' ' ' ILE . 21.5 mm -76.83 -43.1 33.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.375 -0.828 . . . . 0.0 109.746 -179.784 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.471 ' O ' HG13 ' A' ' 10' ' ' ILE . 0.2 OUTLIER -102.07 -15.16 16.83 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.217 -0.927 . . . . 0.0 109.746 -179.592 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 7.1 mt-10 -70.79 -29.5 65.72 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 120.96 -1.088 . . . . 0.0 109.572 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.421 ' O ' HG23 ' A' ' 12' ' ' VAL . 41.3 t-20 -94.45 -37.83 11.23 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.162 -0.961 . . . . 0.0 109.701 -179.884 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.488 HG12 ' O ' ' A' ' 5' ' ' ILE . 18.7 mm -65.53 -41.9 91.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.172 -0.955 . . . . 0.0 109.487 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.471 HG13 ' O ' ' A' ' 6' ' ' LYS . 19.3 mt -49.64 -42.07 17.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.173 -0.954 . . . . 0.0 108.636 179.693 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -68.62 -32.07 74.26 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 108.662 -1.775 . . . . 0.0 108.662 179.14 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.421 HG23 ' O ' ' A' ' 8' ' ' ASN . 68.3 t -73.1 -33.18 41.63 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 O-C-N 121.437 -1.037 . . . . 0.0 108.89 179.395 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.583 ' O ' ' CD2' ' A' ' 17' ' ' TYR . 0.4 OUTLIER -91.04 17.55 7.86 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.439 -0.788 . . . . 0.0 109.187 179.744 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -118.96 -25.18 6.32 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.385 -0.822 . . . . 0.0 109.301 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.496 ' O ' ' HB2' ' A' ' 19' ' ' TYR . 0.1 OUTLIER -94.58 -50.48 5.17 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.291 -0.88 . . . . 0.0 109.425 179.951 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.419 ' C ' ' HB2' ' A' ' 19' ' ' TYR . 1.2 tt0 -51.57 -33.46 32.63 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.403 -0.81 . . . . 0.0 109.665 179.917 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.627 ' N ' ' CD1' ' A' ' 17' ' ' TYR . 3.8 m-30 -82.11 -59.8 2.44 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.293 -0.879 . . . . 0.0 109.042 -179.872 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.846 ' O ' HG12 ' A' ' 22' ' ' VAL . 1.0 OUTLIER -49.97 -24.51 2.62 Favored 'General case' 0 C--N 1.306 -1.302 0 N-CA-C 106.48 -1.674 . . . . 0.0 106.48 177.555 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.774 ' O ' HG13 ' A' ' 22' ' ' VAL . 0.1 OUTLIER -60.55 -35.71 76.7 Favored 'General case' 0 N--CA 1.484 1.245 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 178.502 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.422 ' N ' ' O ' ' A' ' 17' ' ' TYR . 30.8 mtp180 -68.56 -27.66 66.27 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.277 -0.89 . . . . 0.0 109.462 -179.696 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 5.7 t -92.13 29.37 1.65 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.283 -0.886 . . . . 0.0 109.336 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.846 HG12 ' O ' ' A' ' 18' ' ' ARG . 0.3 OUTLIER -150.34 -40.61 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.298 -1.644 0 O-C-N 121.609 -0.682 . . . . 0.0 109.229 -178.492 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.741 HD11 ' CD1' ' A' ' 19' ' ' TYR . 2.7 mt -85.22 -56.99 4.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.072 -1.018 . . . . 0.0 108.86 179.492 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.476 ' HG2' ' N ' ' A' ' 25' ' ' ALA . 0.1 OUTLIER -61.56 146.85 47.46 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.21 -0.931 . . . . 0.0 109.195 179.788 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.476 ' N ' ' HG2' ' A' ' 24' ' ' LYS . . . . . . . . 0 N--CA 1.489 1.506 0 CA-C-O 117.943 -1.027 . . . . 0.0 109.482 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.455 ' CG ' ' O ' ' A' ' 1' ' ' MET . 0.1 OUTLIER . . . . . 0 N--CA 1.494 1.762 0 CA-C-O 120.737 0.303 . . . . 0.0 110.219 . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . 0.422 ' O ' ' C ' ' A' ' 3' ' ' GLY . 46.7 Cg_endo -73.21 -11.14 24.88 Favored 'Trans proline' 0 C--N 1.307 -1.65 0 O-C-N 124.062 1.559 . . . . 0.0 110.722 -179.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . 0.422 ' C ' ' O ' ' A' ' 2' ' ' PRO . . . 43.04 56.46 4.52 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.796 -1.322 . . . . 0.0 109.796 179.954 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.1 t -116.22 -32.44 5.32 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.099 -1.236 . . . . 0.0 109.583 179.892 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.43 ' O ' HG12 ' A' ' 9' ' ' ILE . 7.1 mt -70.44 -35.15 60.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.174 -0.954 . . . . 0.0 109.275 179.897 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.47 -27.08 58.71 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.299 -0.875 . . . . 0.0 109.435 179.794 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -65.9 -25.14 67.03 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.269 -0.894 . . . . 0.0 109.382 179.889 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 9.3 t-20 -84.21 -48.65 9.57 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.361 -0.837 . . . . 0.0 109.255 179.768 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.43 HG12 ' O ' ' A' ' 5' ' ' ILE . 37.5 mm -50.03 -38.37 14.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.307 -0.871 . . . . 0.0 108.917 179.719 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 21.7 mt -50.9 -40.81 20.87 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 179.562 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -68.79 -35.72 80.6 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 108.875 -1.69 . . . . 0.0 108.875 179.45 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.477 HG12 ' O ' ' A' ' 12' ' ' VAL . 71.8 t -74.37 -9.96 13.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.345 -1.091 . . . . 0.0 109.225 179.592 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -103.17 -47.31 4.37 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.451 -0.78 . . . . 0.0 109.578 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -54.61 -41.33 69.85 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.184 -0.947 . . . . 0.0 109.652 -179.817 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 2.2 t0 -68.9 -47.51 65.63 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.228 -0.92 . . . . 0.0 109.116 179.915 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.467 ' O ' ' HB2' ' A' ' 19' ' ' TYR . 0.2 OUTLIER -47.53 -31.91 4.8 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.268 -0.895 . . . . 0.0 108.828 179.611 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.575 ' CG ' ' N ' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -71.99 -65.84 0.72 Allowed 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 179.425 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.575 ' N ' ' CG ' ' A' ' 17' ' ' TYR . 5.0 ttp180 -47.04 -26.02 0.95 Allowed 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 179.215 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.738 ' CD2' HD13 ' A' ' 23' ' ' ILE . 1.6 m-85 -66.5 -48.81 68.61 Favored 'General case' 0 C--N 1.302 -1.462 0 CA-C-O 121.242 0.544 . . . . 0.0 109.733 179.713 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -53.87 -18.94 3.79 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.323 -0.861 . . . . 0.0 109.665 -179.741 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 2.4 t -89.14 -19.5 25.43 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.23 -0.919 . . . . 0.0 110.569 -179.42 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.456 ' CG1' ' O ' ' A' ' 18' ' ' ARG . 0.3 OUTLIER -123.13 -8.4 7.95 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.689 0 O-C-N 121.168 -0.958 . . . . 0.0 110.364 -178.133 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.738 HD13 ' CD2' ' A' ' 19' ' ' TYR . 2.5 mp -118.33 -33.24 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 120.923 -1.111 . . . . 0.0 109.923 -179.8 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.424 ' O ' ' HB3' ' A' ' 25' ' ' ALA . 20.4 mmtm -98.04 175.64 6.04 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.217 -0.927 . . . . 0.0 109.492 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.424 ' HB3' ' O ' ' A' ' 24' ' ' LYS . . . . . . . . 0 N--CA 1.489 1.497 0 CA-C-O 117.958 -1.02 . . . . 0.0 109.491 -179.939 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.9 mtt . . . . . 0 N--CA 1.492 1.662 0 CA-C-O 120.787 0.327 . . . . 0.0 110.314 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -74.8 1.06 8.04 Favored 'Trans proline' 0 C--N 1.305 -1.733 0 O-C-N 123.976 1.514 . . . . 0.0 110.453 179.92 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -87.04 132.18 11.01 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.704 -1.359 . . . . 0.0 109.704 -179.924 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 10.7 t -126.14 14.54 7.84 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.28 -1.129 . . . . 0.0 109.498 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.459 ' O ' HG12 ' A' ' 9' ' ' ILE . 12.0 mt -82.6 -29.22 8.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.169 -0.957 . . . . 0.0 109.368 -179.961 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.775 ' O ' HD12 ' A' ' 10' ' ' ILE . 4.8 mttm -83.3 -45.01 14.29 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.243 -0.91 . . . . 0.0 109.421 179.941 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -51.8 -20.56 2.25 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.27 -0.894 . . . . 0.0 109.556 179.886 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 10.8 t-20 -87.41 -42.75 12.6 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.195 -0.941 . . . . 0.0 109.462 -179.86 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.459 HG12 ' O ' ' A' ' 5' ' ' ILE . 17.6 mm -78.12 -38.72 24.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.248 -0.907 . . . . 0.0 109.555 -179.923 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.775 HD12 ' O ' ' A' ' 6' ' ' LYS . 1.1 mp -54.15 -42.2 54.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.107 -0.996 . . . . 0.0 109.001 179.946 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.421 ' HA2' ' HB2' ' A' ' 14' ' ' TYR . . . -59.01 -36.28 87.63 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.296 -1.522 . . . . 0.0 109.296 179.828 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.439 ' HB ' ' O ' ' A' ' 9' ' ' ILE . 24.8 t -58.52 -42.41 84.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.282 -1.128 . . . . 0.0 109.419 179.969 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 8.5 t -85.03 -19.32 32.15 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.168 -0.957 . . . . 0.0 109.521 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.421 ' HB2' ' HA2' ' A' ' 11' ' ' GLY . 1.5 m-85 -78.0 -21.74 50.39 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.268 -0.895 . . . . 0.0 109.362 179.917 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 76.0 m-20 -74.09 -55.8 5.68 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.312 -0.867 . . . . 0.0 109.428 179.917 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.479 ' HA ' ' OE1' ' A' ' 16' ' ' GLU . 0.9 OUTLIER -50.72 -41.27 56.09 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.265 -0.897 . . . . 0.0 109.11 179.949 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.629 ' CG ' ' N ' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -67.11 -62.18 1.56 Allowed 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 179.465 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.629 ' N ' ' CG ' ' A' ' 17' ' ' TYR . 0.3 OUTLIER -51.3 -22.52 2.86 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 179.223 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.673 ' CD2' HD13 ' A' ' 23' ' ' ILE . 3.3 m-85 -85.26 -27.48 25.99 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.762 -0.587 . . . . 0.0 109.77 -179.86 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.29 4.95 13.62 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.251 -0.906 . . . . 0.0 109.634 -179.795 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 4.2 t -111.13 -29.99 7.65 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.137 -0.977 . . . . 0.0 110.68 -179.517 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.484 HG13 ' O ' ' A' ' 18' ' ' ARG . 2.0 m -111.83 -38.35 3.12 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.679 0 O-C-N 121.114 -0.991 . . . . 0.0 110.413 -177.81 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.673 HD13 ' CD2' ' A' ' 19' ' ' TYR . 3.0 mp -84.41 -45.51 17.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.015 -1.053 . . . . 0.0 109.829 -179.478 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 5.6 mttt -117.02 156.44 27.49 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.24 -0.912 . . . . 0.0 109.635 -179.749 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.574 0 CA-C-O 118.021 -0.99 . . . . 0.0 109.502 -179.869 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.433 ' O ' ' CG ' ' A' ' 1' ' ' MET . 1.2 ptm . . . . . 0 N--CA 1.492 1.639 0 CA-C-O 120.688 0.28 . . . . 0.0 110.37 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . 0.461 ' O ' HG22 ' A' ' 4' ' ' THR . 45.9 Cg_endo -73.76 -5.86 17.73 Favored 'Trans proline' 0 C--N 1.304 -1.805 0 O-C-N 123.986 1.519 . . . . 0.0 110.329 179.885 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . 0.536 ' O ' ' CG2' ' A' ' 4' ' ' THR . . . 57.03 -126.39 41.88 Favored Glycine 0 N--CA 1.493 2.439 0 N-CA-C 109.883 -1.287 . . . . 0.0 109.883 179.82 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.536 ' CG2' ' O ' ' A' ' 3' ' ' GLY . 3.3 t 41.2 34.41 0.31 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.546 -0.973 . . . . 0.0 109.295 -179.703 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 2.5 mp -64.85 -16.67 20.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.581 -0.699 . . . . 0.0 109.802 -179.892 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 12.8 tttt -116.42 -30.43 5.89 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.111 -0.993 . . . . 0.0 109.666 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -78.76 -25.44 44.44 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.197 -0.939 . . . . 0.0 109.582 -179.915 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.426 ' HB2' ' OG1' ' A' ' 4' ' ' THR . 0.4 OUTLIER -83.0 -26.62 31.08 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.238 -0.914 . . . . 0.0 109.478 -179.929 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.479 ' O ' ' N ' ' A' ' 12' ' ' VAL . 24.9 mm -86.01 -48.24 16.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.232 -0.918 . . . . 0.0 109.515 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -48.02 -32.16 3.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.288 -0.883 . . . . 0.0 109.117 -179.851 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.451 ' O ' ' OD2' ' A' ' 15' ' ' ASP . . . -75.25 -27.31 64.17 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 108.964 -1.655 . . . . 0.0 108.964 179.547 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.479 ' N ' ' O ' ' A' ' 9' ' ' ILE . 45.9 t -55.54 -27.27 20.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.345 -1.091 . . . . 0.0 109.141 179.808 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -107.55 -4.47 18.33 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.303 -0.873 . . . . 0.0 109.498 179.906 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.449 ' HB2' ' HA2' ' A' ' 11' ' ' GLY . 0.3 OUTLIER -100.08 -21.28 15.65 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.189 -0.944 . . . . 0.0 109.658 -179.834 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.478 ' OD1' ' N ' ' A' ' 16' ' ' GLU . 2.3 p30 -95.32 -44.71 7.46 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.235 -0.916 . . . . 0.0 109.418 179.874 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.478 ' N ' ' OD1' ' A' ' 15' ' ' ASP . 0.1 OUTLIER -56.96 -45.46 82.85 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.173 -0.954 . . . . 0.0 109.103 179.805 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.661 ' CG ' ' N ' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -59.75 -56.77 17.72 Favored 'General case' 0 N--CA 1.487 1.378 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 179.234 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.661 ' N ' ' CG ' ' A' ' 17' ' ' TYR . 0.0 OUTLIER -53.43 -20.88 5.15 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 178.881 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.565 ' HA ' HG13 ' A' ' 22' ' ' VAL . 2.5 m-30 -90.69 -12.91 35.32 Favored 'General case' 0 C--N 1.306 -1.323 0 CA-C-O 121.422 0.63 . . . . 0.0 109.386 179.768 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.454 ' HA ' ' HB2' ' A' ' 24' ' ' LYS . 0.9 OUTLIER -71.76 -31.72 66.94 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.374 -0.829 . . . . 0.0 110.371 -179.208 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 3.1 t -96.17 24.37 5.72 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.031 -1.043 . . . . 0.0 109.796 -179.567 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.567 HG22 HG13 ' A' ' 23' ' ' ILE . 0.2 OUTLIER -149.82 -40.4 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.299 -1.598 0 O-C-N 121.346 -0.846 . . . . 0.0 109.426 -178.889 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.567 HG13 HG22 ' A' ' 22' ' ' VAL . 7.7 mt -109.89 -60.26 2.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.26 -0.9 . . . . 0.0 109.299 -179.886 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.454 ' HB2' ' HA ' ' A' ' 20' ' ' ARG . 5.9 mtpp -85.3 -176.93 6.34 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.242 -0.911 . . . . 0.0 109.333 179.905 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.612 0 CA-C-O 117.961 -1.019 . . . . 0.0 109.504 179.962 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.5 ttt . . . . . 0 N--CA 1.492 1.645 0 CA-C-O 120.813 0.339 . . . . 0.0 110.206 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -79.34 11.55 2.62 Favored 'Trans proline' 0 C--N 1.306 -1.66 0 O-C-N 123.98 1.516 . . . . 0.0 110.817 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -86.92 33.54 3.75 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.797 -1.321 . . . . 0.0 109.797 179.932 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.9 t -84.26 -13.39 52.7 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.209 -1.171 . . . . 0.0 109.255 179.89 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.61 HG23 HG13 ' A' ' 9' ' ' ILE . 33.8 mt -99.01 -19.2 5.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.273 -0.892 . . . . 0.0 109.307 179.889 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.517 ' O ' HD12 ' A' ' 10' ' ' ILE . 0.7 OUTLIER -102.02 18.71 20.02 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.321 -0.862 . . . . 0.0 109.56 179.991 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -136.9 -39.92 0.61 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.106 -0.996 . . . . 0.0 109.563 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 21.5 t-20 -94.52 -53.01 4.06 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.307 -0.87 . . . . 0.0 109.503 -179.863 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.61 HG13 HG23 ' A' ' 5' ' ' ILE . 34.8 mm -55.83 -20.86 9.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.245 -0.91 . . . . 0.0 109.329 179.983 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.517 HD12 ' O ' ' A' ' 6' ' ' LYS . 23.9 mt -68.77 -43.55 82.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.309 -0.869 . . . . 0.0 109.198 179.809 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -65.65 -31.6 80.48 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.358 -1.497 . . . . 0.0 109.358 179.851 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 39.4 t -58.64 -29.02 38.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.262 -1.14 . . . . 0.0 109.448 179.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.577 ' O ' ' CZ ' ' A' ' 17' ' ' TYR . 22.6 m -86.2 -34.07 20.59 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.203 -0.936 . . . . 0.0 109.468 -179.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.593 ' HA ' ' CD2' ' A' ' 17' ' ' TYR . 0.3 OUTLIER -75.76 -27.3 58.0 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.256 -0.902 . . . . 0.0 109.434 -179.996 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.464 ' O ' ' CD1' ' A' ' 19' ' ' TYR . 0.7 OUTLIER -61.55 -45.04 95.83 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.287 -0.883 . . . . 0.0 109.31 179.902 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.412 ' O ' ' HB2' ' A' ' 19' ' ' TYR . 0.0 OUTLIER -60.29 -41.34 93.18 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.254 -0.904 . . . . 0.0 109.377 179.896 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.602 ' N ' ' CD1' ' A' ' 17' ' ' TYR . 1.2 m-30 -67.07 -42.15 85.18 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.273 -0.892 . . . . 0.0 108.943 179.978 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.529 ' O ' ' CG1' ' A' ' 22' ' ' VAL . 0.0 OUTLIER -80.58 7.64 9.59 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 108.62 -0.882 . . . . 0.0 108.62 178.725 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.715 ' CG ' HD13 ' A' ' 23' ' ' ILE . 3.2 m-30 -103.34 -42.62 5.66 Favored 'General case' 0 C--N 1.309 -1.16 0 O-C-N 121.493 -0.754 . . . . 0.0 109.456 -179.577 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 29.1 mtp180 -56.45 -33.81 66.24 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.441 -0.787 . . . . 0.0 110.276 -179.255 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 23.3 t -84.16 12.38 6.59 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.111 -0.993 . . . . 0.0 110.277 -179.35 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.802 HG22 ' N ' ' A' ' 23' ' ' ILE . 0.1 OUTLIER -146.73 -78.55 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.299 -1.601 0 O-C-N 121.184 -0.947 . . . . 0.0 110.094 -178.718 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.802 ' N ' HG22 ' A' ' 22' ' ' VAL . 1.7 mp -44.22 -26.79 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.032 -1.043 . . . . 0.0 109.432 -179.62 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.403 ' N ' ' O ' ' A' ' 22' ' ' VAL . 10.2 mttp -113.85 -88.46 0.55 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.251 -0.906 . . . . 0.0 109.364 179.752 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.611 0 CA-C-O 118.023 -0.989 . . . . 0.0 109.437 -179.983 . . . . . . . . 0 0 . 1 stop_ save_